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Abstract 
The interaction between the Leishmania parasite and the macrophage is a 
bidirectional one of which the outcome of is important for determining if disease 
progresses or regresses. The parasite is able to modulate the host cell at 
epigenetic, transcript and metabolic levels. In the context of the latter, immune 
metabolism is a rapidly growing area of research, and its importance in the 
context of normal immune function and pathology is increasingly being 
recognised. 
In this thesis a robust, untargeted metabolomics protocol has been developed in 
order to profile a classical in vitro model of immune metabolism, the 
inflammatory M1 macrophage. While previous studies use single or multiple M1 
stimuli without dissecting their importance, a combinatorial approach is used 
here to dissect the contribution and interaction of two key M1 stimuli, interferon 
γ (IFNγ) and LPS. An obvious stimulus-specific response is obvious in our data. 
We next used this untargeted metabolomics protocol in parallel with RNAseq to 
examine the cost of hosting a parasite to the macrophages metabolic and 
transcriptional profile. By using a heat-killed control it was possible to 
differentiate between general immune responses and response specific to the 
live parasite. Additionally, a FACS protocol coupled to untargeted metabolomics 
was used in order to focus on the infected cell. Furthermore, the inclusion of 
the above mentioned M1 control revealed that either live or heat-killed 
Leishmania failed to elicit as strong a response. Finally, stable isotope labelled 
metabolomics was used to validate key findings. 
In summary, our untargeted metabolomics protocol has revealed immune-
metabolic perturbations that are induced by IFNγ and LPS or their interaction. 
This information should be considered if targeting these pathways in a 
therapeutic context. Furthermore, by using an integrated metabolic-
transcriptomics profiling approach, perturbations in glycerol-phospholipid 
metabolism, central carbon metabolism and arginine metabolism were found. 
Using stable isotope labelled metabolomics (U13C-Arginine) the current study has 
given unprecedented insight into how the parasite utilises this crucial amino 
acid, as well as confirm novel pathways.  
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1. General Introduction 
1.1. Leishmania species 
1.1.1. Leishmaniasis: pathology and prevalence 
The Leishmaniases are a spectrum of diseases caused by protozoan parasites 
belonging to the genus Leishmania, and is transmitted by sandfly vectors of the 
genus Phlebotomus. While there are over 40 different species of Leishmania, 20 
of these are known to be infectious to man. Depending on the infecting species, 
the parasite causes visceral (VL) or cutaneous (CL) forms of leishmaniasis. 
 CL is the most prevalent form of this disease. It is characterized by chronic 
progression, which affects the skin and cartilaginous structures. The main 
clinical forms of diseases associated with CL are localized cutaneous 
leishmaniasis (LCL), mucocutaneous cutaneous leishmaniasis (MCL), and diffuse 
cutaneous leishmaniasis (DCL). CL characterised by skin ulcers that, in a 
majority of cases, are self-resolving. VL begins with skin ulcers and progresses to 
infection of the liver and spleen while MCL is characterised by ulcers throughout 
the skin, mouth and nose. According to the second World Heath Organisation 
(WHO) report on neglected tropical diseases (NTDs), 1.2 million people are 
currently infected with 20 to 30 thousand of these cases resulting in deaths each 
year (Alvar et al. 2012). The WHO also estimated that a total of about 556 
million people are at risk of VL in VL high-burden countries, and almost 399 
million people are at risk of CL in CL high-burden countries.  
Over 90% of VL cases occur in six countries: Bangladesh, Brazil, Ethiopia, India, 
South Sudan and Sudan. For CL, the majority of cases occur in Afghanistan, 
Algeria, Brazil, Colombia, the Islamic Republic of Iran, Pakistan, Peru, Saudi 
Arabia and the Syrian Arab Republic. In the instance of mucocutaneous 
leishmaniasis, 90% of cases occur in Bolivia, Brazil and Peru. CL can arise from 
anthroponotic transmission mainly in urban areas (Leishmania tropica) or 
zoonotic transmission in more rural areas (Leishmania major). 
Poverty is a major factor in the prevalence of Leishmaniasis according to the 
WHO (WHO 2010). For example, surveillance programs can be inadequate or 
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destroyed during war, medicines are relatively expensive and therefore often 
unaffordable in the countries where they are most needed, or treatment 
protocols may not be optimal or adhered to. The malnutrition of people in poor 
epidemic regions increases the likelihood that infection of VL causing parasites 
will result in a clinical disease. The recent civil war in Syria has led to a 
breakdown in medical services and increased prevalence of (Hayani et al. 2015). 
22,365 cases were reported in 2013 in Aleppo alone. One of the causes of this is 
the fact that since 2002 the government has control over only one part of the 
city. This in combination with the influx of hundreds of thousands of refugees 
has led to an increase in the presence and dissemination CL. 
Human behaviour is important with regards to epidemiology. In areas with 
zoonotic transmission of Leishmaniasis, animals that attract sandflies are kept in 
or in near proximity to human settlements and therefore favour transmission to 
humans. Human migration, often forced in the case of poverty, famine and war 
can increase disease prevalence. This mainly effects anthroponotic transmission 
and is characterised by large outbreaks in densely populated cities, as seen in 
Kabul in the 1990s and early 2000s (Bern et al. 2008). Economically driven 
migration may result in non-immune individuals entering epidemic areas. 
Reasons for migration can include the lack of agricultural land due to increased 
population or drought or lack of jobs (Ramdas 2012). Expansion into tropical 
areas for agricultural land or jobs such as mining not only increases exposure to 
disease but also moves individuals away from established primary health care 
centres.  
Several initiatives have been established with the overall goal of tackling the 
global health burden caused by neglected tropical diseases (NTDs), including 
leishmaniasis. A sustained advocacy campaign culminated in the London 
Declaration, which was launched in January 2012, and supported by a coalition 
of international and philanthropic organizations, together with 14 
pharmaceutical companies (WHO 2012). One of the commitments of the London 
Declaration was control of VL among other NTDs by 2020; the others included 
the elimination or eradication of other NTDs. To meet this aim it was agreed 
that drug access programmes would be sustained and expanded to ensure a 
sufficient supply of drugs and other interventions. Furthermore, it was agreed 
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that funding would be provided for research and development to discover the 
next generation of anti-leishmanial treatments. The publishing of the fourth 
progress report of the London Declaration in 2016 has recorded a 75% reduction 
in the number of cases of VL (UtcNTDs, 2016). In Bangladesh, India and Nepal, 
10,209 cases were reported, the lowest recorded number since the target of 
elimination as a public health problem was launched (UtcNTDs 2016). In Africa, a 
marked decrease in numbers of cases was reported, with no major outbreaks 
occurring (UtcNTDs 2016). 
Despite progress towards disease control there is a dearth of treatments 
available. Of the 850 new therapeutic products approved between 2000 and 
2011, only 4% were indicated for NTDs, despite these diseases accounting for 
11% of the global disease burden (Pedrique et al. 2013). As NTDs are epidemic in 
developing nations there is little or no financial incentive for pharmaceutical 
companies to develop new treatment. To address this, in 2003 the Drugs for 
Neglected Disease initiative (DNDi) was established as a collaborative effort 
between global partners including academic researchers, the public sector and 
the pharmaceutical industry. As of 2015, DNDi has raised €350 million and 
delivered six treatments and by 2023 DNDi aims to deliver 16 to 18 new 
treatments with an estimated total budget of €650 million. Delivered treatments 
include combinations of existing therapies, of which two were developed for VL. 
There are currently seven Leishmania-specific compounds in the DNDi portfolio 
that are at development stages ranging from hit-to lead up to Phase IIa/Proof of 
concept. Two are these are targeted against CL. Such business models are 
critical to ensure the availability and development of safe, cheap and potent 
medicines with a simple administration route. 
1.1.2.  Leishmaniasis an ancient disease  
Accounts of Leishmaniasis have been dated as far back as 700 BC where lesions 
similar to CL were inscribed on tablets from King Ashurbanipal whose empire 
covered large swathes of the Middle East and North Africa (Cox 2002). Some of 
these accounts may have originated from even earlier texts from 1500 to 2500 
BC. In regards to New World CL, anthropomorphic pottery discovered on the 
Peruvian coast from the Mochica and Chimu periods (200 AD to 1100 AD) show 
facial lesions that depict ‘espundia’ (MCL) (Gade 1979).  
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Credit for discovery of the parasites responsible for the Old World CL is 
debatable (Cox 2002). In 1895, David Douglas Cunningham, Surgeon Major of the 
British Indian army, reported observing parasitic organisms in the tissue of a 
specimen of “Delhi boil” without knowing what they were. Peter Borovsky, a 
Russian military surgeon based in Tashkent, examined the aetiology of the 
"oriental sore and in 1898 published the first accurate description of the 
causative agent, and correctly referred it to the protozoa. However, this work 
was not widely disseminated. In 1903, James Wright reported observing round 
bodies, 2-4 µM in diameter from ‘tropical ulcers’ biopsies and proposed them to 
be the causative agent (Wright 1903). These parasites later classified as 
Leishmania tropica. 
The discovery of the parasite (amastigote stage) that causes VL, Leishmania 
donovani, is widely accredited to the Scottish pathologist and army doctor, 
William Leishman (Leishman 1903), and the Irish medical officer Charles Donovan 
(Donovan 1903). Leishman stained infected spleen samples with ‘Leishman’s 
stain’, a methylene blue and eosin mixture while, in parallel and independently, 
Donovan discovered the parasite in the spleens of patients with kala-azar (VL). 
Leishman proposed that the parasites were trypanosomes, found for the first 
time in India. Later the same year Ronald Ross proposed that Leishman-Donovan 
bodies were the intracellular stages of a new parasite, which he named 
Leishmania donovani (Ross 1903). 
In regards to New World CL, in 1911 Brazilian pathologist Gaspar Vianna reported 
that the causative parasites in South America were different to those in Africa 
(L. tropica) and India (L. donovani) leading to the assignment new species, L. 
braziliensis (Lainson 2010). Subsequently, a number of other species unique to 
the New World were described. Sequencing the genomes of Leishmania species 
in combination with phylogenetic techniques have helped aid in categorising the 
various species (Harkins et al. 2016). By carrying out a phylogenomic 
reconstruction using both 200,000 informative sites across the genomes of 
multiple species, and 48 annotated genes, Harkins et al proposed a southern 
super-continental origin and ancient dispersal of the genus. 
The two main sub genera are Leishmania (Old world): L. tropica, L. aethiopica, 
and L. major that predominantly cause LCL and Vianna (New World). However, 
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in the case of New World LCL there are some species that are exceptions. New 
world LCL is mainly caused by species that fit into the Leishmania subgenera 
(L. amazonensis, L. infantum, L. mexicana, and L. venezuelensis) or the Viannia 
subgenera (Leishmania braziliensis, L. guyanensis, L. panamensis, and 
L. peruviana). Interestingly, L. chagasi is not distinct from L. infantum and likely 
represents its New World equivalent. A summary of this diversity is represented 
in Figure 1-1. 
A further compounding factor with attempts to classify Leishmania is that the 
different species can exchange genetic material creating hybrids. Romano et al 
co-infected Lutzomyia longipalpis sandflies with L. major (CL) and L. infantum 
(VL) and obtained eleven full genomic hybrids that displayed differences in their 
ability cause CL or VL in mice (Romano et al. 2014). As these important 
pathological traits seem to be polymorphic within the parental species its may 
be possible to identify them using classical linkage analysis. 
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Figure 1-1: Phylogeny of Leishmania species, including the mainly human-infective 
Leishmania and Vianna.  The clinical forms and geographical location are noted. CL: cutaneous 
leishmaniasis, VL: visceral leishmaniasis, DCL: diffuse cutaneous leishmaniasis, MCL: 
mucocutaneous leishmaniasis. Adapted from Harkin et al (2016). 
1.1.3.  Current diagnosis and treatments: Limitations and future 
To date, there is no vaccine nor is there a single effective treatment for all 
Leishmania species and syndromes. However considerable advances have been 
made in our understanding of both protective and pathological immune 
responses to Leishmania infection. For centuries, live parasites have been used 
for protection in a procedure called leishmanization (Khamesipour et al. 2005). 
Although usually effective, leishmanization was limited by loss of parasite 
virulence, difficulty in standardization and, most importantly, the development 
of non-healing lesions. Additionally, as total parasite clearance does not occur, 
recurrent infections are likely if a patient were to become immune-
compromised. While crude and not without adverse outcomes, its success 
indicated that a vaccine should be possible. While attenuated or killed parasites 
and DNA vaccines have had limited success, it was recently discovered that a 
parasite protein; glycosomal phosphoenolpyruvate carboxykinase provokes an 
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immune-dominant response from CD4+ T cells (Mou et al. 2015). Importantly, it 
is conserved across many different Leishmania parasite. Promisingly, 
immunization with this protein provided significant protection in mice models 
against both CL and VL. 
For VL, diagnosis can include clinical, parasitological, and serological diagnosis 
and these methods have various limitations (WHO 2010). Chronic malaria, 
schistosomiasis or other systemic infections can have similar clinical symptoms. 
In regards to parasitological diagnosis, microscopy has high specificity but low 
sensitivity, and while polymerase chain reaction (PCR) is sensitive, it is currently 
restricted to referral hospitals and research centres. Serological tests based on 
immunofluorescence antibody test (IFAT), enzyme-linked immunosorbent assay 
(ELISA) or western blotting all demonstrate good diagnostic accuracy in most 
studies but require equipment that is ill suited to field settings. Additionally, 
parasite-specific antibodies remain detectable up to several years after cure. 
For CL, the preferred method is parasitological diagnosis; with microscopy 
(Giemsa stained slides) often the only available method at primary, secondary or 
tertiary health care level. In endemic areas and multiplex-PCR is used to 
improve the diagnostic sensitivity as well as to identify the responsible 
Leishmania species. The latter is useful for New World CL where several 
Leishmania species coexist, some with differing clinical outcomes and responses 
to treatment. 
While there is as yet no vaccine, several treatments exist. In 1912, Gaspar 
Vianna described the use of tartar emetic in the treatment of CL though this 
drug was later found to be highly toxic (Nagle et al. 2014). In 1925, Sir 
Upendranath Brahmachari synthesized the less toxic pentavalent antimony 
compound, urea stibamine which was instrumental in saving the lives of millions 
of Indians infected with VL during the 1922 epidemic. Further progress in 
reducing toxicity of antimony therapy of VL followed with the synthesis of 
antimony gluconate (Solustibosan) in 1937 and sodium stibogluconate 
(Pentostam) in 1945. Currently, there are two formulations of pentavalent 
antimonials in use: sodium stibogluconate (100 mg antimony/100 mL) and 
meglumine antimoniate (85 mg antimony/100 mL) (Nagle et al. 2014) (Table 1-
1).These drugs are limited by their cardiotoxicity, relative expense, need for a 
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long, paternally administered treatment and widespread resistance leading to a 
high failure rate. In the Bihar state (where ~90% of VL cases in India occur) more 
than 60% of VL cases were found to be refractory to pentavalent antimonials 
(Bhandari et al. 2012). 
Increased investment in identifying anti-Leishmania compounds has led to 
alternative treatments such as Amphotericin B, Paromomycin, Miltefosine, and 
Pentamidine. There are on-going collaborations between the Drugs for Neglected 
Disease initiative (DNDi), pharmaceutical companies and academia aiming to add 
to the anti-leishmanial repertoire. The access to pharmaceutical compound 
libraries will allow for similar or improved analogues of seed compounds and this 
will aid greatly with lead optimization. 
In 1955, Amphotericin B, an antifungal polyene antibiotic was discovered and 
subsequently it was found that it was effective against VL. Amphotericin B 
increases membrane permeability by binding to ergosterol present in the 
parasite cell membrane. While highly efficacious, Amphotericin B caused 
adverse side affects such as nephrotoxicity and this led to the development of 
the lipid formulation, AmBisome®. In 2011 the WHO negotiated a partnership 
deal with the suppliers Gilead to donate 445,000 vials of AmBisome® over five 
years, which was essential in allowing developing countries access to an 
otherwise unaffordable drug. Currently the WHO recommends a single 
AmBisome® infusion as the first line therapy in epidemic countries. 
Other anti-fungal medicines have also been used such as Ketoconazole, which 
inhibits ergosterol biosynthesis at the lanosterol demethylase step. Additional 
anti-fungal medicines have been found to be anti-leishmanial and these are 
reviewed elsewhere (Nagle et al. 2014). 
Paromomycin is an aminoglycoside broad-spectrum antibiotic that inhibits 
protein synthesis by binding to 16S rRNA in bacteria. It was shown to be 
efficacious for the treatment of VL and CL. Paromomycin is also used in 
ointment form for the local treatment of CL by application to the lesion twice 
daily for 20 days. Other locally applied treatments include intra-lesional 
stibogluconate, “Flash” cryo-therapy or heat-therapy. 
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Miltefosine was originally developed as an anticancer drug but in the 1990s, 
several laboratories discovered that Miltefosine has antileishmanial activity 
(Nagle et al. 2014). It is currently the only orally available treatment for VL and 
CL, which is invaluable as patients can use it in remote areas that lack either the 
resources or facilities for paternal administration. It is limited by the fact that 
treatment times are long (28 days or up to 12 weeks for post-kalazar dermal 
(PKDL)) and common adverse side effects include gastrointestinal side effects 
and nephrotoxicity. Additionally, its teratogenicity and long half-life (1 week) 
means that women of child-bearing age must use contraceptives during 
treatment and for 3 weeks after (Nagle et al. 2014). 
Pentamidine, which has been in use since the 1940s for treatment of sleeping 
sickness, is used both to treat CL via an intra-lesional injection as well as VL 
(Ramdas 2012). Its injection is extremely painful and relatively unaffordable 
($90 for 3 rounds of injections).  This, in combination with limited access to 
treatments, has led to some cultures avoiding CL treatment. Instead, they turn 
to self-‘treatment’ with harsh chemicals such as battery acid and pesticide 
(Ramdas 2012). Increased use of topical Paromomycin should help reduce the 
occurrence of these actions. 
 A single AmBisome infusion is the preferred first line therapy for VL. For CL 
locally applied treatments such as Paromomycin in conjunction with systematic 
stibogluconate are commonly used. Nevertheless there are still different 
treatments\combination of treatments currently used depending on the parasite 
species, the disease form, and the country in question. This is reviewed 
elsewhere (WHO 2010; McGwire & Satoskar 2014). 
The use of immunomodulatory inhibitors and agonists that are already used in 
cancer treatment has been investigated. Drugs that have shown promise are the 
inhibitor of TNF-α; pentoxyphylline, and the anti-viral TLR7 agonist; imiquimod 
(Nagle et al. 2014; Lessa et al. 2001; Miranda-Verastegui et al. 2009). These 
have been used as adjunct therapies to antimonials resulting in shorter 
treatment times. These approaches have great promise and the DNDi’s funding 
of the latter study shows its commitment to this area of research. A summary of 
current treatments and their limitations is presented in Table 1-1. 
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Table 1-1: Current treatments for Leishmaniasis. The available treatments and their 
limitations are listed. These are used to treat cutaneous (CL), visceral (VL), mucocutaneous 
(MCL) and post-kalazar dermal (PKDL) leishmaniasis. Adapted from (Croft & Olliaro 2011). 
 
Treatment Property and route of 
administration 
Disease Treated Limitations 
Pentavalent 
antimonials: 
(sodium 
stibogluconate 
[SSG]) 
And meglumine 
antimoniate 
Organo-metal complexes; 
intravenous and 
intramuscular 
VL, CL, PKDL & 
MCL 
Acquired resistance. Serious cardiotoxicity 
leading to death 
In monotherapy, they require a 30-day 
parenteral treatment 
 
Amphotericin B 
deoxycholate: 
Polyene antibiotic; 
intravenous 
VL, CL, PKDL & 
MCL 
Need for hospitalization, constant renal 
monitoring of patients, 28-day duration of 
treatment, infusion-related adverse events, and 
dose-limiting toxicity. 
AmBisome® Unilamellar liposome; 
intravenous (WHO 
recommends single 
application) 
VL, CL, PKDL and 
MCL 
High cost and the need for a cold chain 
Miltefosine: Hexadecylphosphocholine; 
oral 
VL, CL (3 species), 
PKDL and MCL 
Is expensive and requires 28-day treatment. 
Suffers from low compliance, risk of resistance, 
and its contraindication in pregnancy and 
mandatory contraception for women of 
childbearing age for the duration of therapy 
and three months beyond limits its use.  
Is not registered in many endemic countries and 
consequently not available 
Paromomycin Aminoglycoside, 
intramuscular (VL) or 
topical (CL) 
VL & CL Requires three weeks of painful intramuscular 
administration. Is highly efficacious in Asia but 
is associated with some degree of renal and 
ototoxicity, with limited efficacy as 
monotherapy in East Africa 
Pentamidine Diamidine, intramuscular CL and VL 
(variable) 
Requires intramuscular injection, side effects 
include diabetes mellitus, severe 
hypoglycaemia, shock, myocarditis and renal 
toxicity 
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1.1.4. Sandflies: life cycle in the vector 
In 1921 the Sergent brothers, Edouard and Etienne demonstrated the 
transmission of CL to humans by sandflies of the genus Phlebotomus, and in 1941 
the requirement of the bite was shown (Cox 2002). It was subsequently shown 
the genus Lutzomyia is the vector of CL causing parasites in the New World. 
Comparison studies of L. mexicana and L. braziliensis-infected sandflies led to 
the original classification of Leishmania into two distinct subgenus:  Viannia and 
Leishmania. The former was defined by the presence of a hindgut stage and the 
latter by its absence (Lainson 2010). This introduction will focus on Leishmania, 
to which L. mexicana belongs. Leishmania parasites undergo an obligate 
intracellular stage (amastigote) when inside its mammalian host. This begins 
when an infected female sandfly takes a blood meal; infective metacyclic 
parasites are injected into the host (Figure 1-2). 
Here the parasites are taken up directly by professional phagocytes such as 
macrophages, or by neutrophils, which are in turn phagocytised by macrophages. 
Ultimately the increased temperature and decreased pH of the host cell, causes 
differentiation into the amastigote. The parasites’ complex and dimorphic life 
cycle is completed when an uninfected sandfly feeds. Within the fly, the 
infected host cell lysis, at this lower temperature, the amastigotes differentiate 
into sluggish extracellular, procyclic promastigotes that replicate within the 
blood meal. The following section describes metacyclogenesis, which is the 
transformation of procyclic promastigotes to infective metacyclic promastigotes. 
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Figure 1-2: Life cycle of Leishmania parasite in the fly. 1 & 8: Lifecycle begins when non-
infected female sandfly takes up infected mammalian host cells during blood meal. Lysis in the 
anterior midgut (AMG) releases the amastigote, which differentiate into the replicating procyclic 
promastigote. 2: Differentiation into non-replicating nectomonads migration to and traversal of 
the peritrophic matrix (not shown, located near 1) into the thoracic midgut (TMG). 3: Parasites 
differentiate into replicating leptomonads. 4a: These can differentiate into infectious, non-
replicating metacyclic promastigotes 4b: Either nectomonads or leptomonads (not known which) 
differentiate into haptomonads, which attach to cardiac or stomodeal valve, possible preventing 
its opening (CV/SV). 5: metacyclics can infiltrate the foregut (FG) or are injected into the 
mammalian host. Heavy infection causes the accumulation of promastigote salivary gel (PSG) in 
the TMG. 6: Parasites are taken up either directly via professional phagocytes or first by 
neutrophils, which are in turn phagocytised by macrophages. 7: Metacyclics differentiate into 
the intracellular stage: the amastiogote. Adapted from (Rogers 2012). 
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In order to survive the lytic environment of the fly gut, promastigotes must 
upregulate expression of glycoconjugates. These are a group of phosphoglycans 
either attached to the cell surface via glycosylphospatidylinositol lipid anchors 
(lipophosphoglycans (LPG), and phosphoglycans (PPG) or secreted PPG  (sPPG) 
(Secundino et al. 2010). In Phlebotomus papatasi, the LPG of L. major attaches 
to a midgut epithelial galectin. Expression of the galectin, and specific binding 
to it by LPG is essential in determining species-specific vector competence in 
sandfly species (Kamhawi et al. 2004). LPG binding to galectin also prevents 
parasite clearance by fluid flow in the gut. 
Near the end of blood meal digestion (72-94 hours) procyclics transform into the 
more motile, larger and slender nectomonads (Kamhawi 2006). Nectomonads 
migrate towards the anterior part of the peritrophic matrix (PM). By secreting a 
chitinase, nectomonads can disrupt PM integrity, transverse it, and establish an 
infection at the stomodeal valve and transform into the replicative leptomonads 
(Schlein et al. 1991). (Figure 1-2). Over the next 4-7 days, leptomonads produce 
promastigote secretory gel (PSG), a gel-like matrix that plays a key role in 
transmission by forming a ‘plug’. This prevents parasite clearance and results in 
the enrichment of the subsequent, infective stage metacyclic promastigotes 
(Rogers et al. 2002; Rogers et al. 2004). Metacyclics, which are highly motile, 
express a modified non-attaching LPG that allows anterior migration in response 
to a chemotactic cue, and subsequent transmission (Rogers et al. 2002; Kamhawi 
2006). In the host, this modified LPG aids in resisting and/or avoiding host 
immune responses 
To replicate some of the life stages mentioned above in vitro, parasites are 
seeded at low cell density (1-5x105/mL). This results in rapidly dividing procyclic 
promastigotes that proliferate to a high density, where they undergo growth 
arrest and differentiation into the virulent, stationary metacyclic stage. For 
species such as L. major and L. infantum it was shown that their metacyclic 
forms can be enriched using agglutination by the lectin peanut agglutinin (PNA) 
which negatively selects metacyclics (R. da Silva & Sacks 1987). This study by 
da Silva and Sacks also showed there is a loss of virulence caused by serial 
passage, an important consideration for in vivo studies. 
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There is another subpopulation derived from either nectomonads or leptomonads 
that are named haptomonads. These attach to the cuticle-lined surface of the 
stomodeal valve (SV) via the expansion of the flagellar tip into hemi-desmosome-
like structures, preventing its opening (Kamhawi 2006). In heavily infected 
sandflies, the SV degenerates and a few metacyclics migrate into the foregut. 
The ‘blocked’ fly attempts to feed multiple times, eventually regurgitating the 
metacyclic-rich ‘plug’, and this altered feeding pattern may enhance 
transmission (Figure 1-2) (Stierhof et al. 1999). 
1.2. Host-pathogen interactions: a multifaceted 
relationship 
The interaction between Leishmania parasites and the immune system involves 
both the innate and adaptive arms. The fly delivers approximately 600 
metacyclic parasites during feeding (Kimblin et al. 2008). These parasites are 
first subjected to the host complement system, as well as professional 
phagocytes such as dendritic cells (DC) or macrophages. In addition, in the fly, 
metacyclics secrete PSG, which is regurgitated by the biting fly. This has been 
shown to recruit macrophages to the site of the bite (Rogers et al. 2009). During 
metacyclogenesis, the parasites upregulate expression of the GPI-anchored 
metalloprotease (gp63) and lipophosphoglycan (LPG). While procyclic 
promastigotes have a high abundance of LPG to permit binding to the sandfly 
midgut, in metacyclic promastigotes it is elongated by the addition of 
phosphorylated disaccharide repeat unit. This modification gives protection to 
complement mediated lysis (Puentes et al. 1990).  
Once phagocytosed by the macrophage the parasite must differentiate into its 
obligate intracellular form: the amastigote. The differentiation to this form is 
driven by both the higher temperature of the host and the lysosome-driven 
acidification of the parasitophorous vacuole (Alexander et al. 1999). The 
subsequent replication of amastigotes can lead to lesion development and in the 
case of visceral leishmaniasis, dissemination to internal organs such as the liver 
and spleen. In mouse models, the immune response of the host is critical to if 
and to what extent these latter events occur, and thus determine how the 
disease progresses. 
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1.2.1.  Animal models of Leishmaniasis:  a brief history 
Using in vitro or in vivo models of the immune response to Leishmania species 
has revealed a great deal about the roles of different immune cells but it is 
important to note that the results of these studies can, and are impacted on by 
the species/strain of parasite, and/or the species/strain of animal used. For a 
review of the different mice models currently used to study leishmaniasis see 
(Loeuillet et al. 2016). Despite these limitations, the detailed insight these 
models give into the complex immune responses in disease resolution and 
disease progression is invaluable. By identifying appropriate and inappropriate 
responses it will be possible to target pathological immune responses with 
chemotherapy.  
Animal models have a long history in Leishmaniasis research dating back to the 
early 1900s when Charles Nicolle obtained cultures in Novy and McNeal's medium 
(NNN medium) medium of L. tropica, which is the parasitic agent of cutaneous 
leishmaniasis and went on to transmit the dermatosis to monkeys and dogs (Pelis 
2006). A key milestone in modelling host pathogen immunity was discovery of L 
major-resistant and -susceptible mouse strains (Kellina 1973). This allowed the 
investigation and modelling of immune responses that drive disease progression 
or resolution. Further work revealed the requirement of suppressor T cells in 
regulating susceptibility in BALB/c mice (Howard 1980).  
1.2.2. Discovery of the Th1/Th2 paradigm: pioneered by 
Leishmania research 
Experimental leishmaniasis was the first model that directly demonstrated the 
relevance of the T helper 1/T helper 2 (Th1/ Th2) dichotomy for the outcome of 
an infectious disease in vivo (Heinzel et al. 1989). Here it was found that IFNγ 
and IL-4 were produced reciprocally in resolving or progressive infection in 
murine leishmaniasis. Furthermore, by administering a neutralising IL-4 
antibody, the requirement of this cytokine for disease progression became 
apparent. IL-12 was shown to be essential for the development of protective 
CD4+ Th1 cells, as determined by antibody treatments (Heinzel et al. 1993). 
Timing of the response seems to be important in the context of IL-12 (Sacks & 
Noben-Trauth 2002). In studies where anti-IL-12 antibody treatment was used to 
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exacerbate the Th2 mediated disease in susceptible BALB/c mice, the greatest 
effect was observed when administration was delayed until seven days after 
infection. This was in agreement with studies of IL-12-deficient C57BL/6 mice 
subjected to a low-dose challenge, where parasite growth was identical to that 
in wild-type mice during the first 4-5 weeks (Belkaid et al. 2000).  
C57BL/6, C3H or CBA have been used as a model of the self-resolving type of 
disease while Balb/c mice have been used as a model to study the progressive 
form. There are exceptions in that C57BL/6 mice are susceptible to L. mexicana 
and L. amazonensis (Sousa et al. 2014; Hurrell et al. 2015). Thus resistance and 
susceptibility here is not strictly associated with the Th1 vs. Th2 immune 
response paradigm. Nevertheless, C57BL/6 mice, which are resistant to L. major 
infection, become susceptible when they are deficient in draining lymph nodes 
(Ehrchen et al. 2008). The net result here demonstrated that the inability to 
develop a Th1 response is important for disease progression. 
 
1.3.  The immune Response: the components 
1.3.1.  Site of the bite; the early immune response 
Transmission is initiated when an infected female sandfly takes a blood meal. 
The bite wounds the local microvasculature, creating a hemorrhagic pool from 
which to feed. The epidermis is mainly composed up of keratinocytes. The 
dermis, which is connected to epidermis via the basal membrane, is primarily 
formed by fibroblasts and extracellular tissue and is vascularized with both 
blood and lymphatic vessels. The damage response of keratinocytes at the local 
microenvironment of the bite has been found to be important in the context of 
the resistance of C57BL/6 mice to L. major (Ehrchen et al. 2010). Here the 
authors analysed gene expression at infected epidermis and found that IL-1β, IL-
12, osteopontin (opn), IL-4 and IL-6 were more strongly produced in the skin of 
resistant mice. Keratinocytes also produced CXCL2, which leads to the 
recruitment of neutrophils as well as opn, CCL2, and CCL5, which drive 
macrophage recruitment (Figure 1-3).  Expression of these genes was temporally 
restricted to the crucial time of Th1/2 differentiation (Ehrchen et al. 2010). 
Furthermore, either using mice with keratinocytes deficient in IL-6 or the early, 
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local neutralisation of IL-4, both led to a Th2 switch, and worse disease 
outcome, demonstrating the importance of epidermal cells to disease control 
(Ehrchen et al. 2010). 
The contribution of fly specific factors to disease outcome is of interest, 
specifically, their immunogenicity. It has been found that rhesus macaques 
exposed to non-infected Phlebotomus duboscqi sandfly bites or immunized with 
salivary protein PdSP15 were protected against cutaneous leishmaniasis 
(L. major) initiated by the bite of infected flies (Oliveira et al. 2015). This 
protection resulted in reduced parasite and disease burden and correlated with 
the early appearance of Leishmania-specific CD4+ IFNγ + lymphocytes. In a 
separate study, a correlation was found between the presence of antibodies 
against the salivary protein PpSP32 from Phlebotomus papatasi and reduced 
disease severity (Mondragon-Shem et al. 2015). 
In addition to vector specific factors, it has emerged that parasite-synthesised 
factors formed in the fly and injected alongside the parasite, can impede 
immune cell function (Rogers et al. 2009). The use of models of fly transmission 
of Leishmania has shown that the flies regurgitate a proteophosphoglycan gel 
synthesized by the parasites. This substance termed promastigote secretory gel 
(PSG), occludes the anterior midgut of the sandfly preventing parasite clearance 
(Rogers et al. 2004). It has been found to be present in all Leishmania-sandfly 
combinations studied to date. Rogers et al showed that this gel enhances 
infection in the context of L. mexicana (Rogers et al. 2009). The authors showed 
that PSG caused the early recruitment of macrophages to the site of infection 
(Figure 1-3). Additionally, PSG drove the macrophages to an alternative 
activation state by increasing host cell arginase activity. 
In the case of L. major infected C57BL/6 mice, it as found that, within 30 
minutes for infection there is a massive neutrophil extravasation from 
vasculature. This occurred in a directed manner to the inoculation site (Peters 
et al. 2008a). Here the authors used two-photon intravital microscopy (2P-IVM) 
to study the events that occur during infection. They also reported that the 
influx of neutrophils was independent of the infection state of the fly. This 
seems to preclude the involvement of a parasite specific factor in the context of 
neutrophil recruitment. However, it has been shown that the combination of 
Chapter 1  34 
 
saliva from Lutzomyia longipalpis and Leishmania chagasi parasites enhances the 
CCL2-dependent recruitment of macrophages and neutrophils in susceptible 
BALB/c mice, but not in resistant C57BL/6 mice (Teixeira et al. 2005). This could 
be due to differences in engaging adaptive immune responses or different 
recruitment of innate immune cells (Sousa et al. 2014). 
1.3.2.  The complement system: an instant response 
Once the parasites come in contact with host blood, they immediately encounter 
the complement system (Figure 1-3).  The three main complement-activating 
pathways are the Classical, Lectin and Alternative pathways. The net result of 
these pathways is the formation of the C3 convertases, which cleave C3 into C3b 
and C3a. These products combine to form the C5 convertase that cleaves C5, 
generating the C5a chemotactic factor and C5b. Subsequently C5b, C6, C7, C8 
and C9 combine, resulting in the formation of the C5b-C9 membrane attack 
complex (MAC) (Peitsch & Tschopp 1991). This results in a pore like structure 
that causes lysis of the target cell. The lectin pathway is activated when 
mannose-binding lectin (MBL) binds to mannose on the pathogen surface and in 
the alternative pathway; C3 in the plasma interacts with the pathogens surface. 
Additional functions include inducing inflammation due to the generation of the 
potent pro-inflammatory anaphylatoxins C3a, C4a, and C5a that interact with 
macrophages and DCs. Finally, the opsonisation and clearance of opsonized 
pathogens is mediated by C4b, C3b, and C3bi that bind to complement receptors 
(CR1 and CR3) on phagocytic cells. In studies that used non-immune human 
serum (NHS) and depleting classical pathway activators is was reported that 
majority of Leishmania species such as L. major and L. mexicana activate the 
alternative complement pathway while in contrast, L. donovani appears to 
activate the classical pathway (Mosser et al. 1986). Studies using whole human 
blood or containing physiological concentrations of serum have revealed 
however, that opsonisation occurs rapidly against L. major, L. amazonensis, 
L. donovani and L. infantum (Domínguez et al. 2003). Thus it seems that there 
are multiple complement pathways that are engaged by Leishmania species, and 
the extent of which, depends on parasites life-phase and additional host factors.  
Leishmania parasites have developed numerous strategies to evade the 
complement system, including the zinc-dependent metalloproteinase gp63 and 
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lipophosphoglycan (LPG), which are among the most abundant surface 
molecules. When compared to promastigotes. L. major metacyclics are more 
resistant to MAC mediated lysis and this resistance has been attributed to an 
elongation modification of LPG (Figure 1-3) (Puentes et al. 1990). It has also 
been shown that gp63 hinders MAC formation by accelerating the conversion of 
C3b to iC3b (Figure 1-3) (Brittingham et al. 1995). Here the authors used a 
gp63-deficient clone of L. amazonensis that were transfected with constructs 
encoding either proteolytically active or inactive gp63 from L. major. Cells 
expressing the wild type gp63 rapidly converted C3b to iC3b and these iC3b-
coated parasites were found to interact strongly with CR3. This led to authors to 
propose that the parasites exploit the opsonic properties of complement while 
avoiding its lytic effects. 
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Figure 1-3: Early events at the site of the bite. The fly creates a hemorrogic pool during 
feeding, damaging skin cells including keratinocytes in the process. 1: the parasites avoids the 
complement system by LPG preventing membrane attack complex (MAC) binding and gp63 
cleaving C3b into inactive iC3b. Red lines refer to the parasite inhibiting/diverting the anti-
parasitic complement response (green lines). 2a: damaged keratinocytes release cytokines that 
interferes in the inflammatory response. 2b: PSG injected alongside parasites cause macrophage 
recruitment and interferes in function. 3a: CCL3 and 4 recruit neutrophils. 3b: Parasites cause 
selectin CD68L (rolling) to be down regulated and integrin CD18 to be upregulated to allow 
neutrophil migration. 4a: Neutrophil secretion of DNA (NETosis) can have positive or negative 
effects depending on parasite species. 4b: Neutrophils may provide silent entry into 
macrophages with parasites either inside (‘Trojan horse’) or along alongside (‘Trojan rabbit’) 
neutrophils. 4c: Apoptotic infected neutrophils can down regulate inflammatory DC responses. 
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1.3.3. Neutrophils 
While macrophages, the definitive host cell, can phagocytise parasites directly, 
the tissue damage induced by insect biting results in a massive influx of 
neutrophils while the increased influx of macrophages occurs 2 days later. These 
poly-nucleated granulocytes are short-lived but upon infection their lifespan can 
be increased from ~6-10 hours to a few days. In order to exit blood circulation, 
they down regulate the selectin CD68L that is responsible for cell rolling, and 
upregulate the integrin CD18 that allows for transmigration (Figure 1-3) (Falcão 
et al. 2015). In the case of L. major, the parasites have been reported to delay 
apoptosis in human blood derived neutrophils by inhibiting the processing of 
procaspases in the infected cells, similar to what has been reported for 
toxoplasma (Aga et al. 2002). This was not found to be the case of L. major 
infected murine dermal neutrophils so cell type specific factors may be 
important (Ribeiro-Gomes et al. 2012).  
Some species of parasites have been observed to avoid neutrophil killing 
mechanisms. L. donovani parasites for example, prevent lysosome fusion with 
the phagosome in a lipophosphoglycan (LPG, on the promastigotes surface) 
dependant manner (Gueirard et al. 2007). It has been proposed that neutrophils 
serve as a transient host and it has been reported that infected apoptotic 
neutrophils are phagocytised by macrophages that are recruited by the 
chemokine CCL3 and CCL4 (van Zandbergen et al. 2004). Furthermore, 
phagocytosis of the apoptotic neutrophil caused an increase in macrophage 
produced anti-inflammatory cytokine TGFβ, which interferes with appropriate 
inflammatory parasite responses. This method of invasion that allows silent 
entry into the macrophage has been termed ‘Trojan horse’. 
In contrast to the rapid motility reported for mosquito-transmitted Plasmodium 
sporozoites, which appear to actively seek out blood vessels; L. major parasites 
are relatively immobile, so it has been hypothesised that neutrophils can 
retrieve parasites from sites that professional phagocytes can’t access (Peters et 
al. 2008a). In this study, neutrophils were found to phagocytise the parasites 
efficiently with the parasites remaining viable. When these infected neutrophils 
or parasites were injected into naïve mice, equivalent infections were 
established. Furthermore, the authors observed that parasites were being 
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released from apoptotic neutrophils prior to being phagocytised, while the 
authors found no evidence, however for uptake of intact, infected neutrophils by 
macrophages. This result has led to the proposal of the ‘Trojan rabbit’ scenario 
where extracellular parasites alongside apoptotic neutrophils are phagocytised 
by macrophages (Figure 1-3) (Ritter et al. 2009). As for a role in infection, when 
Peters et al depleted neutrophils using a monoclonal antibodys (mAbs), a 
decrease in parasite burden was observed.  
There have been conflicting results from studies examining the role of 
neutrophils with regards to L. major infection. A possible source of variation in 
studies investigating neutrophils role in leishmaniasis are the mAbs that have 
been used (Charmoy, Auderset, et al. 2010). RB6-8C5 depletes not only 
neutrophils but also affect other cells such as monocyte-derived macrophages, 
eosinophils, dendritic cells, and subpopulations of lymphocytes and monocytes. 
Other available mABs such as NIMP-R14 and 1A8 are more neutrophil specific. 
Thus studies where RB6-8C5 was used are difficult to interpret as other 
important leukocytes may have been depleted. 
L. braziliensis triggers neutrophil activation resulting in reactive oxygen species 
generation, release of TNF-α and neutrophil elastase, and finally, neutrophil 
apoptosis (Figure 1-3) (Falcão et al. 2015). Interestingly the closely related 
species L. amazonensis are not as efficiently phagocytised as L. braziliensis, are 
not as potent at activating neutrophils and are more resistant to the neutrophils 
microbicidal mechanisms (Carlsen et al. 2015). However, depletion of 
neutrophils prior to infection with L. amazonensis increased parasite burden in 
Balb/c but not C57BL/6 mice (Sousa et al. 2014). Furthermore, in contrast to 
L. major, L. amazonensis caused a greater recruitment of neutrophils than in 
PBS infected mice. 
With regards to L. mexicana, neutrophils have recently been shown to have a 
negative role in disease development (Hurrell et al. 2015). Using 2P-IVM in 
conjunction with Balb/c or C57BL/6 mice with neutrophils depleted with 
mAB 1A8, the authors observed that the absence of neutrophils led to lesion 
control. In addition the authors corroborated this finding by using genista mice, 
which lack mature neutrophils. The authors also demonstrated that L. mexicana 
induced neutrophils to form extracellular traps (NETs). These are DNA structures 
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coated with antimicrobial molecules and in the case of L. mexicana, had no 
impact on parasite survival (for review on role of NETs see (Hurrell et al. 2016). 
In the absence of neutrophils, parasites were found in monocytes, dendritic cells 
and macrophages and this was due to restored expression of monocyte specific 
chemokines such as CCL2. The authors next examined T-cell functions in the 
dermal lymph node. In the absence of neutrophils, the authors reported an 
increase in the levels of Th1 cytokines IFNγ and TNFα with no change in Th2 
cytokines (IL-4 and IL-13). This led to the to proposal that in the context of 
L. mexicana, neutrophils provide temporary respite from dendritic cells and 
macrophages, and induce the development of a protective immune response 
that favours L. mexicana infection. Interestingly, even though L. amazonensis 
and L. mexicana both cause non-healing lesions in C57BL/6, only L. amazonensis 
are killed by NETs so there seems to be differences even between these closely 
related new world species (Guimarães-Costa et al. 2009; Hurrell et al. 2016). 
The role of human neutrophils in the context of patients with cutaneous 
leishmaniasis (CL) caused by L. braziliensis has been investigated (Conceição et 
al. 2016). Here the authors used in vitro infection with L. braziliensis to 
examine differences in response of CL patient and health subjects neutrophils.  
CL patient neutrophils produced more ROS and higher levels of CXCL8 and 
CXCL9, which reflects an increased capacity to recruit T cells. These differences 
did not lead to parasite control they were not more proficient in phagocytosis or 
in being activated. Additionally, during infection any activation also occurred to 
an equal extent in bystander (non-infected) neutrophils. (Figure 1-5). A 
summary of the recent studies examining the role of neutrophils in Leishmania 
infection is presented in Table 3 (Adapted and updated from (Ritter et al. 
2009)). 
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Table 1-2: Summary of studies examining the roles of neutrophils in Leishmania infection.  
Species and sub-strain of parasites used, neutrophil depleting antibody, mouse breed or human 
samples are specifies. Note that NIMP-R14 can deplete cells other than neutrophils. Updated 
from (Ritter et al. 2009). 
Strain In vitro/in vivo Model Result Ref 
L. major LV 39 
(MRHO/Sv/59/P) 
BALB/c, 3x106 stationary 
promastigotes, SC 
Depletion of 
neutrophils by 
NIMP-R14  
Hampered the development of 
a Th2 response. Disease 
course is improved.  
(Tacchini-Cottier 
et al. 2000) C57BL/6, 3x106 
stationary 
promastigotes, SC 
Does not affect the 
development of a Th1 
response or disease course 
L. major 
(MHOM/IL/80/Friedlin) 
C57BL/6, exposition to 
infected sandflies 
Depletion of 
neutrophils by 
RB6-8C5 
Decreases the parasite burden 
at the infection site (4 weeks 
p.i.). 
(Peters et al. 
2008a)  
L. major 
(MHOM/IL/81/FE/BNI) 
Highly purified non-
stimulated neutrophils 
infected with stationary 
promastigotes 
Trojan horse 
model with human 
primary 
macrophages  
Leishmanial transfer to 
macrophages induces 
amastigote development and 
TGF-ß production  
(van Zandbergen 
et al. 2004) 
L. major Friedlin strain 
FV1 (MHOM/IL/80/FN) 
C57BL/6 and B6.SJL 
congenic mice, and 
RAG1-deficient OT-II 
CD4+ TCR transgenic 
mice 
Depletion of 
neutrophils by 
RB6-8C5 or 1A8 
mAb 
Infected neutrophils are 
phagocytised by dendritic cells 
inhibiting their activation and 
subsequent priming of L. 
major specific CD4+ T cells 
(Ribeiro-Gomes et 
al. 2012) 
L. donovani 
(MHOM/SD/00/1S-2D) 
and lpg1-/- and lpg2 -/- 
mutants 
Purified dog neutrophils 
or RB6-8C5 sorted 
C57BL/6 neutrophils 
both infected with 
stationary promastigotes  
Trojan horse 
model with murine 
macrophages  
LPG-dependent survival in 
C57BL/6 neutrophils enables 
silent transfer to murine 
macrophages  
(Gueirard et al. 
2007) 
L. amazonensis (strain 
RAT/BA/74/LV78) 
 C57BL/6, 3x106 axenic 
amastigotes 
  
Neutrophils better 
internalized. L. braziliensis 
amastigotes, L. braziliensis 
infection was a much more 
potent trigger for neutrophil 
activation. Neutrophils were 
able to kill L. braziliensis 
amastigotes, while L. 
amazonensis amastigotes, 
were highly resistant to this. 
(Carlsen et al. 
2015) L. braziliensis (strain 
LC1418) 
 C57BL/6, axenic 
amastigotes (3: And 5:1 
MOI) 
L. amazonensis 
(IFLA/BR/67/PH8) 
 C57BL/6, 1X106 
amastigotes, IV 
Depletion of 
neutrophils by 
RB6-8C5 or 1A8 
mAb 
No influence on disease 
course. 
(Sousa et al. 2014) 
BALB/c, 1X106 
amastigotes, IV  
Increased parasite burden at 
infection site. 
L. braziliensis 
(MHOM/BR/01/BA788) BALB/c mice stationary 
phase promastigotes  
(2:1 and 5:1 MOI) 
  
Only neutrophils infected with 
L. braziliensis become 
activated and displayed 
markers of early apoptosis 
(Falcão et al. 
2015) L. major 
(WHOM/IL/80/Friedlin) 
L. mexicana 
(MYNC/BZ/62/M379) 
C57BL/6 Depletion of 
neutrophils by 1A8 
mAb or use of 
neutropenic 
genista mice 
Neutrophil depletion leads to 
control of lesion development, 
increased recruitment of 
monocytes and dendritic cells 
and early control of parasites (Hurrell et al. 
2015) 
 BALB/c As above 
Neutropenic Genista 
mice As above 
L. braziliensis 
(MHOM/BR/LTCP11245) 
Neutrophils isolated 
from CL patients and 
healthy individuals 
In vitro infection 
(5:1 MOI) 
CL neutrophils are more 
inflammatory producing higher 
ROS, CXCL8 and CXCL9. No 
observed difference in ability 
to phagocytise or con control 
parasite levels 
(Conceição et al. 
2016) 
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1.3.4. Macrophages: hosting the intracellular parasite stage 
In order for the parasite to undergo its obligate intracellular stage, Leishmania 
parasites need to be phagocytised by residential macrophages or macrophages 
derived from recruited monocytes (bone marrow derived macrophages: BMDM or 
MΦ). It is important to note that monocytes can act as effector cells as has been 
reported in the case where platelet activation attracts pro-inflammatory 
effector monocytes to sites of Leishmania major infection (Goncalves et al. 
2011). While pro-inflammatory monocytes exhibit a strong respiratory burst upon 
infection, leading to early parasite control, macrophages need to be activated 
by IFNγ first to kill the parasites.  
Common to all model infections examined to date is a PSG, which causes 
recruitment of macrophages (Rogers et al. 2009). Additionally, PSG causes the 
macrophage to upregulate arginase, which is a marker of alternatively activated 
macrophages. Macrophage activation can be described as a spectrum that at one 
extreme has ‘Classically activated’ or pro-inflammatory M1 macrophages and on 
the other extreme has the ‘Alternatively activated’ or anti-inflammatory M2 
macrophages. A range of receptors including complement receptors (CR1 and 
CR3), mannose receptors (MR), fibronectin receptors and FcRγ receptors are 
responsible for pathogen uptake. The roles of different receptors in phagocytosis 
of Leishmania parasites is comprehensibly reviewed by (Shweash et al. 2011). 
1.3.4.1. M1 macrophages  
These cells have a role in the resistance against pathogens and tumours. Models 
of M1 macrophages include murine macrophages activated by a toll like receptor 
(TLR) agonist (e.g. Lipopolysaccharides (LPS)) or certain cytokines 
(TNFα/GM-CSF). Additionally, one of these stimuli, in combination with either 
prior or simultaneous IFNγ priming leads to a more pro-inflammatory M1 
polarisation. M1 macrophages produce various pro-inflammatory cytokines 
including IL-1β, IL-6, IL-12, TNFα and IFNγ as well as chemokines and growth 
factors. If IFNγ is used as a stimulus, these macrophages substantially upregulate 
surface MHC II (major histocompatibility complex class II) and produce nitric 
oxide via inducible nitric oxide synthase (iNOS). 
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1.3.4.2. M2 macrophages  
Differentiation of macrophages into an M2 phenotype is driven by cytokines such 
as IL-4, which results in the up-regulation of CD206 (a MR) and galactose-type C-
type lectin CD301 (Raes et al. 2005). The up-regulation of the arginase gene 
(Arg1) is a prototypical marker for murine macrophage alternative activation and 
in the context of Leishmania parasites; this diverts arginine away from iNOS and 
generates polyamines beneficial to parasite (Rogers et al. 2009). Additionally, 
IL-4 activation of macrophages directly suppresses the hallmarks of M1 
macrophage activity, acting to inhibit both the respiratory burst (Abramson & 
Gallin 1990) and the production of pro-inflammatory cytokines (Levings & 
Schrader 1999).  
1.3.4.3. Macrophage effector functions and evasion of these by the parasite 
As previously mentioned gp63 favours the opsonic recognition of metacyclic 
promastigotes by macrophage by cleaving complement component C3b into its 
inactive form iC3b (Brittingham et al. 1995).  Differentiation to metacyclic 
parasites results in the doubling of the phosphorylated disaccharide backbone 
repeats and addition of terminal arabinose to LPG oligosaccharide. This aids the 
parasite to bypass a broad-range pattern recognition receptors such as MR. 
Structural differences in LPG exist, with L. major LPG having a highly substituted 
nature (Pimenta et al. 1994). Species-specific differences in abundance of LPG 
and gp63 will also impact on host cell association. Additionally, the phase of the 
parasite’s lifecycle is important for route of uptake. This is the case for lesion-
derived amastigotes of L. mexicana, that have a paucity of LPG and gp63, and 
here uptake is regulated by FcRII-B2 (receptor Fc-domain of immunoglobulins) 
(Peters et al. 1995b). 
Once within the phagosome of the macrophage, the parasites have to deal with 
oxidative stress. Early during phagosome formation NADPH oxidase is recruited, 
resulting in the generation of reactive oxygen species (ROS). L. donovani prevent 
this in a LPG dependant manner, as LPG deficient mutants were unable do so 
(Lodge et al. 2006). Whether this is the case for L. mexicana has not been 
investigated due to metacyclics of this species having relatively low levels of 
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LPG. Other factors such as calnexin and SNAREs are recruited from the 
endoplasmic reticulum and are essential for phagosome development. 
 A key step in phagosome maturation is acidification caused by lysosome fusion 
leading to the formation of the parasitophorous vacuole (PV). Lysosomes are 
hydrolase rich organelles that can sustain a low pH via a proton-ATPase 
(Figure 1-4 (B)). LPG inhibits this process in the case of L. donovani (Vinet et al. 
2009). Here LPG excluded the exocytosis regulator Synaptotagmin (Syt) from the 
phagosome, which in turn, prevented the recruitment of the proton-ATPase and 
hydrolase cathepsin D. 
 
Figure 1-4: (A) Phagocytosis of metacyclic parasite.  
 1: Phagocytosis is mediate by a variety of surface receptors, 2: Endosome is formed the 
recruitment of NADPH oxidase occurs at this point, 3: vesicles from endoplasmic reticulum 
shuffle SNAREs and calnexin to the endosome while lysosomes, which originate from the Golgi, 
fuse and cause acidification. This decrease in pH as well as changed temperature drives 
differentiation of metacyclic into amastigote form. Depending on host-pathogen interactions 
there can either be, 4a: parasite control mediated by iNOS or, 4b: parasite proliferation driven 
by Arginase. (B) Parasite manipulation of host. Lysosomes are acid vesicles that contain acid 
hydrolases and proteases and amino acids (aa). The lysosome’s pH is maintained by a proton 
ATPase and a chloride antiporter. Additionally, mTORC1 acts as an aa sensor that activates 
inflammatory pathways during infection. Other than inhibiting NADPH oxidase recruitment to 
phagosome and delaying lysosome fusion, Leishmania parasites have been shown to 1: secrete 
gp63 protease to cleave mTORC1, 2: upregulate IL-10, which inhibits mTORC1, 3: upregulate IL-
4, IL-12 and TGF-ß resulting in increased Arginase activity, 4: down regulate iNOS activity either 
via gp63 or LPG. 
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 After the completion of phagocytosis, the main effector function of 
macrophages is inducible nitric oxide synthase (iNOS) (Figure 1-4, 1-5)(Wang et 
al. 2009a). Using arginine as a substrate, iNOS generates reactive nitrogen 
species (RNS) including nitric oxide (NO) and citrulline as a by-product. ROS can 
combine with NO to generate peroxynitrite (ONO2-). NO can diffuse across cell 
membranes, it can mediate parasite killing in both immune cells with iNOS 
activity and bystander cells (Olekhnovitch et al. 2014). Olekhnovitch et al found 
that protection was associated with the total levels of NO produced and was not 
cell extrinsic. The authors demonstrated this by setting up infected cultures 
where iNOS expressing cells made up a small fraction, they were infected as 
readily as iNOS negative cells. When the fraction was increased, all cells were 
equally protected. 
LPG from L. major has been found to inhibit iNOS upregulation (Proudfoot et al. 
1996). In contrast to this, L. mexicana promastigotes activate MAP kinase 
signalling through a TLR-4 dependent mechanism to prolong COX-2 and iNOS 
expression, and enhance PGE2 and NO production (Shweash et al. 2011). 
Interestingly, these effects were required for the parasites upregulation of host 
Arg1 as well as the inhibition of IL-12 upregulation. The role of NO in humans is 
less clear. In the case of L. chagasi, as NO could not be measured in human cell 
cultures but iNOS inhibitor still abrogated IFNγ mediated parasite clearance 
(Gantt et al. 2001). Thus there is mixed evidence on the role of NO in humans. 
L. mexicana amastigotes have been shown to inhibit LPS induced IL-12 
production via a cysteine peptidase B (CPB) mediated degradation of the NF-κB 
pathway (Cameron et al. 2004). Leishmania also utilise a CPB-positively 
regulated metalloprotease gp63, which is abundantly expressed on the cell 
surface of promastigotes (Casgrain et al. 2016). The protease GP63 has 
numerous host targets that are critical for the hosts pro-inflammatory response 
including NF-κB and mTORC1 (Gregory et al. 2008; Halle et al. 2009). The result 
of NF-κB cleavage was a generation of a novel heterodimer that translocate to 
the nucleus, driving expression of pro-inflammatory cytokines such as CXCL2, 
CCL2, CCL3 and CCL4. Interestingly this effect was restricted to pathogenic 
strains including L. mexicana, L. donovani and L. major but not in the non-
pathogenic strain L. tarentolae. 
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Finally, the Leishmania parasite combines various defence mechanisms to cope 
with oxidative stress caused by ROS and RNS (Van Assche et al. 2011). These 
include peroxidases, which reduce H2O2, the trypanothione/trypanothione 
reductase system that is unique to trypanosomatid parasites, pentose phosphate 
pathway metabolism that maintains intracellular NADPH levels and the cellular 
redox balance, and superoxide dismutase (SODs), which catalyse the dismutation 
of superoxide (O2-) into oxygen and hydrogen peroxide. Leishmania also 
expresses an unusual plant-like ascorbate peroxidase: an enzyme that transfers 
electrons from ascorbate to H2O2 during peroxide detoxification. 
1.3.5. Dendritic cells: sentinels bridging the innate and adaptive 
immune system 
Much research on the role of dendritic cells (DCs) has focused on the parasite 
species causing CL in the Old world, L. major. The role of DCs in New world CL 
causing species is quite different. It the following sections, the two are 
separated. 
1.3.5.1. Leishmania major:  
There has been some work showing that dermal dendritic cells (dDCs) harbouring 
parasite antigens, migrate out of the skin and transport the antigens to the 
draining lymph node (dLN) (Ng et al. 2008; Ritter et al. 2004). Ng et al using 2P-
IVM showed that shortly after parasite inoculation motile dDCs decreased 
velocity to phagocytise parasites.  
It has been demonstrated that at 3 to 4 weeks after infection two new subsets of 
DCs make up the majority in cells in the popliteal lymph nodes and increases of 
these subsets correspond with a similar increase in monocytes (León et al. 
2007). The authors demonstrated that one of the new subsets were monocyte 
derived DCs (Mo-DCs) that differentiated at the site of infection and the other 
were monocytes that matured at the lymph nodes. This dermal-derived subset 
potently induced CD4+ and CD8+ T cell production of IFNγ (Figure 1-5). 
Furthermore, the time-points examined (3-4 weeks) were the same time-points 
where C57BL/6 mice decrease IL-4 levels versus IFNγ in comparison to BALB/C 
mice. As the latter event is critical to controlling disease progression, the 
authors proposed that DCs are important for parasite control. The recruitment of 
Chapter 1  46 
 
these monocytes requires CCL3 produced by neutrophils once again highlighting 
the complexity of cell-cell interactions and dependencies (Charmoy, Brunner-
Agten, et al. 2010). Infected dendritic cells migrating to the lymph node in a 
CCR7-dependent manner resulting in LN hypertrophy (Figure 1-5) (Carvalho et 
al. 2012). Mice (C57BL/6) unable to recruit cells to the lymph node (selectin 
CD62L-/-) were more susceptible to infection. The authors were unable to explain 
why only bystander (non-infected cells) upregulated CCR7. This CCR7 signalling 
was dependent on TLR9 as TLR9-/- dendritic cells migrated less efficiently to the 
draining lymph node and had decreased CCR7 levels. Furthermore, the mice 
exhibited a deficit in lymph node expansion following L. major infection, as well 
as increased susceptibility. Finally, there has been some evidence for a 
supportive role for natural killer cells (NK) in activating DCs (Remer et al. 2010). 
Co-culture of DC with NK led to NK-DC- cross activation and an induction of IFNγ 
while depleting NK (using anti-asialo antiserum) during vaccination of BALB/C 
mice with conditioned DC resulted in reduced protection. 
1.3.5.2. New world species: 
In the context of L. major, C57BL/6 mice infected via the ear pinnae have been 
used to model the self-resolving form of the disease as they mount a vigorous 
Th1 response and resolve their lesions. C57BL/6 mice infected with L. mexicana 
however, fail to do the same and studies have been carried out to elucidate the 
mechanisms responsible (Petritus et al. 2012; Hsu & Scott 2007). Petritus et al 
showed that fewer monocytes are recruited to the site of infection in the case of 
L. mexicana and those that differentiated into Mo-DCs, had lower iNOS activity 
and were less efficient at migrating to the dLNs. IL-10 was found to have a role 
inhibiting the Th1 response as treatment of L. mexicana infected mice with an 
anti-IL-10R antibody resulted in increased recruitment of monocytes to the 
lesion along with greater production of IFNγ and increased iNOS positive cells. 
Hsu et al demonstrated that while there was no difference in the inducement of 
T cell proliferation between L. mexicana and L. major, the former failed to 
cause LN hypertrophy, had lower absolute numbers of T-cells (Hsu & Scott 2007). 
These results were associated with fewer cells migrating to the LN. Additionally, 
T-cells responding to L. mexicana infection were less able to differentiate into 
IFNγ producing cells. The role of NK cells has been investigated in the context of 
L. amazonensis where co-culture of NK cells have been shown to activate 
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infected DCs (Sanabria et al. 2008). When activated NK cells were injected into 
infected mice, there was an increase in activated DCs present at lymph nodes 
and a decrease in parasite burden. 
 
Figure 1-5: Engagement of the adaptive immune response to resolve disease. 1: Infected 
neutrophils secrete chemokines CCL3 and CCL4. 2: these chemokines recruit monocytes from 
bone marrow. 3: upon arrival monocytes can differentiate into macrophages or dendritic cells 
(DCs). 4: Dendritic cells that take up parasite antigen can migrate via lymphatic vessels to the 
draining lymph node (dLN). 5: Here DCs can secrete IL-12, which causes dLN hypertrophy and 
naive TH0 CD4+ cells to mature into pro-inflammatory Th1 CD4+ T-cells by around 1 week after 
infection. 6: Th1 CD4+ T-cells migrate to the site of infection. 7: IFNγ secreted by these cells 
actives macrophages, causing them to produce sufficient nitric oxide for parasite clearance. 8 
Natural killer (NK) cells are another source of IFNγ in Leishmania infection, which can cause 
cross activation of DCs. 
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1.3.6. T-Cells 
The immunological spectrum observed in patients with leishmaniasis has 
individuals at both extremes with regard to aberrant T-cell responses. It extends 
from individuals with delayed-type hypersensitivity (DTH) and high levels of 
IFNγ, to individuals lacking a DTH response but having a strong humoral response 
(Scott & Novais 2016). Thus patients without a T cell response exhibit a severe 
disease called diffuse cutaneous leishmaniasis (DCL) whilst at the other end of 
the spectrum, patients with an exaggerated immune response also experience a 
pathological condition known as mucosal cutaneous leishmaniasis (MCL). While 
CD8+ T-cells do have roles in Leishmaniasis this section will focus on the well-
studied CD4+ T-cell. A detailed description of subtypes such as effector T cells, 
central memory T cells (upon secondary stimulation cells differentiate into 
effector T cells), and tissue-resident memory T cells, some of which are 
important in the context of immunity and vaccine development is reviewed 
elsewhere (Scott & Novais 2016). 
In classical animal models of L. major infection, parasite-activated CD4+ T cells 
rapidly proliferate in the expanded dLNs, differentiate and secrete specific 
cytokines. Th1 (pro-inflammatory) cells secrete IL-2, IFNγ and TNFα, leading to 
macrophage activation and parasite elimination. Conversely, the Th2 (anti-
inflammatory) response is associated with IL-4, IL-5 and IL-13 production, 
leading to increased parasitaemia. To target these parasites with 
immunomodulatory agents, the mechanisms of host immunity and of parasite 
pathogenicity need to be thoroughly examined. For this purpose, mouse models 
are widely used. However, as seen above for other immune cells, the results 
obtained with these models are influenced by several experimental parameters, 
such as the genetic background of the mouse, parasite species and subspecies, 
inoculation site of infection, parasite dose and use of needle or fly host for 
parasite inoculation (Uzonna et al. 2004). 
Upon inducement an appropriate Th1 pro-inflammatory response, the expansion 
of the dLN is required for disease resolution in the case of L. major (Figure 1-5) 
(Carvalho et al. 2012). As mentioned above, this process is driven by the 
migration of dendritic cells from the site of the bite to the dLN (Hsu & Scott 
2007). Here they (DCs) induce IFNγ-upregulation in CD4+ Th1 cells by antigen 
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presentation and release of IL-12. This process is perturbed by L. mexicana 
where it has been shown that cysteine protease B (CPB) deficient parasites 
induce a Th1 response and as a result, fail to establish infection in susceptible 
CH3 mice (Buxbaum et al. 2003). 
To inhibit an appropriate Th1 response, L. mexicana induces upregulation of 
IL-10. Treating mice infected with L. mexicana with an anti-IL-10R antibody 
resulted in parasite control (Petritus et al. 2012). It has been shown recently 
that IL-10 is produced by CD4+ and CD8+ T-cells (Buxbaum 2015). Interestingly, 
CD4-cre IL-10flox/flox mice lacking IL-10 from T cells (both CD4+ and CD8+) heal 
their L. mexicana lesions, and control parasitemia. Additionally, mice lacking IL-
10 from macrophages and granulocytes still develop chronic disease, like their 
wild-type C57BL/6 counterparts. 
A key cytokine in disease resolution is IFNγ. When purified, naive CD4+ T cells 
were transferred into Thy1-disparate C57BL/6 or IL-10-deficient recipient mice, 
it was found that alongside poor dLN hypertrophy, IFNγ producing percentages of 
both CD4+ and CD8+ responding T cells remained greatly diminished after four 
weeks following L. mexicana infection (Hsu & Scott 2007). Hsu et al also found 
that the co-administration of CpG-containing oligodeoxynucleotides at the time 
of infection overcame this IFNγ deficit and promoted disease resolution. CpG-
containing oligodeoxynucleotides function as a ligand for toll-like receptors 9 
(TLR9) expressed on the surface of dendritic cells. As mentioned earlier, TLR9-/- 
dendritic cells migrated less efficiently to the draining lymph node and have 
decreased CCR7 levels (Carvalho et al. 2012). Thus it appears the migration of 
professional antigen presenting cells such as DC to the dLN and the subsequent 
interactions with and activation of CD4+ T- cells is critical for a successful Th1 
response. 
It will be important that further studies comparing disease resolution of 
different parasite species are carried out to determine if the L. major Th1 vs. 
Th2 paradigm of pathogenesis and protection holds true for New World CL. 
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1.4. Omics: A short and recent history 
Traditionally ‘Omics’, has referred to genomics, transcriptomics, proteomics and 
metabolomics but this has been extended to include closely related fields such 
as epigenetics and lipid-omics. Dr. Thomas Roderick, a geneticist at the Jackson 
Laboratory, first coined the word genomics in 1986 when discussing a name for a 
new journal (Yadav 2007).  The word genome is much older, its creation being 
attributed to Hans Winkler who used it to describe a haploid chromosome set by 
making a portmanteau of the words gene and chromosome. Today genomics 
refers to the complete genetic makeup of an organism. The other omics followed 
much later when, in 1995, Marc Wilkins coined the word ‘proteomics’ to 
describe an entire organism’s protein complement. Integration of the different 
omics will be invaluable in discovering systems emergent properties. These are 
features of a system, which only become observable when the system is studied 
as a whole and not as the sum of its parts. In the following section, the 
background and current state of the different omics will be covered. 
Metabolomics will be covered in more detail, as it was the most important and 
commonly used technique for this thesis. 
1.4.1. Genomics 
One of the earliest forms of nucleotide sequencing was RNA sequencing which 
led to Bacteriophage MS2 genome being published by Walter Fiers group in 1976 
(Fiers et al. 2004). RNA sequencing was initially more amenable due to the wide 
array of RNA editing enzymes available at the time. A seminal moment in DNA 
sequencing came with the chain-termination method developed by Frederick 
Sanger and co-workers in 1977 (Sanger et al. 1977). While this method made 
possible the sequencing of the human genome, next generation sequencers 
(NGS) have superseded it. In 2004, 454 Life Sciences released a parallelized 
version of pyrosequencing that was 6 times cheaper than Sanger sequencing. 
Today sequencing by synthesis (Illumina), which uses reversible dye-terminators 
technology is the most widely used technique for genome sequencing. While 
these techniques require amplification of template, PacBio and Oxford Nanopore 
offer single molecule real time sequencing platforms. These platforms give 
longer read lengths, which are extremely useful for de novo genome sequencing. 
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Genome assembly is a computationally intensive task, which today, is executed 
by specialized algorithms such as Bowtie (Trapnell et al. 2012). 
1.4.2. Transcriptomics and epigenetics 
RNA and DNA sequencing protocols are similar once a RNA ‘Poly (A)' library has 
been prepared. Critical to this is reverse transcriptase, a viral enzyme that was 
independently discovered in 1970 by Howard Temin and David Baltimore. PolyA 
selection excludes non-coding RNAs and reverse transcriptase creates a 
complementary DNA (cDNA) that is further fragmented to reach the desired 
fragment length of the sequencing system.  NGS platforms also can be used to 
sequence the ‘methylome’. This is an important epigenetic modification of 
cytosine (typically in promoter regions) that typically acts to repress gene 
transcription. Library preparation consists of bisulfite treatment of some of the 
DNA, which converts cytosine residues to uracil, but leaves 5-methylcytosine, 
which is read as a cytosine. Thus the DNA that has been treated with bisulfite 
retains only methylated cytosine, while non-methylated sequences are read as 
thymine. This approach gives single-nucleotide resolution information about the 
methylation status of a segment of DNA. 
1.4.3. Metabolomics 
Metabolomics is a recent and rapidly growing area of research. Primitive 
examples of metabolomics can be dated back to 1500-2000 BC in ancient China 
where doctors used ants to detect abnormal glucose levels in patients urine (van 
der Greef & Smilde 2005). In the middle ages “urine charts" that were based on 
colours, tastes and smells of urine were used to diagnose various medical 
conditions. The concept of a metabolic profile was advanced by Roger Williams 
who, in the late 1940s, used hundreds of thousands of paper chromatographs to 
look for disease-linked patterns in urine and saliva. The term "metabolic profile" 
was first introduced in 1971 when Horning et al demonstrated that gas 
chromatography-mass spectrometry (GC-MS) could be used to analyse 
compounds present in human urine and tissue extracts (Horning & Horning 1971). 
The term metabolomics was first coined in 1998 (Oliver 1998). Metabolomics is 
defined as the measurement of small molecules (Mr<1200) within a given system 
and the importance of this area of research is being increasingly appreciated. 
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The central dogma of molecular biology first proposed by Crick in 1956 has been 
further refined to show the complex regulatory networks that act at 
transcription, replication, translation and post translational modifications.  
Metabolism is the closest level to phenotype, with metabolites acting as building 
blocks of cell structure, effector molecules, products and cofactors of enzymatic 
reactions (Figure 1-6) and thus is an invaluable readout. Today there are various 
techniques available to measure pathways including carbohydrate metabolism, 
lipid metabolism, nucleotide metabolism and amino acid metabolism. These two 
general approaches called Untargeted metabolomics and Targeted 
metabolomics. Untargeted metabolomics gives a qualitative metabolic profile of 
a system, and while aiming to maximise coverage, it can be biased by sample 
preparation and choice of platform. This approach is useful for hypothesis 
generation and discovery of novel mechanisms of drug resistance (Vincent et al. 
2010). Targeted metabolomics is used to focus on a specific pathway. By using 
stably labelled isotopes, metabolites fate can be traced while spiking samples 
with varying concentrations of labelled metabolite can allow for quantification. 
By spiking samples with extracts of E.coli grown on labelled glucose in 
conjunction with a calibration curve, it has been possible to quantify up to 65 
metabolites (Kim et al. 2015a).  Targeted metabolomics can be regarded as 
hypothesis testing. These initial hypotheses can be derived from previous 
investigations, including untargeted metabolomics. 
 
Figure 1-6: How the Omics technologies can cover all levels and directions of the central 
dogma of molecular genetics. 
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1.4.4. Sample preparation 
The hypothesis to be tests is critical to this step in that it determines if a 
targeted or untargeted approach is required (Figure 1-7). Additionally, the 
solvent used will determine how well certain metabolite classes are detected 
(Sellick et al. 2010). As metabolism is by its nature quite unstable, rapid 
quenching is essential to slow or stop metabolism (Sellick et al. 2010). This 
involves removing medium, rapidly cooling sample and adding extraction solvent 
such as methanol, hot ethanol or chloroform/methanol/water. If cells are in 
suspension, samples can be quickly cooled using a dry ice ethanol bath before 
centrifuging.  For this project cold chloroform/methanol/water (1:3:1) was 
used, as this provides good coverage and is stable for oxidation sensitive 
metabolites such as trypanothione (t'Kindt et al. 2010). Essential technical 
controls include a solvent blank and pooled sample. The pool can be used in a 
“burn” at the prior to samples to coat columns in matrix similar to sample, and 
in between samples to ensure instrument reproducibility and stability of 
samples. Finally, use of internal (labelled) standards in extraction solvent can 
reveal unequal evaporation in samples. 
1.4.5. Platforms 
While NMR offers absolute quantification, coverage is quite low when compared 
to mass spectrometry (MS) systems. MS measures the mass to charge ratio of 
metabolites and accurate mass allows for the assignment of a chemical formula. 
A combination of either gas (GC-MS) or liquid (LC-MS) chromatography with a MS 
platform can be used. In GC-MS the sample is usually ionised directly (EI), or 
indirectly (CI) by an electron beam. LC-MS is useful for thermally unstable 
molecules that are soluble in the LC’s mobile phase while GC-MS is applied 
mainly for the analysis of volatile compounds. For life sciences, LC-MS is widely 
used as it has much wider coverage. However there are many biological 
important classes of metabolites that do not readily yield derivatives that are 
needed for GC. 
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1.4.6. Liquid Chromatography 
This method allows for molecules of the same mass to be separated allowing for 
more accurate annotation. Additionally, the initial separation provided can 
reduce ion suppression and matrix effects, thereby reducing chemical 
interactions within samples (Cubbon et al. 2010). Ion suppression is where the 
ionisation of one molecule inhibits that of another, thereby limiting its ability to 
be detected. Separation occurs in a column that consists of a stationary phase 
and mobile liquid phase carrying the sample. The physiochemical properties of 
these phases determine the target classes of metabolites. For MS, High-
performance liquid chromatography (HPLC) columns are preferred. HPLC uses 
smaller sorbent particles (2–50 µm), giving it superior resolving power. 
Three common types of LC are partition chromatography, normal phase (NP-
HPLC) and reversed phase HPLC (RP-HPLC). NP-HPLC has a polar stationary 
surface and a non-polar, non-aqueous mobile phase. RP-HPLC has a non-polar 
stationary phase and an aqueous, moderately polar mobile phase. Finally, 
partition chromatography gives separation from interactions with a solvent 
retained on the surface of column matrix or with the matrix itself. A variant of 
normal phase liquid chromatography that partly overlaps with ion 
chromatography and reversed phase liquid chromatography is hydrophilic 
interaction chromatography (HILIC). HILIC uses a hydrophilic stationary phase 
and a water-acetonitrile mobile phase. RP-HPLC uses a decreasing gradient of 
polar solvent to elute polar compounds first, which is good for lipophilic 
compounds while NP-HPLC uses an increasing gradient and is better for polar 
compounds. HILIC uses a normal-phase type of separation but uses reversed-
phase type eluents (Figure 1-7). 
Stationary phases use functional groups such as a zwitterionic functional group, 
which carry both positive and negative charges that limit interactions with 
charged metabolites or octadecyl carbon chain (C18), which is good for lipid 
separation (Di Palma et al. 2011). For our work a ZIC-pHILIC column was used as 
it gives good separation for both polar and non-polar metabolites and thus was 
our method of choice (Cubbon et al. 2010). The silica-containing ZIC-HILIC 
column can be used but while it can separate polyamines well, it is inferior for 
phosphosugars. 
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Figure 1-7: Schematic outlining of a typical metabolomics experiment. Solvent choice is 
critical in determining the types of metabolites that will be best covered. For an example of 
liquid chromatography, the ZIC-pHILIC system used in this study is shown. Here the presence of 
zwitterionic ligands and water allow for a wide range of metabolites to be separated in reverse 
phase elutions. The Orbitrap MS platform shown here was used in this study. Briefly, the ion 
source switches between positive and negative mode for ionisation of a maximum number of 
metabolites. Ions are selected based on mass in the quadropole and diverted via a C-trap 
quadropole for accurate mass measurements in the Orbitrap detector.  
1.4.7. Ionisation and detection 
In order for metabolites to be detected via their mass to charge ratio, they must 
first be ionised. A commonly used method is electrospray ionisation (ESI), which 
operates in positive (adds proton), negative (removes a proton) or switching 
(between positive and negative) modes (Figure 1-7). The latter mode is 
preferable as samples containing acidic compounds such as phosphates that are 
more stable when deprotonated and thus will be detected in negative mode 
while the opposite is true for amines, which are detected in positive mode 
(Watson 2010; Yuan et al. 2012). In addition to isomers, common unwanted ion 
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species include multi-charged species and adducts (salt, or fragments generated 
in source) can complicate metabolite identification. The use of authentic 
standards and targeted fragmentation of select features can increase confidence 
in identifications. Nevertheless, the coverage of each platform is limited by the 
presence of unstable metabolites and those outwith their mass or detection 
range.  
Many different mass-analysers are used, each offering different accuracy and 
resolution. Commonly used mass-analysers include Quadrupoles that filters ions 
based on mass and charge, Time of flight (TOF) instruments that accelerate ions 
and measure time taken to reach a detector and Orbitrap platforms that record 
the current generated by a ion’s oscillation back and forth along central 
electropole (Dunn 2008). A hybrid Orbitrap instrument was used for this project 
as it offers achieves ultra-high mass accuracy (as low as 0.21 parts per million 
(ppm)) and a resolving power greater than 100,000 fwhm (full width at half 
maximum) at a scan speed of three spectrum per second (Figure 1-7). The 
qExactive used here uses a quadropole to select precursors and a C-trap 
(trapping quadropole) for injection into the Orbitrap (Figure 1-7). The accurate 
mass allows for the assignment of mass spectral featured to few (isomers) or 
even one metabolite. 
1.4.8. Data analysis 
Analysis often proceeds by converting instrument propriety data files to a format 
that is amenable open source software. Subsequently features are selected that 
meet arbitrary thresholds for abundance, retention time, shape of 
chromatogram peak, and relative standard deviation (RSD) within replicates. 
Choosing each threshold is essential in determining the trade-off between false 
positives and false negatives. Furthermore, gaps in chromatographic peaks can 
be filled, and additional features be annotated, especially for related peaks (ESI 
artefacts such as Isotopes, adducts, fragments, and multiply-charged species) 
(Scheltema et al. 2008). Use of an appropriate solvent blank can be used to 
define detection limit and pooled samples across the experimental batch can be 
used to for batch correction algorithms and correct for instrument drift across a 
run (Dunn 2008). Setting a common system for denoting confidence in 
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metabolite identifications has been advanced by the Metabolomics Standards 
Initiative (MSI) (MSI Board Members, 2007).  
Statistical analysis can be carried out prior or after metabolite identification. 
However, by filtering out non-metabolites, the false discovery rate is decreased. 
Using authentic standards as part of a batch helps identifying matching 
metabolites in samples as well as prediction of other metabolites retention time 
based on their physio-chemical properties. Essential to identification are 
compound databases. Examples of these are Human Metabolome Database 
(HMDB), MZCLOUD, ChemSpider and Kyoto Encyclopedia of Genes and Genomes 
(KEGG) (Vinaixa et al. 2016). While these are comprehensive, a match here does 
not preclude the possibility of an alternative ion, fragment or isomer.  
According to the MSI, high confidence can be achieved by measuring accurate 
mass and retention time data and comparing it to that of authentic standards 
(Sumner et al. 2007). Furthermore, it is possible to increase confidence in 
metabolite identifications by fragmenting a metabolite to provide information 
about its structure. 
While use of multi-variate analysis and statistics is essential to obtain confidence 
intervals and fold-changes, these metabolites belong to pathways and sometimes 
occur in multiple pathways. Furthermore, metabolites can act in positive or 
negative feedback loops, and inhibit or induce enzymes in other pathways. To 
get a meaningful biological interpretation of complex samples, it is essential to 
explore alterations across entire pathways. Tools such as PATHOS and 
MetaboAnalyst allow for such analysis (Leader et al. 2011; Xia et al. 2015). 
Furthermore, integration of data from different omics can reveal novel 
discoveries that would not be possible to make from the individual data sets (Jha 
et al. 2015). Finally, there has been a push recently to create data depositories 
such as MetaboLights (Haug et al. 2013). These will be essential to not only 
archive data, but also create a record of intermediate and final files from data 
processing pipelines, methodologies, and software (version). Such information 
will be invaluable in creating highly reproducible results. 
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1.5. Omics and macrophage function 
1.5.1. Transcriptomics: insight into the role, origin and 
differentiation of macrophages 
Macrophages are pivotal to innate immune responses in a diverse range of tissues 
including the brain, liver, spleen and lung. During challenge, many of these 
macrophages originate from bone marrow monocyte precursors. An additional 
population are tissue macrophages. These arise from primitive hematopoietic 
progenitors present in the yolk sac during embryonic development independently 
of the monocyte lineage that persists in tissue up to at least 4 months age. 
There is a new dogma called homeostasis where monocytes differentiate into a 
long-lived, macrophage that can undergo non-stochastic self-renewal (Bain et al. 
2016). These cells increasingly replace the embryonic population with age in a 
process that is highly gender dependent.  
As well as macrophages, a highly similar cell type, dendritic cells (DCs) are also 
present. DCs can be identified by their ability to migrate to the lymph node to 
present antigens and activate T-cells. Transcriptomics has offered invaluable 
insight into elucidating the contribution of organ environment and lineage to 
macrophage cell function as well as differentiating them from DCs (Gautier et 
al. 2012). Gautier et al found that only several hundred mRNA transcripts are 
selectively expressed by macrophages when compared to dendritic cells. Many of 
these were absent in some of the macrophage from different tissues. On the 
other hand some that were expressed were specific to certain tissues such as 
transcription factor GATA-6 in peritoneal macrophages. This information is 
crucial in modelling diseases that are restricted to certain tissues. 
As mentioned in 1.3.4, macrophages polarisation has traditionally been 
considered to result in the generation of classically activated, inflammatory (M1) 
or alternatively activated, anti-inflammatory (M2) effector cells. Recently it has 
become apparent that these phenotypes are edges of spectrum (Xue et al. 
2014). In this key study, the authors examined the transcriptional profile of 
human macrophages polarised to M1 or M2 phenotypes using a diverse range of 
stimuli. Correlation network analysis revealed that, while for the most part, the 
transcription profiles was largely bipolar, the addition of either free fatty acids, 
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high-density lipoprotein (HDL), or combinations of stimuli associated with 
chronic inflammation, a spectrum of distinct macrophage-activation signatures 
became apparent. This spectrum became more apparent when multiple time-
points were included in analysis. Interestingly, these signatures were absent in 
human lung macrophages taken from smokers and patients with chronic 
obstructive pulmonary disease (COPD). Such phenotypes are difficult to 
reproduce using standard protocols where limited stimuli (and combinations) and 
time points are used. 
1.5.2. Immuno-metabolomics: an essential rewiring 
Immuno-metabolism is a recent and rapidly growing area of research with the 
discovery that changes in cell metabolism not only occur to meet the need for 
metabolic end products but also are necessary for inflammatory and anti-
inflammatory effector functions of macrophages, dendritic cells and T-cells 
(O'Neill & Pearce 2016). Immuno-metabolism is distinct from anabolism and 
catabolism, in that it describes how metabolites control transcriptional and post-
transcriptional events. 
Otto Warburg first recognised this phenomenon when he observed cancer cells 
upregulate glycolysis to meet ATP demands, as well as NADPH and nucleotides 
from the pentose phosphate pathway (PPP). This phenomenon is known as the 
Warburg shift and occurs in inflammatory, LPS stimulated macrophages. While 
the LPS induced upregulation of both glucose transporter GLUT1 (Fukuzumi et 
al. 1996), and arginine SLC7A2 has been known for some time (Figure 1-8), the 
mechanisms and functional importance has only become apparent with the 
advent of immune-metabolism. 
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Figure 1-8: Summary of metabolites and pathways the alteration of what required for 
macrophage effector functions. Red represents pro-inflammatory M1 changes and blue 
represents anti-inflammatory M2 changes. 1: LPS binding to TLR4 is shown as an example of a M1 
stimulus. 2: LPS causes up regulation of Glucose and Arginine uptake. 3:flux is increased through 
glycolysis. 4a flux is increased through the pentose phosphate pathway (PPP) for NADPH and 
nucleotide generation. 4b: LPS inhibits the kinase CARLK, which itself prevents flow between 
glycolysis and the PPP. CARLK is upregulated in IL-4 treated M2 macrophages. 5a: citrate 
accumulates and is diverted for prostaglandins and Itaconate synthesis. 5b. Itaconate inhibits 
conversion of succinates into fumarate thereby preventing ROS formation and excessive 
inflammation. 6a: Accumulated succinate induces HIF-1, which up regulates the M1 cytokine IL-
1β. 6b: LPS activates the inflammasome that processes pro-IL-1β in to its active form. 7: In M1 
cells arginine is converted into nitric oxide and citrulline via iNOS, the latter, helps replenish 
fumarate via the arginino-succinate shunt. In M2 cells arginine is diverted to ornithine via 
arginase. 8: in M1 cells, glutamine supplements the TCA cycle via the GABA and argino-succinate 
shunt. 9: IM2 cells divert glutamine to UDP-GlcNAc synthesis, which is important for pathogen 
recognition receptors. 
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In a seminal study, Tannahill et al used targeted metabolomics to show that LPS 
increases flux through glycolysis and induced an accumulation of succinate in 
bone marrow derived macrophages (BMDM) (Figure 1-8). This increase in 
succinate induces the HIF1α transcription factor that binds to the promoter of 
the pro-inflammatory cytokine IL-1β, driving its expression (Tannahill et al. 
2013). Succinate can also serve as a substrate for succinylation. This is a post-
translational modification of proteins in which a succinyl group is added to a 
lysine residue. LPS increases succinylation of multiple proteins including the 
glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH), as well 
as malate dehydrogenase (MDH), lactate dehydrogenase (LDH), and glutamate 
carrier. The impact of this on these enzymes functions remains to be elucidated. 
Succinate induced pro-IL-1β needs to be processed by the NLRP3 inflammasome, 
which itself requires glycolysis to function (Moon et al. 2015). Following up on 
these findings, Jha et al used integrated untargeted metabolomics and 
transcriptomics to reveal important pro- and anti-inflammatory metallic modules 
(Jha et al. 2015). In validation experiments using labelled glucose and 
glutamate, the authors found that, in addition to a succinate accumulation, 
there is a break in the TCA cycle after citrate caused by down-regulation of 
isocitrate dehydrogenase (Idh) (Figure 1-8). This led to citrate being diverted 
towards prostaglandin synthesis and Irg1-catalysed production of the anti-
microbial itaconate. These breaks in the TCA cycle are replenished by glutamate 
via the GABA shunt and by glutamate and arginine via the arginino-succinate 
shunt. The latter reaction links iNOS to the TCA, where citrulline combines with 
asparte (from glutamate) to form fumarate.  
Not only can itaconate inhibit the glyoxylate shunt in Salmonella typhimurium 
and Mycobacterium tuberculosis, it recently been shown to inhibit succinate 
dehydrogenase (Sdh), causing increased succinate levels (Lampropoulou et al. 
2016). Macrophages from mice deficient in Irg1 have increased inflammatory 
responses to LPS implying an additional regulatory role in limiting inflammation. 
Lampropoulou et al combined a flux balanced analysis (FBA) model with RNAseq 
data to show that increased itaconate levels caused increased lactate production 
and decreased flow through Sdh. Itaconate also prevents any accumulated 
succinate being rapidly oxidized, generating ROS via reverse electron transfer 
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(RET) at complex I (Figure 1-8). In alternatively activated M2 macrophages, 
there is an upregulated arginase and intact TCA cycle that is supplemented via 
glutamine. Glutamine and glucose are also diverted to UDP-GlcNAc production 
(Jha et al. 2015). UDP-GlcNAc is used in the glycosylation of lectin or mannose 
receptors, which are essential for pathogen recognition. 
Finally, the PPP has an important role in phagocytes in that in that it provides 
NADPH that is used by NADPH oxidase to produce ROS as well as Ribose-5P for 
nucleotides and nucleic acid synthesis. Additionally, it is used in the glutathione- 
glutathione disulphide (GSH-GSSH) anti-oxidant system, which is needed to 
protect macrophages from the reactive oxygen and nitrogen species produced 
during inflammation. An additional regulatory role was found for the PPP with 
the discovery of the sedoheptulose kinase CarlK (Haschemi et al. 2012). CarlK 
catalyses an orphan reaction in the non-oxidative part of the PPP, generating 
seduheptolose-7-phosphate (S7P) from sedoheptulose. LPS inhibits this while M2 
stimulus such as IL-4 increases it (Figure 1-8). Haschemi et al proposed that 
CarlK, which acts in an ATP dependent manner, facilitates input of glycolytic 3 
carbon phospho sugars by generating the rate limiting S7P. The source of 
sedoheptulose, where the enzyme is located, how it precisely decreases PPP 
flux, and how mechanistically influences cell function remains to be determined. 
1.5.3.  Leish-omics: recent breakthroughs 
Omics technologies have been key to showing changes that take place when the 
parasite moves from the fly to the mammalian host. This move results in an 
increase in temperature and a decrease in pH. By using 13C-stable isotope-
metabolomics and 2H2O labelling, Saunders et al showed that L. mexicana 
parasites reduce glucose and amino acid uptake when transformed into 
amastigotes (in-vitro and in-vivo models) (Saunders et al. 2014). Instead the 
parasites display a stringent metabolic phenotype characterised by increased 
fatty acid β-oxidation and glutamate synthesis but generally less profligate use 
of most metabolites and reduced secretion of metabolic end products. Use of 
inhibitors showed that the increased fatty acid β-oxidation and glutamate 
synthesis are essential to infection progressing.  
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Some work has been done on determining the key metabolic differences 
between L. mexicana, L. major and L. donovani (Westrop et al. 2015). While 
multiple differences were observed in levels of intracellular and secreted 
(extracellular) metabolites, interestingly, novel arginine and tryptophan utilising 
pathways were found, of which the former is studied further in this project. 
Interestingly one novel metabolite, indole pyruvate, which is a transamination 
product of tryptophan, has also been found to be secreted by bloodstream form 
of T. brucei (McGettrick et al. 2016). This study showed that this process is 
essential in bloodstream forms, and, importantly, revealed an 
immunomodulatory role. Indole-pyruvate was found to prevent LPS-induced 
Warburg shift in macrophages (McGettrick et al. 2016). This effect was mediated 
by the degradation HIF-1α, ultimately resulting in a decrease of IL-1β levels. 
Metabolomics has also been used to explore the interface of the host pathogen 
relationship. A 1H NMR spectroscopy approach has been previously used to 
examine the profile of L. major infected BMDM (BALB/c) (Lamour et al. 2012). 
Differences were detected in only 7 out of 34 metabolites including alanine, 
citrate and succinate. A summary of the various comparisons is shown in Table 
1-3.  This study was limited by the low coverage of 1H NMR. Another limitation 
was the lack of an attenuated control. The latter is important in differentiating 
between general infection responses and Leishmania specific responses. 
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Table 1-3: Summary of altered metabolites from Lamour et al. Metabolites with increased 
levels in the various pairwise comparisons are in bold, while those decreases are italicised. 
 
M0+ M1+ M2+ 
 
Intracellular Medium Intracellular Medium Intracellular Medium 
M0 
Acetate 
β-alanine 
Citrate 
Creatine 
Creatine-P 
Lactate 
Glycine 
GPC 
PC 
Taurine 
 
Succinate     
M0+ 
 Lactate 
GPC 
Glucose 
Taurine 
Creatine-P 
Lactate 
Pyruvate 
Alanine 
Glucose 
Glycine 
Creatine 
Creatine-P 
Arginine 
Citrate 
Lactate 
Acetate 
Glucose 
Glycine 
Pyruvate 
M1 
 Creatine Acetate 
Alanine 
Fumarate 
Pyruvate 
Succinate 
  
M2 
   Acetate 
β-alanine 
Citrate 
Creatine 
Creatine-P 
Lactate 
Acetate 
Alanine 
Arginine 
Fumarate 
GPC 
PC 
Pyruvate 
Succinate 
Citrate 
Glucose 
For such a control, γ-irradiated parasites were included in a recent study 
examining L. infantum infected BMDM (Moreira et al. 2015). Moreira et al found 
that the live parasites induced a temporary metabolic shift to the aerobic 
glycolytic state in macrophages (6 hours post infection), which later reverted to 
mitochondrial metabolism (18 hours post infection). These changes were 
detected at transcript (quantitative PCR (qPCR) of glycolytic genes) and at the 
level of lactate secretion and oxygen consumption. These modulations related to 
the upregulation of the glucose transporter (Slc2a4 [GLUT1]) and the energy 
metabolism transcriptional co-activator (Ppargc1a), all of which are essential for 
parasite growth. Specifically, this metabolic manipulation was shown to require 
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Sirtuin1 (SIRT1) and a liver kinase B1 (LKB1)/ AMP-activated protein kinase 
(AMPK) axis as macrophages from mice deficient in LKB1 or AMPK were more 
efficient in clearing parasites. This axis relies on these three enzymes, which are 
key energy sensors to switch energy metabolism from glycolysis to mitochondrial 
oxidation. AMPK acts central cellular signalling hub involved in the regulation of 
energy homeostasis while LKB1 is an upstream activator. SIRT1 acts by 
deacetylating key targets (including LKB1) in response to intracellular NAD+ 
levels fluctuations. Thus in the case of L. infantum, it seems that upon infection 
the parasites up-regulates glycolysis leading to an increase in the AMP/ATP ratio 
and a decrease NAD+/NADH ratio. The result of this is that infected macrophages 
are initially subjected to the M1 associated Warburg shift that causes a deficit of 
the energetic and redox status. Later in infection this results in a SIRT1 
activating LKB1 that, alongside the increased AMP/ATP ratio, engages AMPK to 
shift metabolism mitochondrial oxidative phosphorylation. 
Recent studies of the transcriptome of Leishmania-infected macrophages have 
given insight into not only how the parasite manipulates the host, but also what 
changes that occur during the parasites life cycle. Fiebeg et al recently 
published the transcriptome of L. mexicana in promastigotes, axenic and 
intracellular (amastigotes in BMDM) forms (Fiebig et al. 2015). By including 
genome-wide mapping of trans-splice sites and poly-A addition site, the authors 
proposed a revised genome annotation with over 900 novel genes. There was 
over 3000 differentially expressed genes between extracellular and intracellular 
parasites with flagellum-associated genes being down regulated while 
upregulated ones included transporters and peptidases. 
El-Sayeda’s group focused on both host (murine) and parasite (L. major) over the 
first 72 hours of infection (Dillon et al. 2015). The authors reported that it was 
during early infection (4 hours) the most dynamic responses were seen in hosts 
and parasites transcriptome. Significantly upregulated transcripts included those 
involved in pro- or anti-inflammatory immune responses, and glycolysis, while 
genes involved in lipid metabolism and Fc gamma receptor-mediated 
phagocytosis were down regulated. In the parasite, oxidative stress response 
genes were upregulated while significantly down regulated genes were in 
pathways such as translation, cell signalling, and flagellum structure. In a 
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subsequent study, El-Sayeda’s group followed up this experiment in human 
macrophages including L. major, L. amazonensis as well as latex beads to 
subtract the general phagocytosis effect (Fernandes et al. 2016). After 
accounting for phagocytosis, 4 hours post infection displayed the most drastic 
changes in both host and the two parasite species. Furthermore, there was a 
large degree of overlap when the authors compared their data on human and 
murine-specific (Dillon et al. 2015) differentially expressed genes which gave a 
list of genes that make up an infection signature. 
Recently, an Illumina methylation specific array was used to examine 
L. donovani infected THP-1 cells (Marr et al. 2014). Excluding hits that were 
present in their heat-killed control, the authors obtained a high confidence set 
of 443 altered CpG sites that correlated with live L. donovani infection. Notable 
genes that had altered sites in promoter regions were in host defence pathways 
such as the JAK/ STAT signalling pathway and the MAPK signalling pathways. 
While the biological relevance of cell lines may be an issue, it does seem that 
the live parasite can down-regulate appropriate immune responses. 
The combination and integration of -omics approaches i.e. untargeted 
metabolomics and RNAseq has not yet been performed in the case of Leishmania 
infection. In regards to metabolomics, previous studies have utilised low 
coverage techniques such as 1H-NMR or focused exclusively on central carbon 
metabolism heavily depending on assays such as oxygen production and lactate 
secretion, and qPCR. On the other hand, transcriptomics studies have given high 
coverage but cannot show if altered gene expression acts at the phenotypic 
level. As previously mentioned, integrated approaches can reveal changes that 
are of importance or contexts that are not obvious in the individual datasets. In 
chapter 4 of this thesis this strategy is used in order to build a comprehensive 
model of the Leishmania-infected macrophage. 
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1.6. Aims 
A primary limitation of Leishmaniasis treatment is the poor understanding of the 
immune responses that occur in disease resolution and disease progression. 
Parasite species and highly variable immune responses between individuals can 
and does compound the determining of appropriate host responses to infection, 
and how the parasite avoids them. A more immediate and obvious gap in 
knowledge is how the parasite manipulates host cells such as the macrophage. 
While past studies, using narrowly focused approaches, have revealed invaluable 
information, these cannot give the coverage that omics offers. 
Immune-metabolism is a recent and rapidly growing area of research. 
Metabolites that previously thought of as fuel or building blocks have now been 
shown to have signalling purposes, and changes in certain pathways are essential 
to cell’s effector functions. In the context of inflammation, multiple stimuli are 
present and so far there is a lack of understanding of the contribution of these 
cues to phenotype. Whether these metabolic shifts are also induced/supressed 
in Leishmania infection has yet to be determined. A detailed and integrated 
model of the metabolism and transcriptome of the host cell infected with live 
parasites will allow for this to be assessed. 
This projects aims to: 
1. Develop a system for measuring the metabolome of macrophages that 
accounts for the effects of different stimuli on cell size or numbers. 
2. Apply this system to differentiate the contribution of inflammatory stimuli 
alone or in combination, to identify metabolic shifts that are essential for 
immune cell function 
3. Generate a metabolic model of the Leishmania infected macrophage; 
specifically, to model differences stimulated by the live parasite 
4. Generate a high resolution transcriptome of the Leishmania infected 
macrophage and integrate it with the metabolic model 
5. Use stably labelled isotope-metabolomics to validate and investigate 
arginine metabolism in the Leishmania parasite 
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2 Materials and methods 
2.1 Bacterial strains and culture 
2.1.1  E.coli strains used 
For routine ligations, the DH5α competent cells (Invitrogen) were used. This 
strain has been genetically modified as follows: It has a lacZ Delta M15 mutation 
that allows for blue-white screening of recombinant cells. It also has an endA1 
mutation, which causes lower endonuclease degradation. This ensures higher 
plasmid transfer rates. Finally, it has a recA1 mutation that reduces homologous 
recombination hence giving a more stable insert. MAX Efficiency® DH5α ™ 
Competent Cells (Invitrogen), which have a higher transformation efficiency, 
were used for all transformations that had low efficiency. For overexpression of 
recombinant protein, the Rosetta strain of E.coli was used. 
During the project at the OPPF in Harwell all InFusion reactions were 
transformed into the Omnimax E.coli Strain (Invitrogen). In addition to the 
mutation, these strain lack the E. coli K12 restriction systems (mcrA Δ(mrr 
hsdRMS-mcrBC) which allows for the transformation of highly methylated DNA 
Furthermore, this strain is resistance to T1 and T5 phage infection as a result of 
its tonA genotype. For overexpression in E.coli at the OPPF the Lemo21 DE3 
strain (New England Biolabs) and the Rosseta 2 pLacI (Novagen) were used. In 
the former strain T7 polymerase is induced by IPTG. Furthermore, the activity of 
the T7 polymerase is further modulated by its natural inhibitor T7 lysozyme, 
which is expressed from the rhaBAD promoter. T7 lysozyme levels can be finely 
controlled by the titration of L-rhamnose. The P. aeruginosa stain from which 
the dimethylarginase was cloned was strain PAO1. 
2.1.2  Transformations 
Prior to transformation the bacterial stabilate(s) (50 µL) was thawed on ice. 
Plasmids or ligations were added to stabilate and left on ice for 15 minutes. 
Cells were then subjected to heat-shock (1 minute 42ºC), then returned to ice 
for 3 minutes. 250 µL of SOC medium was then added to each transformation 
and the cells were incubated at 37ºC for 30-60 minutes. SOC is composed of 
Super Optimal Broth (SOB medium), which is a nutrient-rich bacterial growth 
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medium, with glucose added for catabolite repression. Subsequently 100 µL of 
the transformation was plated on selective Lysogeny broth (LB)-agar plates 
containing appropriated antibiotic (Ampicillin 150 µG/ml; Kanamycin 60 µG/ml 
(Sigma) before overnight incubation at 37ºC. For plasmids generated using the 
NEBuilder® HiFi DNA Assembly Cloning Kit, heat shock was 30 seconds, 950 µL of 
SOC was added, and incubation was 60 minutes. 
 During the project at the OPPF in Harwell 3 µL of the Omnimax E.coli Strain 
(Invitrogen) was added to In-Fusion® generated plasmids. This mix was left for 
30 minutes on ice, heat-shocked for 30 seconds, 42ºC, then left for 2 minutes on 
ice. 300 µL SOC was added and left for 1 hour at 37ºC with shaking at 225 RPM. 
The transformants were added to 24 well plates containing the following: 1 mL 
of LB agar with X-galactose (allows for blue/white selection), IPTG, carbenicillin 
(Sigma: 50 µG/mL) (similar to ampicillin but less susceptible to pH degradation, 
thus better for growing longer). The amount of cells added was 25 µL per well or 
a 1/5 dilution (5 µL cells plus 20 µL LB). Plates were rotated to spread cultures, 
left ~10 minutes to air dry and incubated overnight at 37ºC. 
2.1.3  Bacterial culture and stabilities 
Unless otherwise stated all stains were grown in LB. Here individual colonies 
were inoculated into LB with the appropriated antibiotic (Ampicillin 150 µg/ml; 
Kanamycin 50 µg/ml (Sigma). For protein over-expression outwits the OPPF 
project, 1 mM IPTG (Sigma) was used for a 4-hour induction at 37ºC with shaking 
at 225 rpm. For long-term storage of E. coli stocks containing plasmid, 700 µL of 
overnight culture was added to 300 µL glycerol and stored at -80ºC. 
During the project at the OPPF in Harwell, to amplify plasmids in E. coli, 2 
colonies from each well were picked and put in a 96 deep-well with 1.2 mL 
Power Prime Broth™ (AthenaES™) and incubated overnight (37ºC with shaking at 
225 RPM). For overexpression, both Power Prime Broth™ with chloramphenicol 
(34 µG/mL) & carbenicillin (50 µG/mL) and 71491 | Overnight Express™ Instant 
TB Medium with chloramphenicol (34 µG/mL) & carbenicillin (50 µG/mL) were 
used. 150 µL of overnight culture was added to 3 mL in 24 deep-well plates, and 
these were incubated at 37ºC, 600 RPM until OD600 was ~0.5. At this point cells 
were in Power Prime Broth™ had 1 mM IPTG added, and all cells were then 
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incubated overnight (cells were in Power Prime Broth™ were incubated at 20ºC 
with shaking at 600 RPM, while cells in auto-induction medium were incubated 
at 25ºC. 
2.1.4  Plasmid purification from E. coli 
Plasmids were purified from 5 mL overnight cultures using the Macherey Nagel 
Nucleospin® Plasmid kit according to manufacture’s instructions. During the 
project at the OPPF in Harwell a QIAGEN BIOROBOT 8000 was used in 
combination with a Wizard® SV 96 Plasmid DNA Purification System Automated 
protocol (with Qiagen Biorobot 8000) to carry out plasmid purification on 1 mL 
cultures. 
2.2 Molecular biology 
2.2.1  Polymerase chain reaction (PCR) 
Oligonucleotides were designed using the NCBI primer designing tool and 
synthesized by MWG Eurofins Genomics (Ebersber, Germany). For screening 
E. coli colonies, GoTaq® G2 polymerase (Promega) was used according to 
manufacture’s instructions. For cloning of genes for the purpose of 
overexpression or gene replacement where an enzyme with proofreading 
capability was required, Phusion® High-Fidelity DNA Polymerase (New England 
Biolabs) was used according to manufactures instructions. For certain reactions, 
annealing temperatures were determined using a temperature gradient and for 
all reactions, extension time was adjusted for different product lengths. 
During the project at the OPPF in Harwell all reactions were carried out in 96 
well micro-plates. Polymerase chain reactions using Phusion Flash Mastermix 
(NEB) were set up on ice following the manufacturer’s protocol. Reactions 
typically contained 25 µL (bringing it to a final concentration of 1X Phusion Flash 
Mastermix) 2X Phusion Flash Mastermix, 17 µL sterile H2O, 3 µL (10 µM) of each 
primer and 2 µL of template. For these samples, the following protocol was 
used: 98°C 10 seconds, 29 cycles (98°C 1 second, 60°C 5 seconds 72°C 30 
seconds), 72°C 2 minutes. For gene blocks, KOD Xtreme™ Hot Start DNA 
Polymerase (Merck-Millipore) were used according to the following protocol: 
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94°C 2 minutes, 29 cycles (98°C 10 seconds, 68°C 30 seconds 68°C 30 seconds), 
68°C 2 minutes. 
2.2.2 Agarose gel electrophoresis 
PCR products or digested DNA was separated on 1% Agarose-TAE gels (Invitrogen, 
UltraPure) containing a 1 in 20,000 dilution of SYBR® Safe (Invitrogen). The PCR 
band (s) restriction digest profile was compared to those of a Promega 1kb DNA 
ladder. Gels were cast in the required size using moulds. DNA was prepared by 
addition of 6x Loading Buffer (Promega) and loaded into wells. Gels were run at 
between 80-100 V for 30-60 min depending on the DNA fragment size or 
separation needed. The method for generating a 2% gel used below was 
identical. Gels were imaged using an UVP Bio doc-it®. 
During the project at the OPPF  1.5% TAE agarose gels were used, (Sybersafe 
1/20,000), 100 V for 40 minutes. 2 µL of loading dye (0.25%w/v Bromophenol 
Blue in 30%v/v Glycerol) was added to each sample. 5 µL of Hyperladder I 
(BioLine BIO-33025/BIO-33026) was used as a reference. 
2.2.3 RNA isolation from cultured cells 
Mid-log phase parasites (5 x 107 cells) were harvested by centrifugation (10 min 
at 1,200 RCF). The pellet was resuspended in 1 mL Trizol (Invitrogen) and 
samples stored at -80°C until RNA isolation. For RNA isolation, to 1 mL of cells in 
Trizol 200 µL of chloroform was added and mixed thoroughly by vortexing. After 
centrifuging (12,000 RCF, 15 min, 4°C), the mixture separated into a lower red 
phase (phenol – chloroform: Protein), an interphase (DNA), and an upper 
colourless aqueous phase (RNA). The upper colourless aqueous phase was 
removed and transferred to a NucleoSpin® RNA mini spin column (Machery 
Nagel). The subsequent steps, including the on-column DNA digest, were carried 
out according to manufacturer’s instruction.  RNA was eluted in RNAse free 
water and concentration was measured using a Nanodrop 1000 
spectrophotometer (Thermo Scientific), with the method RNA-40. 
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2.2.4 Reverse transcription 
For reverse transcription reactions, 1 µg of RNA sample was mixed with 250 ng 
random primers (Sigma), 1 µL of dNTPs (10 mM, Promega) and dH2O to a final 
volume of 14 µL. To remove secondary structures, the sample mix was heated 
(65°C, 1 min) and immediately placed on ice. To synthesise cDNA 6 µL RT-mix 
(containing 5x First-Strand Buffer, 0.1 M DTT and SuperScript III reverse 
transcriptase (Invitrogen) was added to the sample and incubated for 25 min at 
25°C, and then for a further 30 min at 50°C. The reverse transcriptase was 
inactivated by heating (70°C, 15 minutes). Finally, complementary RNA was 
removed by adding 1 µL of E. coli RNaseH (2U) and incubating at 37°C for 20 
minutes. Samples were prepared in duplicate, with one sample set containing 
dH2O instead of SuperScript III RT as negative control. Samples were stored at -
20ºC until subjected to Real time PCR. 
2.2.5 Real-time PCR 
SYBR® Green PCR Mastermix (Applied Bioscience) and 96-well plates (Life 
technologies: MicroAmp® optical 96 well reaction plates) were used for relative 
quantitative PCR. Sample setup included three biological replicates of each 
sample (+/- reverse transcription reaction) for the transcript of interest. Water 
controls (non temple control) were used to detect contamination. Amplification 
of cDNA was performed using Applied Biosystems Prism 7500 Real Time PCR 
system, the default thermocycling settings (ddCt (Absolute quantification: 
Relative Quantification for RT-PCR)), with the reaction volume set to 25 µL, and 
marker set to SYBR. A melt curve analysis step was added to check that only 
primer pairs were forming a single product. Raw data was analysed using Applied 
Biosystems 7500 SDS Real-Time PCR systems software. Specific real-time PCR 
primers for target genes were designed using the GenScript Real-time PCR 
(TaqMan) Primer Design tool (https://www.genscript.com/ssl-bin/app/primer). 
For novel oligos, primer efficiency was tested on L. mexicana genomic DNA to 
verify it was >95%. Primer L. mexicana genomic DNA was used to test primer 
efficiency (doubling dilutions from about 2 ng/25 µl). A standard curve was 
generated by plotting log10[gDNA] vs Ct. The slope of this curve was used to 
calculate the efficiency (E) with the formula: 
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E=10-1/slope 
% Efficiency=(slope-1) x 100% = efficiency% 
2.2.6 Purification of PCR products 
PCR products were purified using NucleoSpin® Gel and PCR Clean-up (Machery 
Nagel) according to manufacturer’s instructions. In order to purify DNA 
fragments from agarose gels the DNA was visualised using a DarkReader blue 
light transilluminator (Clare Chemical) and the band excised using a sterile 
scalpel blade. 
During the project at the OPPF PCR purification was carried out using Agencourt 
AMPure XP magnetic beads (Beckman Coulter, Inc.) were used with a MWG 
Bilatest Seperator M96 small volume. Briefly 1.8 volumes of beads (81 µL) was 
added to each PCR reaction in a 96 well plate. The plate was then left for 2 
minutes on the separator, the supernatant discarded and 200 µL of 70% ethanol 
was added. After a 2-minute incubation on the separator, the supernatant was 
discarded and the ethanol was repeated. Again the supernatant was discarded 
and the plate was left to air dry for 10 minutes. The DNA-magnets mix was 
resuspended in 30 µL of dH2O. After a further 2-minute incubation, the DNA was 
transferred to a new 96-well plate. 
2.2.7  Quantification of DNA concentration and purity 
A NanoDrop 1000 Spectrophotometer (Nanodrop-Thermo) was used to quantify 
DNA concentration and purity (A NanoDrop 8000 Spectrophotometer (Nanodrop-
Thermo) was used at the OPPF in Harwell). The ratio of absorbance at 260 nm 
and 280 nm was used to assess DNA purity. A ratio of ~1.8 is generally accepted 
as “pure” for DNA while the presence of contaminants such as phenol or protein 
can lower this. The ratio of absorbance at 260 nm and 280 nm was used as a 
secondary measure of nucleic acid purity. Expected 260/230 values for “pure” 
nucleic acid are often higher than the respective 260/280 values. Concentration 
was given as ng/µL. 
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2.2.8  DNA isolation from cultured cells 
For Leishmania parasites, ~10 mL of mid-log culture was pelleted by 
centrifugation, washed with PBS, and the genomic DNA isolated using a 
Nucleospin Tissue kit (Machery-Nagel®) according to manufacture’s instructions. 
2.2.9 Ethanol precipitation of DNA 
To each sample of DNA, 1/10 volume of sodium acetate (3 M, pH 5.2) was added. 
After mixing, 2.5 volumes of ice cold 100% ethanol were added. After mixing 
samples were placed in -80ºC for a minimum of 20 minutes. The precipitated 
DNA was pelleted by centrifugation (18,000 RCF, 4ºC). The supernatant was 
removed and the pellet washed with 1 mL of 70% ethanol. The precipitated DNA 
was again pelleted by centrifugation (18,000 RCF, 4ºC), the supernatant 
removed and the pellet was left to air-dry briefly. Finally, the pellet was 
resuspended in 20 µL sterile water. 
2.2.10  Plasmid and Oligo design 
The relevant DNA sequences were retrieved from TriTrypDB in FASTA format 
(http://tritrypdb.org/tritrypdb/) and imported into CLC-Genomics Workbench 6. 
In the case of overexpression of the P. aeruginosa protein, the gene symbol is 
PA1195 and the Fasta sequence can be retrieved from NCBI gene (ID: 883112). 
Oligos were designed using the NCBI primer blast tool 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/) to ensure optimal binding 
and specificity. 
During the project at the OPPF codon optimisation against E. coli K12, HEK293 
and Drosophila melanogaster was first carried out using the online Jcat tool 
(http://www.jcat.de/). Dr Louise Bird further modified the output of this in 
order to ensure compatibility with the InFusion (Clontech) system. The final 
codon-optimised sequences were ordered from IDT® as sequence-verified 
genomic blocks (gBlocks®). Dr Louise Bird also used the InFusion primer design 
tool to select oligos which were ordered from IDT® in the form of 96 well oligo 
plates. This, and following protocols were conducted at the OPPF in accordance 
with established protocols (Berrow et al. 2007; Bird 2011; Bird et al. 2013; 
Nettleship et al. 2009; Nettleship et al. 2015). 
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Table 2-1: List of primers used for real-time PCR in this study. 
Name Sequence Comment 
MB1026 CGGCTATGACATCGAGCTTA Lmxm.08.1225 fw (qPCR) 
MB1027 GACACGTCCTCCACAAACAT Lmxm.08.1225 fw (qPCR) 
OL4595 GATCGCACTGAGGAGGGTAT LmxM.18.0360 fw (qPCR GPI)  
OL4595 GTGGTCGAACTCTTGCAGAA LmxM.18.0360 rv (qPCR GPI) 
Arg1 fw AGTGTTGATGTCAGTGTGAGC Arg1 fw (Murine) 
Arg1 rv GAATGGAAGAGTCAGTGTGGT Arg1 fw (Murine) 
Arg2 fw ACCAGGAACTGGCTGAAGTG Arg2 fw (Murine) 
Arg2 rv TGAGCATCAACCCAGATGAC Arg2 fw (Murine) 
18s fw GTAACCCGTTGAACCCCATT 18s fw (Murine, housekeeping) 
18 s rv CCATCCAATCGGTAGTAGCG 18s rv Murine, housekeeping) 
Table 2-2: List of primers used for cloning this study.  Start codons are underlined and bold, 
stop codons are bold, underlined and red. 3’ his-tag is highlighted in grey #: The OPPF id is given 
for each primer and the last column refers to the plasmid  (Table2-4) within which it is inserted. 
GPI8 primers were obtained from Prof. Jeremy Mottram, Arginase primers from Dr Mariola 
Kurowska-Stolarska and 18 s primers from Prof.Iain McInnes. 
Name Sequence Comment 
MB1028 CAGGATCCCATATGTTCAAGCACATCATCGCTCG P. aer POA1 fw (DDAH, BamHI) 
MB1029 CGGAATTCTCAGAAGCGCAGCGACATG P.aer POA1 rv (DDAH, EcoRI) 
MB1030 GCCCCGGGATGATCGAGGACGGCTATGA LmxM.18.0360 fw (Episomal: No tag, XmaI)  
MB1031 GCGGATCCCTACGCGCTGTAGCTCAGAA  LmxM.18.0360 rv (Episomal: No tag, BamHI) 
MB1032 GCCCCGGGATGATCGAGGACGGCTATGA LmxM.18.0360 fw (Episomal: 3’ tag XmaI) 
MB1033 GCGGATCCCTAGTGGTGGTGGTGGTGGTGCGGGCCCTGAAACAGCACCTCCAGCGCGCTGTAGCTCAGAA LmxM.18.0360 rv (Episomal: 3’ tag, BamHI) 
OPPF17669F AGGAGATATACCATGATCGAGGACGGCTACGACATCGAGC Harwell 1 Fw 
OPPF17669R GTGATGGTGATGTTTGGCGCTGTAGCTCAGCAGGCTG Harwell 1 Rv 
OPPF17671F AAGTTCTGTTTCAGGGCCCGATCGAGGACGGCTACGACATCGAGC Harwell 2 Fw 
OPPF17671R ATGGTCTAGAAAGCTTTAGGCGCTGTAGCTCAGCAGGCTG Harwell 2 Rv 
OPPF17673F CATCAGTTCTGCATGCTATCGAGGACGGCTACGACATCGAGC Harwell 3 Fw 
OPPF17673R GTGATGGTGATGTTTGGCGCTGTAGCTCAGCAGGCTG Harwell 3 Rv 
OPPF17677F CATCAGTTCTGCATGCTATCGAAGACGGTTACGACATCGAACTGATC Harwell 4 Fw 
OPPF17677R GTGATGGTGATGTTTAGCAGAGTAAGACAGCAGAGAGCAGCAGG Harwell 4 Rv 
OPPF17677F CATCAGTTCTGCATGCTATCGAAGACGGTTACGACATCGAACTGATC Harwell 5 Fw 
OPPF17677R GTGATGGTGATGTTTAGCAGAGTAAGACAGCAGAGAGCAGCAGG Harwell 5 Rv 
OPPF17665F AAGTTCTGTTTCAGGGCCCGATCGAAGACGGTTACGACATCGAACTGATC Harwell 6 Fw 
OPPF17665R ATGGTCTAGAAAGCTTTAAGCAGAGTAAGACAGCAGAGAGCAGCAGG Harwell 6 Rv 
Table 2-3: List of primers used for sequencing or analysis (insert orientation) in this study. 
SP6 and T7 were use to sequence episomal over-expresser genes in pGEMT-Easy, while MB0212 
and MB479 were used to the final construct (in pGL1002).  T7 and T7 terminator was used to 
sequence P. aer or L. mexicana gene (Lmxm.08.1225) in pET28a (+). 
Name Sequence Comment 
MB0095 CTGGATCATTTTCCGATG Leishmania ITS1 (S) 
MB0096 TGATACCACTTATCGCACTT Leishmania ITS1 (AS) 
MB0215 TAATACGACTCACTATAGGG T7 
MB0663 GCTAGTTATTGCTCAGCGG T7 terminator* 
MB0213 TGTCTCTTGTCGGTGCTCAC pXG Fw (Episomal) 
MB479 GAGCACAACACCAAGACGGG pXG Rv (Episomal) 
T7** 
 
 
 
GACCGAAATTACGACTCACTATAGGG OPPF-provided primer 
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Table 2-4: List of plasmids generated in this study.  The pET28a (+) plasmid was used for 
overexpressing the P. aeruginosa protein, pGL1002 was used for episomal overexpressors and 
pOPIN series was used at the OPPF. Molecular weight (MW) is in kDa. POI = protein of interest, 
His6 = His6 tag, His8 = C-terminal His8 tag, 3C = Rhinovirus 3C protease site, GST = Glutathione-
Stransferase, TRX = E. coli Thioredoxin reductase, RPTPmu = receptor-type tyrosine-protein 
phosphatase mu, eGFP = enhanced Green Fluorescence Protein. * PDB id for P. aeruginosa gene. 
Abr refers to antibiotic resistance marker, the second one, if any is for in mammalian cells. 
Name Gene MW Abr MW tag MW 
total 
Codon usage Backbone Comment 
pMB234 P.aer (1h70*) 28.5 Kanamycin ~1 29.5 N/A pET28a (+) HIS6-POI 
pMB235 Lmxm.08.1225 26.6 Ampicillin/G418 0 26.6 N/A pGL1002 No tag 
pMB236 Lmxm.08.1225 26.6 Ampicillin/G418 ~1 27.6 N/A pGL1002 POI-HIS6 
pMB237 Lmxm.08.1225 26.6 Ampicillin/G418 ~1 27.6 HEK293 pOPINEneo POI-3C-HIS8 (1) 
pMB238 Lmxm.08.1225 26.6 Ampicillin ~1 27.6 HEK293 pOPINF HIS6-3C-POI (2) 
pMB239 Lmxm.08.1225 26.6 Ampicillin ~3.6 30.2 HEK293 pOPINTolB SS [TolB]-POI-KHIS6 (3) 
pMB240 Lmxm.08.1225 26.6 Ampicillin 14 40.6 Bac/insect pOPINTRX HIS6-TRX-3C-POI (4) 
pMB241 Lmxm.08.1225 26.6
2 
Ampicillin ~5.2 31.8 Bac/insect pOPINH SS [RPTPmu]-HIS6-3C-POI (5) 
pMB242 eGBP* 32.7 Ampicillin N/A 32.7 N/A pOPINE-3C-GFP Empty vector control (+GFP) 
pMB243 Lmxm.08.1225 26.6 Ampicillin ~5.2 31.8 E.coli pOPINH SS [RPTPmu]-HIS6-3C-POI (6) 
 
Table 2-5: Gene blocks used in this study: Codon optimisation is as described above. 
Name Sequence 
E. coli 
ATCGAAGACGGTTACGACATCGAACTGATCGAACTGCCGGCTCTGAACGAACTGCCGGACTCTATGTTCGTTGAAGACGTTTCTATGATCTACAACA 
CCTGCGCTGTTATCACCCGTCCGGGTGCTCCGTCTCGTCGTCCGGAAGTTGACCCGATCCTGGACACCGTTACCGCTCTGCGTCAGGAACACTACCGTAT 
CTAAATACGTTTTCGTTGGTAAATCTACCCGTTCTAACGACTCTGGTTACCTAAATACGTTTTCGTTGGTAAATCTACCCGTTCTAACGACTCTGGTTAC 
GAACAGCTGCGTGACTACCTGGGTAAACACGGTCTGGAATGCGTTCAGTGCGTTGTTAAAAACTGCCTGCACCTGAAATGCGCTGTTACCTTCCTGTCTG 
AAAACACCCTGCTGGTTTCTCCGAAATGGGTTGACCCGGGTATCTTCACCTCTCGTGGTTTCAAAGTTGTTGAAGTTGACTCTAACGAACCGGCTTCTGC 
TAACGTTCTGTCTTTCTCTGCTGAAAAAAACGGTAAACCGCTGCGTACCATCGTTACCGCTGCTGAATTCCCGGGTACCGCTTCTCGTGTTGAAGCTTTC 
GCTGAAGAAGAAACCGCTCAGGGTCGTCCGACCCGTCAGGTTGTTCTGAAAGCTGACGAAATCGCTAAAGCTGAAGGTTCTCTGACCTGCTGCTCTCTGC 
TGTCTTACTCTGCTTAA 
 
 
Hek293 ATCGAGGACGGCTACGACATCGAGCTGATCGAGCTGCCCGCCCTGAACGAGCTGCCCGACAGCATGTTCGTGGAGGACGTGAGCATGATCTACAACA 
CCTGCGCCGTGATCACCCGCCCCGGCGCCCCTAGCCGTCGTCCTGAGGTGGACCCCATCCTGGACACCGTGACCGCCCTGCGCCAGGAGCACTACCGCAT 
CTGCGAGCCCGGCACCGTGGACGGCGGCGACGTGATGCACGTGGCCAACAGCAAGTACGTGTTCGTGGGCAAGAGCACCCGCAGCAACGACAGCGGCTAC 
GAGCAGCTGCGCGACTACCTGGGCAAGCACGGCCTGGAGTGCGTGCAGTGCGTGGTGAAGAACTGCCTGCACCTGAAGTGCGCCGTGACCTTCCTGAGCG 
AGAACACCCTGCTGGTGAGCCCCAAGTGGGTGGACCCCGGCATCTTCACCAGTCGTGGCTTCAAGGTCGTGGAGGTGGACAGTAACGAGCCTGCCAGCGC 
CAACGTGCTGAGCTTCAGCGCCGAGAAGAACGGCAAGCCCCTGCGCACCATCGTGACTGCTGCTGAGTTCCCTGGTACCGCTAGCCGCGTGGAGGCCTTC 
GCCGAGGAGGAGACCGCCCAGGGCCGCCCCACCCGCCAGGTGGTGCTGAAGGCCGACGAGATCGCCAAGGCCGAGGGCAGCCTGACCTGCTGCAGCCTGC 
TGAGCTACAGCGCCTAA 
 
Bac/insect ATCGAGGACGGCTACGACATCGAGCTGATCGAGCTGCCCGCCCTGAACGAGCTGCCCGACAGCATGTTCGTGGAGGACGTGAGCATGATCTACAACA 
CCTGCGCCGTGATCACCCGCCCCGGCGCCCCTAGCCGTCGTCCTGAGGTGGACCCCATCCTGGACACCGTGACCGCCCTGCGCCAGGAGCACTACCGCAT 
CTGCGAGCCCGGCACCGTGGACGGCGGCGACGTGATGCACGTGGCCAACAGCAAGTACGTGTTCGTGGGCAAGAGCACCCGCAGCAACGACAGCGGCTAC 
GAGCAGCTGCGCGACTACCTGGGCAAGCACGGCCTGGAGTGCGTGCAGTGCGTGGTGAAGAACTGCCTGCACCTGAAGTGCGCCGTGACCTTCCTGAGCG 
AGAACACCCTGCTGGTGAGCCCCAAGTGGGTGGACCCCGGCATCTTCACCAGTCGTGGCTTCAAGGTCGTGGAGGTGGACAGTAACGAGCCTGCCAGCGC 
CAACGTGCTGAGCTTCAGCGCCGAGAAGAACGGCAAGCCCCTGCGCACCATCGTGACTGCTGCTGAGTTCCCTGGTACCGCTAGCCGCGTGGAGGCCTTC 
GCCGAGGAGGAGACCGCCCAGGGCCGCCCCACCCGCCAGGTGGTGCTGAAGGCCGACGAGATCGCCAAGGCCGAGGGCAGCCTGACCTGCTGCAGCCTGC 
TGAGCTACAGCGCCTAA 
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2.2.11 Ligations 
Ligations were carried out at 16ºC, overnight using a T4 DNA ligase (Promega) 
and the 10x Ligase Buffer supplied with it. The backbone: insert ratios used were 
1:1 or 1:3 in a 10 µL volume. Some inserts were sub-cloned into pGEMT-Easy 
(Promega) if ligation efficiency was low. 
2.2.12  DNA sequencing 
MWG Eurofins (i54 Business Park, Valiant Way, Wolverhampton, WV9 5GB) 
carried out Sanger DNA sequencing on a 96-capillary Applied Biosystems model 
3730XL DNA sequencer using a SmartSeq kit. Forward and reverse reads were 
routinely obtained. For sample preparation in dH2O, plasmids and PCR template 
were prepared at 50-100 ng/µL and 5-10 ng/µL respectively in a total volume of 
15 µL (including 15pmol of relevant primer). Results (.scf format) were analysed 
using CLC-Genomics Workbench 6 (CLC Bio), aligning reads to a relevant 
reference sequence, and viewing sequencing traces. During the project at the 
OPPF sequencing was carried in house at the University of Oxford. 
2.2.13 Cloning of P. aeruginosa DDAH 
Gene was amplified using Phusion high fidelity polymerase (New England 
Bioscience (NEB)) according to manufactures instructions. The PCR protocol was 
as follows: 98ºC denaturing 30 second, 34 cycles (98ºC denaturing for 30 
seconds, 70ºC annealing for 30 seconds. 72ºC extension for 30 seconds), 72ºC, 5 
minutes for final extension. PCR product was purified as above and sub-cloned 
into pGEMT-easy vector (Promega) and transformed into DH5α E. coli. Mini-
prepped PCR product (in pGEMT EASY) and pET28a (+) vector were digested with 
NdeI (NEB) and EcoRI (NEB). pET28a (+) was then treated with Antarctic 
Phosphatase (NEB). This step was as follows: 5.7 µL 10x Antarctic phosphatase 
buffer and 1 µL phosphatase were mixed with 50 µL digested vector. The sample 
was then heated to 60 minutes at 37ºC then 70ºC for 5 minutes. All products 
were gel purified and ligated overnight at 16ºC (Promega, T4 ligase). Ligations 
were transformed into DH5α E. coli. PCR positive (SP6 and T7 primers) colonies 
were grown (5 mL LB) overnight, and mini-prepped. Finally, the isolated plasmid 
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was sent for sequencing  (T7 and T7 terminator primers) at MWG Eurofins prior 
to transformation into the Rosetta E.coli strain for over-expression work. 
2.2.14 Generation of episomal overexpression plasmids 
Gene was amplified using Phusion high fidelity polymerase (New England 
Bioscience (NEB)) according to manufactures instructions. The PCR protocol was 
as follows: 98ºC denaturing, 34 cycles (98ºC denaturing for, 69ºC annealing for 
30 seconds. 72ºC extension for 30 seconds), 72ºC, and 5 minutes for final 
extension. PCR product was purified as above and sub-cloned into pGEMT-easy 
vector (Promega), transformed into DH5α E. coli and subsequently mini-prepped 
as described above. As there was a conflict of restriction sites, genes were 
digested out using SpeI, then blunt-ended using DNA Polymerase I, Large 
(Klenow) Fragment (NEB M0210). Briefly DNA was dissolved in 1x NEBuffer 
(supplied with polymerase) supplemented with 33 µM of each dNTP. 1 unit of 
Klenow was added per microgram DNA mix and incubated for 15 minutes at 
25°C. Reactions were stopped by adding EDTA to a final concentration of 10 mM 
and heating for 20 minutes at 75°C. The reaction was cleaned up and eluted into 
20 µL, prior to digestion with Bam HI HF (NEB). The pGL1002 was digested with 
BamHI HF and SpeI, treated with Antarctic Phosphatase. The remaining steps, 
including ligation, and transformation into DH5α E. coli are as described above. 
Final plasmids were sent for sequencing  (MB0213 and MB0479 primers) at MWG 
Eurofins prior to transfections. 
2.3 Biochemical methods 
2.3.1  SDS page 
Samples were typically diluted according to OD600 or protein content (Bradford 
reagent, Biorad). Diluted samples were mixed 3:1 (sample: loading dye) with a 
4x stock of loading buffer (2.0 ml 1 M Tris-HCl pH 6.8, 0.8 g SDS, 4.0 ml 100% 
glycerol, 0.4 ml 14.7 M β-mercaptoethanol, 1.0 ml 0.5 M EDTA, 8 mg 
bromophenol Blue) and denatured (95ºC, 10 minutes). Samples were run on 
NuPAGE Novex 4-12% Bis-Tris Protein Gels, 1.0 mm, 12-well (Thermo), using 
NuPage MES SDS running buffer (Thermo) ensuring that milliamps (mA) did not 
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exceed 120 mA. To determine protein size, a dual colour marker protein 
precision plus ladder (Biorad) was run alongside samples. 
During the project at the OPPF 24 well gels were used as well as wide and low 
range his-tagged markers (Sigma S8445 and M3913). For E.coli experiments a 
1 µL of His-tagged Protein Standard (BenchMark™ Thermo) was run alongside 
Precision Plus dual colour marker. 
2.3.2  Western blotting 
Protein was transferred to Amersham Hybond ™ ECL membranes (GE Healthcare) 
using the Novex XCell II™ Blot module (Thermo) using manufactures instructions. 
Membranes were blocked for one hour at room temperature with 5% milk in PBS-
T (PBS with 0.05% Tween-20). Membranes probed with the relevant primary 
antibody overnight at 4°C, washed three times with PBS-T, and probed with 
relevant primary antibody for one hour at room temperature. Membranes were 
then washed three times with PBS-T. The Pierce ® ECL Western blotting 
substrate (Thermo) was used on membranes according to manufactures 
instructions and chemiluminescence visualised using the Amersham Hyperfilm ™ 
ECL (GE Healthcare) on a Xomat (Konica Minolta, Cat no. SRX-101A). Primary 
antibodies used in this study include a monoclonal anti-polyhistidine (Mouse, 
Sigma: H1029) or polyclonal anti-transketolase (rabbit, Barrett group). 
Secondary antibody used was anti-mouse (Promega: W4021) or anti-rabbit 
(Pierce: 31464). 
During the project at the OPPF the protocols were similar except that an iBlot 
(Invitrogen) was used with iBlot® Transfer Stack, nitrocellulose for transfers and 
the Amersham ECL Prime Western Blotting detection reagent was used to detect 
chemiluminescence. The primary antibody used was the MAB050 anti-his-tag 
Monoclonal Mouse IgG1 (R&D Biosystems) and the secondary used was Anti-Mouse 
IgG (Sigma: A9044). 
2.3.3  Coomassie blue, Ponceau SYPRO ruby (Thermo) and silver 
staining of protein gels 
25 g of Coomassie Brilliant Blue (Thermo) was dissolved in 250 mL of the 
following solution: Methanol (50% [v/v]) Glacial acetic acid (10% [v/v]) H2O 
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(40%) the solution was stirred for ~1 hour and then passed through a 0.2 µM filter 
(Merck Millipore). Gels were stained for a minimum of 30 minutes, and de-
stained using the following solution:  H2O, methanol, and acetic acid 
(50/40/10: v/v/v). Gels were imaged using a Thermo Scientific myECL Imager. 
Ponceau S (Thermo, 0.1w/v, 5% Acetic acid, 20 min) was used to confirm 
successful transfer of proteins to membrane. SYPRO ruby (Thermo) was used 
according to manufactures instructions and gels imaged on a Typhoon scanner 
(GE healthcare) in acquisition mode  (Protocol: 6130 BP30 Deep purple 
SYBERPROGreen). For silver staining, the SilverQuest™ Silver Staining Kit 
(Thermo) was used according to manufacture’s instructions. 
2.3.4  Nickel affinity chromatography 
A pellet from 110 mL of culture (OD600 = 2.407) thawed on ice was resuspended 
in 5 mL of 100 mM sodium phosphate buffer (pH7, 1x PIC (Roche EDTA free), 
100 µL lysozyme (Sigma), 2 µL Benzonuclease (Sigma, 500 U)). Sample was 
sonicated (MSE Soniprep with 19 mM (3/3’) probe, 8 cycles x 30s on/off, medium 
amplitude [14 microns]). The insoluble fraction was sedimented by 
centrifugation (4ºC, 9500 RCF, 15 minutes) and supernatant stored at -20ºC until 
processed further. 
Protein was purified using a HisTrap HP 5 ml Ni Sepharose column (GE 
Healthcare) on an AKTAprime plus (GE Healthcare) with binding buffer 
containing 200 mM NaCl, Tris HCl 50 mM, 10 mM imidazole (Sigma) pH7.5, and 
eluting into same buffer containing 500 mM imidazole (16 minute gradient). The 
five 2 mL fractions containing most protein were pooled and protein was 
dialysed (Spectrum labs Spectr/Por® MCWO 6-8000) into 100 mM phosphate 
buffer, pH6.8 [2x1L] [1hr first, then overnight] to remove the 500mM imidazole 
and any L-citrulline/urea present. Protein was concentrated using a 
concentrator (Vivaspin 20, 5,000 MCW cut off, 4,000 RCF, 4ºC) and diluted to 
yield a (4.3 mg/mL) solution consisting of 100 mM sodium phosphate buffer 
pH6.8, 15% glycerol (cryoprotectant to stabilizes protein), which was stored at -
80ºC. 
During the project at the OPPF for HEK 293 cells, supernatant was removed 
(secreted sample), plate stored at -80°C for 30 minutes. Plates were defrosted 
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and 150 µL of lysis buffer (50µL NPI-10 + DNase (Sigma, 8000U) + 50µL protease 
inhibitors SIGMA P8340) were added to each well and left shaking for 30 minutes 
(300RPM, 20ºC). 10 µL of the resulting homogenate was added to a 96well plate 
(total protein). The remaining homogenate was transferred to the 96-deep well 
plate and centrifuged (6000 RCF, 30 minutes). 10 µL of supernatant (soluble 
fraction) was then mixed with 10 µL of SDS-PAGE sample buffer. 
For E. coli samples, 1 mL of overnight culture was transferred to two 96 deep 
well blocks, centrifuged (6000 RCF, 10 minutes) and supernatant was discarded. 
Samples were frozen (-80ºC, 20 minutes) and processed using a QIAGEN 
BIOROBOT 8000 with the following reagents NP-10, NP-20, DNASE/Lysosyme mix, 
GE beads (His Mag sepharose Ni, 1 mL). The protocol included a 30 minute 
centrifugation step (6000 RCF) after lysis and samples were eluted in 250 mM 
imidazole. 
2.3.5 2’-5’ –ADP agarose affinity chromatography 
The aim of this experiment was to try and reproduce the findings of two 
previous publications (Basu et al. 1997; Genestra et al. 2006). 5 x 1010 mid log 
promastigotes were harvested by centrifugation (1200 RCF, 4ºC, 10 minutes). 
Cells were washed once with PBS, re-suspended in 4 mL of 0.25 M sucrose, 5 mM 
KCl with 0.5 mM PMSF and 1 PIC (Roche, EDTA free) tablet and freeze-thawed 4 
times on dry ice ethanol bath. Debris was centrifuged (1000 RCF, 20 minutes, 
4ºC), and supernatant subjected to ultra-centrifugation (100,000 RCF, 1hr, 4ºC). 
Supernatant was ejected onto 2’ 5’ ADP agarose column. 5 mL of 2’ 5’ ADP 
agarose powder (Sigma A 3515) was packed into a 5 mL column according to 
manufacture’s instructions using Buffer A (10 mM Tris-HCL, 1 mM DTT, 1 mM 
EDTA, 0.5 mM L-Arginine). Column was washed with 20 mL of Buffer A. Next the 
column was washed with 20 mL Buffer A (+ 0.5 M NaCl), 20 mL Buffer A (+ 0.5 
mM NADH), then 20 mL Buffer A (+ 0.5 mM NADP (Sigma), and finally, 20 mL 
Buffer A. To elute target protein (S) 10 mL of Buffer A (+ 10 mM NADPH (Sigma), 
10% w/v glycerol + 3 µM H4B (Sigma)) was used. Samples were frozen until 
subsequent anion exchange step was carried out. Fractions A4-7, A8-11, Elutes 
from NACL, NADH, NADP and concentrated to 750 µL and loaded onto anion 
exchange column (Whatman: DE-52) Colum was washed 3 times with 80 mM NaCl 
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(10 mL-20 mL) and target protein eluted using 2 injections of 150 mM NaCl, 3 µM 
biopterin (10-30 mL). 
2.4 Animals 
2.4.1 Mouse strains 
For all experiments, wild-type male C57 BL/6 mice (age 8-12 weeks), were used. 
Mice were purchased from Harlan, and kept at the Central Research Facilities, 
University of Glasgow, Glasgow, U.K. All mice were maintained under standard 
animal house conditions in accordance with local and home office regulations. 
2.5 Culturing of murine (primary and cell line) cells 
Detailed standard protocols of culturing mammalian cells at the OPPF are 
available online (https://www.oppf.rc-harwell.ac.uk/OPPF/protocols/). 
Methods described below are based on a previous publication (Weischenfeldt & 
Porse 2008). 
2.5.1  Culturing of L929 cells 
A vial of frozen cells was removed from liquid nitrogen storage and allowed to 
thaw in an incubator (37ºC, 5% CO2). Cells were resuspended in 5 mL cRMPI and 
then transferred into a vented T25 flask (Corning) and returned to incubator. 
Once confluent, medium was removed by aspiration. To each plate 6 mL of ice-
cold dPBS (Thermo, Magnesium and Calcium free) was added for 1-2 minutes. 
Cells were detached by gentle scraping (Greiner bio-one Cat-No: 541 070), and 
transferred to a 50 mL falcon tube.  Cells were pelleted by centrifugation (300 
RCF, 5 min) and resuspended in cRMPI (15 mL), and then transferred into a 
vented T75 flask (Corning) and returned to incubator. Once confluent, the 
process was repeated, this time transferring cells in a volume of 30 mL to a 
vented T150 flask (Corning). Once this culture was complete the process was 
again repeated, transferring cells into 5 T150 vented flask (Corning) each 
containing 100 mL. Four days after the cells had reached confluence the 
supernatant was collected. Briefly, supernatant was passed through two 
separate 0.2 µM filters (Merck Millipore: Stericup® and Steritop®, vacuum 
driven) and divided into 40 mL aliquots. These were stored at -20ºC until used. 
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In order to quantify M-CSF levels, a Mouse M-CSF DuoSet (R&D Systems) was used 
with L929 supernatant, according to manufacturer’s instructions. 
2.5.2  Culturing of bone marrow derived macrophages (BMDM) 
Mice were culled using cervical dislocation on day 0. First, dissection kit and 
mouse were sprayed with 70% ethanol. Legs were removed from mice and 
surrounding tissue was stripped off using scalpel and bones transferred to a 5 mL 
bijou tube (Thermo) containing RPMI. The subsequent steps were carried out in a 
sterile tissue culture hood. 
Bones were cut at each end and a 5 mL syringe  (BD Plastipak) with 23-gauge 
needle (Kenke Sass Wolf Fine-Ject®) was used to flush out bone marrow out of 
leg bone with complete RPMI (cRPMI) into a 9 cm petri dish (Thermo). Any 
clumps were broken up by repeating the passing through syringe and finally, 
through a 70 µM cell strainer (Easy strainer™ Greiner bio-one) in to a 50 mL 
falcon tube (Corning). Cells were pelleted by centrifugation (300 RCF, 5 min) 
and resuspended in cRMPI (10-20 mL) to obtain a density of 6-7 x 106 cells/mL. 
Cell number was calculated using Trypan blue exclusion (1:1 cells: Trypan blue 
(Sigma)) to ensure that >95% were viable. Next 1 mL of bone marrow suspension, 
2 mL of L929 supernatant and 7 mL cRPMI were added to fresh 9 cm petri dishes. 
Subsequent culturing took place in an incubator (5% CO2, 37ºC). Three days later 
(day 3) 5 mL cRMPI and 2 mL L929 supernatant were added. On day 6 BMDM were 
harvested. 
Medium was removed by aspiration and plates were washed once with warm 
dPBS (Thermo, Magnesium and Calcium free) to remove remaining non-adherent 
cells. To each plate 6 mL of ice-cold dPBS was added for 1-2 minutes. Cells were 
detached by gentle scraping (Greiner bio-one Cat-No: 541 070), transferred to a 
50 mL falcon tube. Plates rinsed once more with 6 mL of ice-cold dPBS, 
transferring the same 6 mL between plates to collect remaining cells. Cells were 
pelleted by centrifugation (300 RCF, 5 min), resuspended in an appropriate 
volume of cRMPI (10-20 mL) and viable cell number was calculated using Trypan 
blue exclusion. Cell density was then adjusted by dilution to desired density (106 
cells/mL in this study). Next cells were left to re-adhere overnight in tissue 
culture plates. Typically 6, 12, 24, 48 and 98 flat well plates were used. These 
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were purchased from Costar, with the exception being the 48 well plates, which 
were purchased from CytoOne. If cells were being used for Leishmania 
infections, they were left overnight at 32ºC, 5% CO2 prior to infections the next 
day. 
2.5.3 Immune-stimulation of BMDM 
The stimuli used were murine IFNγ (Peprotech, 315-05), LPS (Sigma: E. coli 
0111:B4, Ref L2630) and murine IL-4 (Ebioscience: 14-8041). IFNγ (100 U/mL: 
0.02 µG/mL) was typically added for overnight stimulation, after which LPS (100 
nG/mL) or IL-4 (20 ng/mL) was added for indicated times. If different 
concentrations were used, these are indicated. Note that LPS and IL-4 were 
added to wells without replacing medium (i.e. IFNγ was not removed). Cytokines 
(including IFNγ) and LPS were replaced after the washed in Chapter 4. 
2.6 Culturing of L. mexicana cells 
2.6.1  Species identification 
In order to ensure that the parasites used in this study were L. mexicana, a 
simple PCR based strategy was used (Schonian et al. 2003). Briefly a repeat 
region from the 18S ribosomal locus was amplified by PCR using oligonucleotides 
MB00095 and MB00096, and gel purified as described above. The purified DNA 
was digested with Hae III (Promega) and the products separated on 2% Agarose-
TAE gel (Lonza NuSieve® GTG® agarose) containing a 1 in 20,000 dilution of 
SYBR® Safe (Invitrogen). The restriction digest size profile was compared to 
those of a Promega 100 bp DNA ladder and the referenced publication, thus 
enabling identification of the species. 
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Figure 2-1: Species identification of L. mexicana. A: 18S ribosomal locus amplified 
by PCR using oligonucleotides MB95 and MB96. A Promega 1kb DNA ladder was used and band cut 
out for purification of DNA. B: DNA was digested with Hae III and separated on a 2% Agarose gel 
alongside a Promega 100bp DNA ladder. 
2.6.2  Culture of promastigotes 
L. mexicana (MNYC/BZ/62/M379) were grown in modified Eagle’s medium 
(HOMEM, Invitrogen) supplemented with 10 % (v/v) heat-inactivated foetal calf 
serum (HiFCS, Invitrogen) and 1 % (v/v) penicillin streptomycin solution (Sigma) 
at 25ºC. The episomal over-expressor transgenic parasites were maintained in 
G418 (Sigma) at 50 µg/mL. When referring to the stage of growth of cultures, 
mid-log phase corresponds to 2-7 x 106 parasites/mL and stationary phase to 
>1.5 x 107 parasites/mL. Cells were passaged weekly by counting parasites, and 
readjusting density to 1-5 x 105-106 cell/mL. For counting, 25 µL parasites were 
mixed with 25 µL 2 % formaldehyde (in PBS) and mixed by pipetting. Cells were 
placed in a Neubauer haemocytometer (Weber Scientific), allowed 3 minutes to 
settle prior to counting under a light microscope. For all infections, passage 
number 2-3 (number of passages since retrieved from Balb/c mouse) was used. 
For infections cells were seeded to insure that parasites had reached stationary 
phase 2 days prior to infection. For all cultures, non-vented flasks (Corning, 25 
or 75 mL) were used. 
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2.6.3  Transformation and culture of axenic amastigotes 
Medium was made according to a previous publication (Bates et al. 1992). 
Growth medium consisted of Schneider's Drosophila Medium (Thermo) 
supplemented with 20% (v/v) foetal calf serum (HIFCS, Invitrogen) and 1 % (v/v) 
penicillin streptomycin solution (Sigma). The pH of this medium was adjusted to 
5.4 prior to sterile-filtering via a 0.2 µM filter (Merck Millipore: Stericup® and 
Steritop®, vacuum driven). Stationary phase (5 day old culture) of L. mexicana 
were subculture into the above medium at a density of 1x106/mL at 32.0°C, 5% 
CO2 in vented flasks (Corning, 25 mL). Parasites were sub-cultured weekly. For 
metabolomics the initial cell density was 106 cells/mL. 
As axenic amastigotes tend to clump, they were disrupted for the purposes of 
counting or sub-passaging by passing the cells 3 times through a 26-gauge 
needle. 
2.6.4  Heat-killing of L. mexicana parasites 
This protocol was carried out after labelling of parasites for FACS enrichemnet 
(see 2.7.2) to minimise handling of heat-killed cells. The temperatures that 
were trialled were 42ºC for 6 and 12 minutes, 46ºC for 6 minutes, 48ºC for 6 and 
12 minutes, 56ºC for 6 minutes and 65ºC for 45 minutes. The lowest temperature 
that reliably gave heat-killed parasites was 48ºC for 12 minutes. Parasites were 
resuspended in a single cell solution by passing three times through a 23-gauge 
needle in a volume ≤ 250 µL.  The heat-killing was carried out in a water bath 
with the parasites in 0.5 mL micro-tubes (Sarstedt). Parasites were then 
transferred to a vented T25 flask (Corning), a density of 1x106/mL in a volume of 
10 mL in cRMPI. Flasks were placed in at 32.0°C, 5% CO2 in vented flasks 
(Corning, 25 mL) and counted daily. 
2.6.5  Creating stabilates of L. mexicana parasites 
Stabilates were prepared by mixing 500 µL cells with a pre-chilled mixture of 
500 µL consisting of HOMEM, 20 % HIFCS and 10 % DMSO in a 1.5 ml cryovial. 
These were stored at least overnight at -80ºC before transferring to liquid 
nitrogen. 
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2.6.6  Macrophage infection 
Bone marrow derived macrophage were adhered overnight either in 48 well 
plates or 9 cm petri dishes (for FACS enrichment) at a density of 106 cells/mL in 
complete RMPI at 32ºC in 5 % CO2. Macrophages were then infected with 
L. mexicana metacyclic promastigotes at a ratio of 10 parasites per macrophage 
for hour hours. At this point, medium was removed from plates by aspiration and 
wells were washed three times with RMPI (pre warmed to 32ºC). To each well, 
cRMPI was added and plates were returned to the incubator until processing for 
metabolomics. For petri dishes (FACS enrichment) the subsequent steps are 
described below. 
2.6.7  Transfection of L. mexicana parasites 
For each transfection, 5 x 107 cells in mid-log phase of growth were pelleted by 
centrifugation (1200 RCF, 10 min, 4ºC), washed once with ice cold PBS, 
resuspended in 100 µL of ice cold transfection buffer (90 mM Na-PO4, 5 mM KCl, 
50 mM HEPES, 0.15 mM CaCl2, pH7.3) and transferred to a 1 mL cuvette (Bio-rad: 
GenePulser® cuvette 165-2086). A minimum of 10 µg DNA in 20 µL sterile dH2O 
were added to the cells and tapped gently to mix. Cells were electroporated 
using the U-033 program on an Amaxa system (Amaxa AG, Köln, Germany) before 
being transferred to 10 mL pre-warmed complete HOMEM. The culture incubated 
overnight at 25ºC to allow recovery. A negative control was performed where 
20 µL dH2O was added instead of DNA. The following day appropriate antibiotics 
were added to select for successful transfectants. As an episomal over-expressor 
is not a stable phenotype, drug resistant parasites were passaged once before 
making stabilates alongside the wild-type control. 
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2.7 Flow cytometry 
An overview of the FACS antibodies and dilutions used in this study are given in 
Table 2-6. 
Table 2-6: Anti-mouse antibodies, viability and proliferation dyes used in current study. 
Marker Flurophore Clone Dilution Manufacturer Channel Isotype 
Cd11b Brilliant violet 510 M1170 5 µL/106 
cells/100 µL 
Biolegend V2 Rat IgG2a, κ 
F4/80 Brilliant violet 421 BM8 5 µL/106 
cells/100 µL 
Biolegend V1 Rat IgG2a, κ 
Live/dead APC-cy7 Efluor 780 N/A 1 µL/1 mL cells Ebioscience R2 N/A 
Proliferation APC-eFluor 670 N/A 5 µM (6x107 
promastigotes/
mL) 
Ebioscience N/A N/A 
2.7.1 Characterisation of bone marrow derived macrophages 
For cell surface staining, 106 cells were detached from plates as described in 
2.5.2, transferred to 5 ml FACS tubes (BD Falcon), washed with 1 mL twice with 
dPBS (Mg and CL free, 1 mM EDTA). Viability staining was executed using APC-
eFluor 670 (Ebioscience) according to manufactures instructions. This protocol 
ends with cells in FACs buffer (PBS, 1 mM EDTA, 2 % FBS).  After this step, cells 
were re-suspended, 50 µL of a 1:100 dilution of Fc Block (BD Bioscience) added 
and the cells incubated for 15 minutes at 4ºC. Antibodies for were diluted in 
FACS buffer and 50 µL of this mix added to each tube and incubated for 20 
minutes at 4ºC in the dark (in a fridge). Cells were subsequently washed with 1 
mL of FACS buffer and centrifuged (300 RCF, 5 minutes). Cells were then re-
suspended in 300 µL FACS buffer, and passed through a 100 µM cell strainer (Easy 
strainer™ Greiner bio-one) prior to running on a MACSQuant (Miltenyi) as 
described in Chapter 3. For these experiments, alongside fluorescent–1 (FLO-1) 
controls, compensations beads (eBioscience: OneComp eBeads) were used with 
each antibody, according to manufactures instructions. 
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2.7.2  FACS enrichment of infected cells 
Protocol is adapted from previous publication with no carboxyfluorescein 
succinimidyl ester (CFSE) used (Moreira et al. 2015). Required number of cells 
were taken, pelleted by centrifugation (1200 RCF, 5 minutes) and supernatant 
discarded. Cells were wash twice in dPBS (Mg and CL free), and then re-
suspended (passed through 23-gauge) in single cell solution at 6x107 
promastigotes/mL. Cells were stained for 5 minutes with 5 µM eFluor670 (in 
dark, 25ºC). Reaction was stopped by adding 5 volumes of ice-cold cRPMI, 
incubating on ice for 5 minutes. Cells pelleted by centrifugation (1200 RCF, 5 
minutes) and medium discarded. Cells were re-suspended an equal volume of 
ice-cold cRPMI, pelleted by centrifugation (1200 RCF, 5 minutes) and finally, 
resuspended (passed through 23-gauge) at a density suitable for heat-killed. 
Infection was allowed to proceed for 4 hours (32ºC, 5% CO2) in petri dishes 
containing BMDM (106 cells/mL) after which medium was removed. 
To each plate, 6 mL ice-cold dPBS (Mg and CL free) was added for 3 minutes, 
and cells detached by scraping. Cells were washed once with PBS, re-suspended 
in FACs buffer (2% FCS in dPBS (Mg and CL free)) and passed though a 100 µM cell 
strainer into FACS tubes (BD Falcon). Note that EDTA was not used at any point 
of this protocol. Samples were stored on ice until processed. An FACS Aria I and 
III (BD Biosciences) were calibrated (auto-compensation) using same samples 
(Non-infected, infected and heat-killed infected). Cells were sorted into 15 mL 
falcon tubes containing RPMI+50% HiFCS). After collecting all samples, cells were 
pelleted centrifugation (300 RCF, 5 minutes), and resuspended in cRMPI. Cell 
number was calculated using Trypan blue exclusion (1:1 cells: Trypan blue 
(Sigma)) to ensure that >90% were viable. Finally, cells were seeded at a density 
of 106 cells/mL in a volume of 200 µL in 48 well plates. Plates were placed in 
incubator (32ºC, 5% CO2) to allow infection to resume. 
2.7.3  Data and analysis 
Data was imported into FlowJo 10.0.8r1 (Treestar) for analyses. Cell size 
(Forward scatter versus side scatter) and viability (EF780), single stained 
samples, Compensation beads and FMO-1 were used where relevant. 
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2.8 Phenotypic analysis of BMDM 
2.8.1 ELISA 
Cytokine expression was tested in in vitro culture supernatants. ELISAs were 
carried out according to the manufacturer’s protocols. In general, 96-well half 
or full volume high-binding plates (Fisher Scientific) were coated with capture 
antibody in recommended coating buffer and incubated overnight at a 
temperature recommended by the manufacturer. For IL-6 ELISA, a 1/8 dilution 
in assay diluent was used to insure samples were in linear range of assay. After 
incubation with detection antibody and streptavidin- horseradish peroxidase 
(HRP) and subsequent washing, TMB substrate was added to wells and incubated 
at room temperature (in dark) until development of standards appeared middle 
of this linear phase of amplification (i.e. when it was possible to visually note 
the differences in the different concentrations). The reaction was then stopped 
using 4N sulphuric acid, and plates read at 450 nm with wavelength correction 
applied by subtracting the absorbance at 570 nm using a Tecan Sunrise® plate 
reader. See Table 2-7 for a list of ELISA kits used in the current study. Medium 
incubated in empty wells were used as matrix blanks. 
Table 2-7: ELISA kits used in current study. 
Cytokine detected Manufacturer Detection range 
M-CSF R&D Systems 15.6-1000 pg/mL 
IL-6 BD Biosciences 15.6-1000 pg/mL 
MCP-1 Affymetrix Ebioscience 15.0-2000 pg/mL 
2.8.2 Luminex 
The Cytokine Mouse 20-Plex Panel (Thermo: LMC0006) was used according to 
manufactures instructions with the exception being that the reagents were 
dilutes as to spread the assay over two plates (using Extracellular Protein Buffer 
Reagent Kit for Mouse or Rat, LMB0001). Standard protocols provided by the 
Institute of Infection, Immunity and Inflammation’s Flow Cytometry Facility 
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were used (see http://www.gla.ac.uk/media/media_264279_en.pdf and 
http://www.gla.ac.uk/media/media_265386_en.pdf for more information) 
Medium incubated in empty wells were used as matrix blanks. Plates were read 
using Biorad Bio-Plex 100 and data acquired and analysed using Bio-Rad's Bio-
Plex software version 4.1TM. 4 biological replicates were used in this assay. 
2.8.3 Greiss assay 
Supernatant was transferred to 96 well plate, centrifuged (300 RCF, 5 minutes) 
and 50 µL transferred to a new 96 well plate. Standard curves were made using a 
serial dilution of 0.1 M Nitrite (Sigma). The concentrations used were 100, 50, 
25, 12.5, 6.25, 3.125 and 0 µM. To the samples and standards, 100 µL of Greiss 
reagent (Sigma: 03553) was added until development of standards appeared 
middle of this linear phase of amplification. Plates were read at 570 nm using a 
FLUOstar OPTIMA micro-plate reader (BMG Labtech). Medium incubated in empty 
wells were used as matrix blanks. 
2.8.4 MTT assay 
The Vybrant® MTT Cell Proliferation Assay Kit was used to determine the 
toxicity of L-argininic acid and L-pipecolic acid (American Custom Chemical 
Corporation). 1.25 and 20 mM were the concentrations used and the positive 
control was 2% formaldehyde (final concentration). The protocol was carried out 
according to manufacture’s instructions (Quick protocol option) using DMSO to 
re-solubilise formazan crystals. Absorbance was read at 540 nm using a FLUOstar 
OPTIMA micro-plate reader. 
2.9 Enzymatic synthesis and assays 
2.9.1 Synthesis of 2 keto-arginine 
Synthesis was modified from (Wellner & Meister. 1960). Briefly 30 mg L-amino 
oxidase (Sigma: dried venom) 0.2 grams arginine, 47,000 U catalyse (Sigma: 
bovine), 0.39 µM FAD pH 7.2 were mixed together in a volume of 21.4 mL in a 
100 mL conical Erlenmeyer flask. The pH was adjusted to 7.6 with 1 N HCI. The 
flask was plugged with cotton, left shaking overnight at 37ºC. After 6 hours, 
another 47,000 U catalyse was added. Protein was removed by passing through a 
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Vivaspin 20 tube (5,000 MCW cut off, 4,000 RCF). The elute was concentrated by 
evaporation with a Savan DNA120 speed vac concentrator (Thermo) under 
vacuum, medium heat, to about 6.4 mL. For a control, a 1/10 amount of the 
above reagents minus L-arginine was put through the same protocol. For LC-MS 
analysis, samples were diluted to 100 µM (of a theoretical 100% efficient yield) 
in Chloroform/Methanol/dH2O, 1:3:1). 
2.9.2 Assay for L-citrulline detection 
All non-radioactive / non LC-MS methods detect ureido compounds use 
diacetylmonoxime in strong acid for the colorimetric determination of citrulline. 
These assays also detect carbamyl aspartate and urea. The assay used here was 
adapted from a previous study (Prescott & Jones 1969) to a 96 well format. Note 
that for experiments using ADI, reactions took place in glass tubes, 1 mL volume, 
and standards and blanks were developed alongside these in 1 mL tubes, before 
transferring to cuvettes (Fisher Scientific FB55147) for measurement in at 
Shimadzu UV-2550 spectrometer. While this assay lacks the dynamic range of 
alternative protocols (Knipp & Vašák 2000), it is highly sensitive in our hands, 
reproducibly detecting in the low (<50) µM range. Briefly, 100 µL enzymatic 
reactions were set up in a 96 well plate. For ADI, the indicated amount of 
commercial Mycobacterium arginini ADI (Abcam®) was added (5 µL of 0.1 
mg/mL stock) to a volume of 1 mL consisting of 50 µM L-arginine in dH2O. 
Samples were incubated at 37ºC for 60 minutes. 70 µL Urease (Sigma Jack bean 
10 mg/mL in 0.2 M sodium phosphate buffer) was added for a further 10 minutes 
at room temperature. Buffer controls and a L-citrulline standard curve were set 
up on same plates. The L-citrulline standard curve included the following 
concentrations: 200, 100, 50, 25, 12.5, 6.25, 3.125 and 0 µM. 
 For DDAH assay, 2.5 µL of enzyme (4.3 mg/mL) was added to 100 µL solution of 
100 mM Na2HPO4, pH 6.5, containing 100 µM ADMA (Cayman Chemical, stock was 
10 mM in 100 mM Na2HPO4, pH 6.5). Samples were incubated at 37ºC for 60 
minutes. Buffer controls and a L-citrulline standard curve were set as above. 
Two colour development solutions are used in the assay. Solution A is an 
antipyrine/H2SO4 (50% v/v) reagent that is stable at room temperature. Briefly, 
50 mL stock H2SO4  (Sigma, 17.8 M) was slowly added to 25 mL dH2O. Next 25 mL 
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was added to this mix, ensuring solution did not over heat. Once solution cooled 
down to room temperature, antipyrine (Sigma) was added (5 g/L). Solution B 
consists of 0.80 gram of diacetymonoxime (Sigma) in 100 mL of 5% (v/v) acetic 
acid (Sigma). This oxime reagent was stored at 4ºC in a dark bottle covered with 
aluminium foil. It was made fresh every three weeks. 
Immediately before use, 2 volumes of Solution A was mixed with 1 volume of 
Solution B. To each well, 100 µL of this mixture was added (or 1 mL to tubes), 
and the plate placed in an oven at 60ºC for 3 hours. Plates were read on a 
FLUOstar OPTIMA micro-plate reader, measuring 485 nm excitation, 460 nm 
emission. 
2.9.3 G6PDH assay 
Assay was carried out according to previous publication (Maugeri et al. 2003). 
Cells were lysed for one hour on ice in 10 mM Tris HCl buffer (pH 7.4, PIC 
(Roche, EDTA free), 0.4% Triton-X100 (Sigma). Debris was pelleted by 
centrifugation (18,000 RCF, 4ºC, 15 minutes) and 100 µL supernatant transferred 
to each cuvette (Fisher Scientific FB55147). Reactions were measured in quartz 
cuvettes and contained 50 mM Triethanolamine, pH7.5, 5 mM MnCl2, 0.5 mM 
NADP and 2 mM glucose 6-phosphate. Reactions were initialised by adding NADP 
after the 5 minutes allocated to allow measurements to stabilise. The assay was 
performed at 30ºC and absorbance read at 340 nM using a Shimadzu UV-2550 
spectrometer. The positive control was 1 µL of G6PDH, (Sigma, Leuconostoc 
mesenteroides 0.0034 mg of enzyme/2.66 units added). Bradford reagent 
(BioRad) was used according to manufactures instructions with same sample to 
determine protein content. 
2.10  Metabolite extractions 
2.10.1 Preparation of LC-MS samples for L. mexicana parasites 
Protocol for amastigotes and procyclic promastigotes are identical except that 
2 x 108 cells are used for the former, and 1 x 108 cells for the latter. Note that 
for all stable isotope labelling experiments, parasites were grown in 50% labelled 
medium. This medium was made by adding an equal concentration of labelled or 
non-labelled amino acid to either stock HOMEM or axenic amastigote medium. 
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Note that the concentration of L-arginine was 1.01 mM in HOMEM. This means 
that the amino acids concentration was 2x in all samples these experiments. In 
the axenic amastigote medium, SDM makes up 80% of the medium (20% serum). 
As the concentration of L-arginine is 2.3mM in SDM and it was assumed that 
there is some L-arginine present in serum, so 2mM labelled or non-labelled 
amino acid was added. 
Parasites were counted and required number of cells collected in 50 mL falcon 
tubes. Samples were quenched by immersing tubes in a dry-ice ethanol bath and 
a thermometer was used to mix samples and ensure samples did not freeze. In 
our hands, quenching until thermometer reads 10ºC is sufficient to cool samples 
near to 0ºC without freezing. Cells were pelleted by centrifugation (1200 RCF, 
10 minutes, 4ºC). Spent medium as removed by aspiration. Pellets were 
resuspended in 1 mL of ice cold PBS, transferred to 1.5 mL micro-tubes and 
again pelleted by centrifugation (1200 RCF, 10 minutes, 4ºC). PBS was discarded 
and pellets extracted by re-suspending in ice-cold extraction solvent 
(chloroform/methanol/water, 1:3:1). 
Cells were left shaking (1 hour, 4ºC). To make a solvent blank, 200 µL of 
extraction solvent was added to an empty 1.5 mL micro-tube and processed 
alongside these samples. Solvent was then transferred to 1.5 mL micro-tubes 
(Sarstedt), and centrifuged (18,000 RCF, 15 minutes, 4ºC). Supernatant was 
immediately transferred to 2 mL screw-cap tubes (Sarstedt) or glass vials for LC-
MS analysis (Chromacol SV-S11G). Sample from each tube was transferred to a 
new screw-cap tube for pooled sample. The amount taken was calculated so that 
there would be sufficient pooled sample to coat the pHILIC column (6 injections) 
and to be injected after every 4 samples. At this point, samples were capped 
with Argon, and then stored at -80ºC until LC-MS analysis. 
In the case where spent medium analysis was required, 5 µL was extracted in a 
volume of 200 µL extraction solvent and processed as above. For these 
experiments, medium was left in an empty well for duration of experiments to 
give fresh medium samples. 
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2.10.2 Preparation of LC-MS samples for BMDM 
10 µL of medium was transferred to a 48 well tissue culture plate, which was 
kept on ice. When time permitted, this plate was centrifuged (300 RCF for 5 
minutes, 4ºC) and supernatant transferred to new plate for extraction or storage 
(-80ºC). 
Remaining medium was aspirated and cells were washed once with dPBS  
(Magnesium and Calcium free, no EDTA), aspirating immediately. Ice-cold 
extraction solvent (CMW: chloroform/methanol/water, 1:3:1) was added to each 
well, including an empty well (for solvent blank), and cells were left shaking (1 
hour, 4ºC). Solvent was then transferred to 1.5 mL micro-tubes, and centrifuged 
(18,000 RCF, 15 minutes, 4ºC). Supernatant was immediately transferred to 2 mL 
screw-cap tubes. Sample from each tube was transferred to a new screw-cap 
tube for pooled sample. At this point, samples were capped with Argon, and 
then stored at -80ºC until LC-MS analysis. 
For Chapter 3, 3 million macrophages were seeded at a density of 106 cells/mL 
and extracted in a volume of 400 µL CMW. In Chapter 4, for FACS enriched 
samples, 200,000 macrophages were seeded at a density of 106 cells/mL (250 µL) 
and extracted in a volume of 250 µL CMW. For non-FACS enriched samples, 
250,000 macrophages were seeded at a density of 106 cells/mL (250 µL) and 
extracted in a volume of 250 µL CMW. 
2.10.3 Calculation of protein content post-extraction 
To each well, NaOH (0.1 M, 400 µL/106 cells) was added. The plate (s) were left 
shaking (15 minutes 4ºC). Plates were next centrifuged (300 RCF, 5 min) and 10 
µL of supernatant transferred to a 96 well plate. To the same plate, a 10 µL of a 
BSA (Sigma) dilution series (2 fold: 0.5-0 mg/mL in 0.1 M NaOH) was added.  
Finally, 190 µL of Bradford reagent (BioRad) was added to each plate on top of 
samples and standards. Absorbance was measured at 595 nm using a FLUOstar 
OPTIMA micro-plate reader. 
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2.11 Statistical analysis 
Statistical analysis was carried out as described in text using Graphpad Prism. 
Otherwise, MetaboAnalyst or Deseq2 were used as described. For targeted LC-
MS, 3 replicates were used while 3-4 replicates were used for untargeted 
metabolomics. ELISAs, Greiss assays, MTT assays, Luminex assays and qPCRs 
were conducted on 3-4 biological replicates. 
2.12 LC-MS 
Note that experiments in Chapter 3 and the U13C-L-arginine labelling 
promastigote studies used extraction solvent using 1 µM internal standards 
(theophylline, 5-fluorouridine, Cl-phenyl cAMP, N-methyl glutamine, canavanine 
and piperazine). 
The sample platform chosen for this project was liquid chromatography coupled 
with mass spectrometry. All samples were separated with high performance 
liquid chromatography (HPLC) on a Dionex Ultimate 3000 RSLC system (Thermo) 
using ZIC-pHILIC (Merck) column. The mass spectrometry platform used was a 
qExactive Orbitrap mass spectrometer (Thermo), the exception was the dilutions 
of the episomal over-expressors, which were run on a FUSION MS qExactive 
Orbitrap mass spectrometer (Thermo). Analysis was performed in positive and 
negative mode; using 10 µL injection volume and samples were maintained at 
4ºC during analysis. A linear biphasic LC gradient was conducted from 80% B to 
20% B over 26 minutes, where solvent B was acetonitrile and solvent A was 
20 mM ammonium carbonate in water. The flow rate was 300 µL/min, and 
column temperature maintained at 25ºC. For longer LC protocol the gradient was 
identical except that it was over 46 minutes. Each sample was run in a 
randomized order, with a pooled sample run between every 4 samples, 
according to previously published methods (Vincent et al. 2010). 
The MS set up was calibrated [Thermo calmix (Pierce™ calibration solutions from 
Thermo Scientific) with masses at lower m/z; 74.0393 m/z (C2H6NO2: +) and 
89.0244 (C3H5NO3: −)] in both ionization modes before analysis and a tune file 
targeted towards the lower m/z range was used. Full scan (MS1) data was 
acquired in both ionization modes in profile mode at 50,000 resolution (at m/z 
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range 70-1400), an automatic gain control (AGC) target of 106 cts, with spray 
voltages +4.5 kV (capillary +50 V, tube: +70 kV, skimmer: +20 V) and −3.5 kV 
(capillary -50 V, tube: -70 kV, skimmer: -20 V), capillary temperature 275ºC, 
probe temperature 150ºC, sheath gas flow rate 40, auxiliary gas flow rate 5 a.u., 
and a sweep gas flow rate of 1 a.u. For fragmentation analysis the settings are in 
Supplementary File 2-1 and analysis conducted using mZCloud. 
Data analysis was performed using the MzMatch (Scheltema et al. 2008) and 
IDEOM (Creek et al. 2012) software packages for untargeted analysis. The 
Xcalibur (Thermo) software package was used for targeted peak picking and 
exporting fragmentation spectrums which were used as queries with which to 
search mZCLOUD (Vinaixa et al. 2016). A mixture of 240 standards (in three 
separate mixes), covering a range of metabolic pathways, was run alongside 
each sample batch to allow metabolite “identifications” to be made 
(MSI level 1).  
According to the metabolomics standards initiative (MSI), metabolite 
identifications (MSI level 1) are given when more than one feature matches an 
authentic standard (i.e., mass and retention time) and annotations are made 
when matching to a metabolite is made by mass only (MSI level 2) (Sumner et al. 
2007). Peaks were visually interrogated on the identification tab, with some 
“metabolites” removed at this stage. To avoid the lipid bolus, a 4.2-minute 
retention time cut off was applied. As lipids and peptides are not reproducible 
detected, these were removed from statistical analysis. If available, 
fragmentation data was used to strengthen confidence in identifications 
Statistical analysis was conducted using MetaboAnalyst (One way ANOVA with 
false discovery rate correction) or Graphpad Prism (One way ANOVA with Tukeys 
correction for pairwise comparisons). 
2.13 RNA seq 
Glasgow Polyomics carried out library prep and sequencing. Quality of samples 
was verified using a Bioanalyser 2100 (Agilent) and accurate quantity determined 
using a Qubit® (Life technologies). A poly A selection was carried out with the 
SMART-Seq v4 Ultra low Input RNA kit (Clontech) followed by the Nextera XT kit 
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(Illumina). The SMARTer kit selects poly A RNA and creates cDNA then the 
Nextera XT kit fragments the DNA, adds the adapters and amplifies adapter-
fragments by PCR to form the final library. The average size of the first-stranded 
library was 467bp (average size of the library was determined by the 
Bioanalyzer). Samples were run on the NextSeq™ 500 platform to obtain 
approximately 50 million paired end reads (2 x 75bp). Raw data was loaded onto 
the Galaxy server (hosted by Glasgow Polyomics) (Afgan et al. 2016). 
Quality investigated using Fastqc (Andrews 2010) and raw files aligned to the 
mouse mm10 genome using HISAT2 (Kim et al. 2015b). Htseqcount (Anders et al. 
2015) was used to extract counts per gene. The counts were downloaded to be 
run on a local instance of Deseq2 (1.10.1) (Love et al. 2014). Overlap between 
pairwise comparisons and likelihood ratio test (LRT) DE genes (adjusted p-value 
< 0.05) was mapped using Venny (Oliveros 2015). For pathway analysis, the 
filtering described in Chapter 4 was done in Excel (Microsoft). Similarly, filtering 
to get a list of detected (in at least 2 replicates of one condition) was done in 
Excel. Pathway analysis was conducted using the web version of Graphite Web 
(Sales et al. 2013) uploading the background and the indicated lists of DE genes 
with their respective Log2 fold change values. To map mouse to human IDs, 
Biomart was used (Durinck et al. 2009). Raw files and workflow 
(RawàHisat2àHTseqcount, Rawà Fastqc) is available on request on the Galaxy 
server hosted by Glasgow Polyomics. Final (including SPIA pathway analysis) and 
intermediate files, r code (Deseq2 session), are all contained within 
Supplementary File 2-2. 
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2.14  Phylogenetic and structural analysis of 
Lmxm.08.1225 
2.14.1 Clustal Omega and Phyre2 
Homologs from species with DDAH activity were downloaded from BRENDA. A 
select list of ADI sequences was chosen from species with confirmed ADI activity 
on BRENDA. This was so to better match the alignment from a previous 
publication (Knodler 1998). For analysis on Phyre2 the sequence for 
Lmxm.08.1225 was uploaded and default settings were selected. 
Table 2-8: Genes used in Clustal Omega analysis.  Note that ID refers to NCBI Reference 
Sequence or UniProtKB/Swiss-Prot*. 
Name Protein Species ID 
DDAH1_HUMAN DDAH Homo sapiens NP_036269.1 
DDAH2_HUMAN DDAH Homo sapiens XP_011512750.1 
DDAH1_BOVINE DDAH Bos taurus NP_001095671.1 
DDAH2_BOVINE DDAH Bos taurus XP_005223736.1 
DDAH1_MOUSE DDAH Mus musculus NP_081269.1 
DDAH2_MOUSE DDAH Mus musculus XP_006524675.1 
DDAH1_RAT DDAH Rattus norvegicus NP_071633.1 
DDAH2_RAT DDAH Rattus norvegicus NP_997697.1 
DDAH1_Rabbit DDAH Oryctolagus cuniculus XP_002715931.2 
DDAH2_X1_ Rabbit DDAH Oryctolagus cuniculus XP_008260806.1 
DDAH2_X2_ Rabbit DDAH Oryctolagus cuniculus XP_008260808.1 
DDAH_Dog DDAH Canis lupus familiaris XP_005622043.1 
DDAH_Chicken DDAH Gallus gallus NP_989713.1 
DDAH1_ Mycobacterium tuber DDAH Mycobacterium tuberculosis WP_023643926.
1 DDAH_ Streptomyces coel DDAH Streptomyces coelicolor NP_630791.1 
DDAH_P. aer DDAH Pseudomonas aeruginosa NP_249886.1 
Giardia_intest_AD ADI Giardia intestinalis Q27657* 
Pseudomonas_aer_AD ADI Pseudomonas aeruginosa P13981* 
Mycoplasma_arg_AD ADI Mycoplasma arginini P23793* 
Lactococcus_lac_AD ADI Lactococcus lactis P58013* 
NOS2_Human NOS2 Homo sapiens P35228 
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3 A stimulus specific metabolic signature of 
inflammatory macrophage 
3.1 Introduction 
Immune-metabolism is a rapidly growing area of research, whose importance is 
increasingly recognised across the immunology discipline. The complexity of 
cellular metabolism has been the main challenge when it comes to trying to 
relate metabolism to cell function. This complexity stems from the vast number 
of metabolites (thousands), the multiple pathways in which they occur, and the 
complex regulation of enzymes that modulate these pathways. A plethora of 
studies are now investigating and discovering the mechanisms by which 
metabolites modulate the function of key innate immune cells such as 
macrophages and dendritic cells (DCs) (Tannahill et al. 2013; Jha et al. 2015; 
Lampropoulou et al. 2016). In these cells metabolites act not only as precursors 
for anabolic and catabolic process but engage intracellular and extracellular 
signalling pathways to drastically alter the cell phenotype. 
In the 1.5.2 the way in which inflammation leads to an altered energy 
metabolism consisting of an increased flux through glycolysis and the PPP, as 
well as a fragmented TCA cycle is introduced. These perturbations are required 
to meet the inflammatory cells’ demands for ATP, NADPH, and ribonucleotide 
precursors. These events are initiated by ligation of immune signalling molecules 
or pathogen antigen to receptors such as pattern recognition receptors (PRRs), 
cytokine receptors or antigen receptors. Inflammatory macrophages (M1) also 
cause accumulation of or upregulate the production of metabolites such as 
succinate and itaconate, which have effector functions. Itaconate is produced 
from citrate that accumulates as a result of the downregulation of isocitrate 
dehydrogenase (Jha et al. 2015). Citrate is also diverted towards prostaglandin 
synthesis.  Itaconate has been demonstrated to inhibit isocitrate lyase, which is 
part of the glycoxylate shunt in bacteria (Michelucci et al. 2013). 
In contrast to M1 macrophages, anti-inflammatory (M2) macrophages rely on 
oxidative phosphorylation with an intact TCA cycle that is supplemented by 
glutamine. Certain key metabolic processes are differentially regulated in anti-
inflammatory macrophages. This is illustrated by M2 macrophage expression of a 
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specific phosphofructokinase isoform, PFKFB1 (also known as fructose 
bisphosphatase 2 (FBPase2)) that is much less active than the u-PFK2 isoform, 
which is expressed in M1 macrophage (Kelly & O'Neill 2015; Rodríguez-Prados et 
al. 2010). In M1 macrophages Fructose-2, 6-bisphosphate synthesis is driven by 
u-PFK2. Fructose-2, 6-bisphosphate activates glucose breakdown in glycolysis by 
activating the glycolytic enzyme 6-phosphofructo-1-kinase.  
Additionally, M2 macrophages increase uptake of triglycerides using the CD36 
receptor. The triglycerides are subsequently hydrolysed by lysosomal acid lipase 
to yield lipids, which in turn are used for fatty acid oxidation (Huang et al. 
2014). M2 macrophages divert glutamine metabolism to UDP-GlcNAc production 
(Jha et al. 2015). This is critical for the glycosylation of lectin and mannose 
receptors, which are required for pathogen recognition. Jha et al confirmed this 
by showing that both glutamine deprivation (in cell culture medium) and an 
inhibitor of N-glycosylation decreased M2 polarisation. 
The effects of immune-modulating metabolites are not confined to within the 
cell producing them. Immune cells possess extracellular receptors such as 
G protein–coupled receptors (GPCRs) that enable them to detect extracellular 
metabolites. One example of this is where DCs detect extracellular succinate via 
the succinate receptor GPR91. When activated, this receptor triggers an increase 
in intracellular Ca2+ and this combines with TLR3 or TLR7 signalling to enhance 
DC activation and migratory ability (Rubic et al. 2008).  
The microbiome is an additional source of immunomodulating metabolites. A key 
example of this is the short chain fatty acid butyrate, which is produced by 
commensal bacteria in the gut. Butyrate can bind to GPCRs on macrophages and 
DCs. It was recently shown that butyrate facilitates M2 macrophage polarization, 
in vitro and in vivo (Ji et al. 2016). This led to macrophages that were 
tolerogenic, and had increased migrational and wound healing capacity. The 
authors proposed that an H3K9 acetylation/STAT6-signalling pathway was 
responsible for upregulated arginase activity, which was the key mechanism 
responsible for these anti-inflammatory phenotypes. 
The overall aim of the work in this project is to establish a model of metabolism 
within the leishmania-infected macrophage. Prior to this a robust protocol was 
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required to measure the metabolic profile of inflammatory macrophages that 
could reproduce previously validated findings. A classical inflammatory (M1) 
macrophage model was used to establish the immune metabolism therein. This 
involved use of a commonly used M1 stimulus; IFNγ and LPS. The former is an 
immune stimulus while the latter represents a pathogen challenge. 
To generate M1 macrophages in the previously mentioned immune-metabolic 
studies, Tannahill et al used LPS and Jha et al used IFNγ + LPS. These studies 
have not, however, distinguished between what these stimuli do on their own 
and what they do together. An obvious example is the argino-succinate shunt, 
which Jha et al showed is upregulated to replenish a fragmented TCA cycle in M1 
macrophages. An essential part of this shunt is L-citrulline generated by iNOS, 
and this enzyme is maximally upregulated in the presence of macrophages 
treated with both IFNγ + LPS. It is not expected this to occur to the same extent 
in cells rerated with either stimulus on their own. To address this gap in the 
literature, four conditions were used; non-stimulated cells, IFNγ primed cells, 
LPS treated cells and cells that were both IFNγ primed and LPS treated. The 
reasoning behind this was to systematically determine the immune-metabolic 
processes that were driven by the immune system (IFNγ), a pathogen (LPS) or 
the interaction of both (IFNγ + LPS). This knowledge will be essential if deciding 
to target inflammation via the pathogen, immune system, or both. 
3.2 Results 
3.2.1 Characterisation of the bone marrow derived macrophages 
(BMDM) system 
3.2.1.1 Evaluation of L929 supernatant. 
To generate bone marrow derived macrophages (BMDM) bone marrow was taken 
from 8-12 weeks old male C57 BL/6 mice. To differentiate myeloid precursors 
from murine bone into macrophages, supernatant from the L929 murine 
fibroblast cell line was used (see 2.5). The key differentiation factor present in 
L929 conditioned medium is macrophage colony-stimulating factor (M-CSF) 
(Weischenfeldt & Porse 2008). This is a lineage-specific growth factor, which is 
responsible for the proliferation and differentiation of committed myeloid 
progenitors (i.e., monocytes) into cells of the macrophage/monocyte lineage. 
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20% L929 supernatant was routinely used during the 7-day differentiation but in 
order to get a more informative characterisation an M-CSF ELISA was used 
(2.8.1) to provide a quantitative readout on the amount of M-CSF typically used 
during this experiment (Figure 3-1). The results demonstrate that there is 
batch-to batch variation, however, the amount of M-CSF in the L929 supernatant 
ranges between 165 pg/mL to 285 pg/mL. Thus, depending on the batch used 
the cultures will be receiving 33-57 pg/mL; less than a half log difference. 
 
Figure 3-1: MCS-F of 4 batches of L929 supernatant was quantified using ELISA. A one-way 
ANOVA with a Tukeys multiple comparison test was used to test for significance (p<0.05). 
Andrew Pountain and Clément Regnault assisted with this experiment. 
3.2.1.2 Flow cytometry profiling of BMDM 
To assess the purity of BMDM, flow cytometry was used (2.7.1). In our protocol 
the APC-eFluor® 780 (eBioscience) viability dye that is excluded from live cells 
was used (Figure 3-2a). The cells used in this experiment were generated as 
described in 2.5 and left overnight (37ºC, 5% CO2) to re-adhere. It is worth 
noting that removing cells from tissue culture plates was not done for any 
metabolomics experiments presented in this chapter, so the cell death shown in 
Figure 3-2 c is not necessarily indicative of the situation in other experiments at 
the point of sample preparation. Furthermore, for all experiments, viability of 
all cells at time of seeding was, as is standard, verified to be >95% using trypan 
blue exclusion. The receptors assessed to evaluate purity were CD11b and 
F4/80, which are commonly used macrophage markers. As can be seen in 
(Figure 3.2(d-I)), the vast majority of differentiated cells were macrophage. 
Dendritic cells can also express these markers but require either granulocyte-
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macrophage colony stimulating factor (GM-CSF) or FLT-3L for their 
differentiation. 
 
Figure 3-2: Flow cytometry characterisation of cultured macrophage: A: Selecting population 
based on forward scatter area (FSC-Area) against side scatter area (SSC-Area). B: Gating on 
single cells using SSC-Area against side scatter area (SSC-Height). C: Gating on live cells using 
gating on cells negative for the viability dye Ef780. D: Gating on Cd11B+ cells then, E: 
characterising presence of F4-80. F: Fluorescence -1 (FLO-1) control for Cd11b and, G: F4-80. H: 
Histogram overlay of D (blue) and F (red). I: Histogram overlay of E (blue) and I (red). Results are 
representative of 3 biological replicates. Andrew Pountain and Clément Regnault assisted with 
this experiment. 
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3.2.1.3 Cytokine profile and nitric oxide production 
In order to validate the BMDM obtained from in vitro culturing several standard 
immunological assays were used to characterise them. To generate polarised 
macrophage either LPS, IFNγ prior to LPS, or IL-4 were used. IFNγ, LPS or IFNγ 
plus LPS are routinely used to generate pro-inflammatory macrophages. These 
pro-inflammatory cells express a plethora of inflammatory cytokines. A prior 
stimulus with IFNγ is required to obtain detectable iNOS activity and 
upregulation of MHC-II receptors. On the other hand IL-4 is used to generate 
anti-inflammatory macrophage that have higher arginase activity and 
upregulation of mannose and lectin receptors.  
To profile a large number of cytokines the Luminex 20-plex assay (Invitrogen) 
was used. This allowed us the profiling of 20 cytokines in supernatant from 
BMDM that were stimulated with either nothing (naïve), LPS or IL-4 for 6 hours. 
Out of all cytokines evaluated, only six were reproducibly detected in the 
inflammatory macrophage cultures (Figure 3-3). These include classical M1 
cytokines such as TNF-α and IL-6. Although not performed, the author 
anticipates that, based on the literature that if the supernatants were collected 
at a later time-point, or if the cells had been co-stimulated with IFNγ prior to 
LPS, additional cytokines would have been detected.  It is important to note that 
no cytokine were detectable in naive or anti-inflammatory macrophages. While 
some mMCP-1 was detected in some of the M2 macrophages, the levels in M2 
were not significantly (one-way ANOVA, Tukeys multiple comparison test) 
different to those in M0 macrophages. 
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Figure 3-3: Generated BMDM produce pro-inflammatory cytokines in response to LPS. BMDM 
were stimulated for 6 hours in the presence of LPS (100 ng/mL). Supernatants were analysed 
using the Luminex murine 20-plex kit (Invitrogen) as described in materials and methods. M2 
macrophages were stimulated with IL-4 for the same amount of time. 4 biological replicates 
(each in 2 technical duplicates) are included in analysis. Andrew Pountain and Clément Regnault 
assisted with this experiment. 
Furthermore, for the inflammatory BMDM, the IL-6 data produced in the Luminex 
assay was validated using an ELISA using the same supernatants (Figure 3-4a). 
While the anti-inflammatory cytokines IL-4 and IL-10 were profiled in the assay, 
the latter was not detected and the former was not appropriate as it was used 
for stimulation of the anti-inflammatory phenotype. IL-4 primes the cells to 
respond in an anti-inflammatory manner but phenotypic changes are more 
obvious when they are challenged with an immune stimulus (i.e. 
lipopolysaccharides (LPS)). The experiment was repeated with a 24 h IL-4 
stimulation and arginase (Arg1) levels were quantified using qPCR (Figure 3-4b) 
as is a classical M2 marker. The Arg2 transcript was also profiled as this has been 
reported to be pro-inflammatory (Yang & Ming 2014) as well as being 
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upregulated in both M1 and M2 macrophages (Jha et al. 2015). For Arg1 the 
results are as expected with strong upregulation in IL-4 treated macrophages 
while M1 macrophages had higher, albeit variable Arg2 expression levels. Finally, 
as iNOS activity was not reproducibly detected in the absence of IFNγ (Figure 3-
5a), the Griess assay (2.8.3) was carried out on cells primed with IFNγ overnight 
and LPS for 24 h. As expected, this was sufficient to obtain detectable iNOS 
activity (Figure 3-5b). In summary, the protocol used to generate BMDM yields 
cells that display surface markers typical of macrophages. Furthermore, when 
stimulated to M1 or M2 phenotypes, these cells display cytokine/ and transcript 
profiles, that are characteristic of these polarised macrophages.  
 
Figure 3-4: Characterisation of macrophages A: IL-6 quantified by ELISA on the same 
supernatants used for Luminex assay. BMDM from four biological replicates are shown here. IL-6 
was not detectable in M0 or M2-treated BMDM. B: Results of qPCR of Arg1 and Arg2 expression in 
BMDM. Results are indicative of 3 biological replicates. The D-Delta method was used, 
normalising to the18S ribosomal transcript. Andrew Pountain and Clément Regnault assisted with 
this experiment. 
 
Figure 3-5: Nitric oxide production by inflammatory macrophages. A: cells were primed with 
IFNγ (indicated amounts) overnight, then LPS (indicated amounts) for 24h. Nitrite was quantified 
using the Griess assay. Results are indicative of 3 independent experiments. B: Cells from 3 
biological replicates were treated IFNγ (100 U/mL) overnight, then LPS (100 ng/mL) for 24h and 
nitrite quantified using Griess assay. Andrew Pountain and Clément Regnault assisted with this 
experiment (part B). 
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3.2.1 Development of a BMDM extraction protocol 
3.2.1.1 Normalising to protein content 
A major issue with metabolomics is ensuring that samples in different treatment 
groups are comparable. Compounding this are treatments causing loss of 
metabolites due to cell death or alterations in cell size. The author noticed early 
during our studies that the presence of IFNγ led to increased cell density with 
fewer non-adherent cells. This may be due to IFNγ promoting cell survival. This 
is a concern as it is not advisable to normalise at the point of data analysis, as 
many metabolites do not have the same linear range. As macrophages are 
adherent it is not feasible to count cells prior to extraction. Furthermore, cells 
of reduced adherence would be more likely to be counted if attempting this, as 
they would be easier to remove.  
To remove macrophages, either disassociation buffer, which contains EDTA or 
trypsin, are often used but this would interfere with macrophage function by 
cleaving extracellular receptors or depleting ions such as Ca2+ or Mg2+. Ideally the 
aim was to process samples rapidly in situ and to this end a method developed 
that allows the use of protein that was precipitated during extraction as an 
estimate of cell number at the time of extraction. To this end 0.1 M NaOH was 
used to solubilise precipitated protein and this was demonstrated to give a read 
out in the Bradford assay that corresponded to the number of cells present 
(Figure 3.6a). This allowed the author to confirm that the existing cell culturing 
protocol was leading to samples that were not comparable (Figure 3.6b). 
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Figure 3-6: Method of quantifying protein content (mg/mL) post extraction. A: Macrophages 
were seeded at densities indicated and protein content quantified post extraction. Results are 
representative of two independent experiments. B: The same protocol was employed post 
extraction on cells cultured using a standard protocol. Two sample groups were primed with IFNγ 
(100 U/mL) overnight, then LPS (100 ng/mL) for 4h (IFN LPS) while the other sample did not get 
LPS (IFN). One group of samples were treated with LPS without prior IFNγ stimulation (LPS) while 
Un is non-treated. Cells not receiving a given stimulus received an equal volume of cRPMI. Units 
were determined using BSA standards in Bradford assay. 
3.2.1.2 Modified culture protocol to ensure equal cell numbers 
One option available was to correct for unequal cell numbers by adding solvent 
after the post-extraction Bradford assay. However, adding extraction solvent to 
correct after the initial extraction is not ideal, as more pipetting error would be 
introduced and the retrospectively added extraction solvent wouldn’t be subject 
to the same conditions. Furthermore, cell density effects will complicate any 
interpretation of experiments carried out in such a manner. By modifying our 
protocol with the addition of a warm PBS wash to reduce the number of non-
adhered cells present, the result was that each group had a more similar protein 
content (2.10.2). This was true for the samples used in the metabolomics data 
presented in the following sections (Figure 3.7a). Inflammatory macrophages 
have been shown to be larger and to have higher protein content (Jha et al. 
2015; Meiser et al. 2016), but as the majority of our LPS stimulations were less 
than 6 hours this effect should be minimal. Nevertheless, by accurately 
quantifying protein content it was possible to be reasonably sure that conditions 
were comparable and aware of when they are not. 
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Figure 3-7: Modified protocol ensures that samples from different conditions are equivalent. 
A: Bradford assay carried out post extraction on samples that were used for the analysis that is 
shown in section 3.2.2. 16 samples (four from each technical replicate) were measured B: PCA 
on same samples. Data was log transformed prior to analysis. MetaboAnalyst 3.0, which utilises 
the pcaMethods Bioconducter package (Stacklies et al. 2007) was used to construct PCA plots. 
95% confidence intervals are highlighted by the respective background colour. Units were 
determined using BSA standards in Bradford assay. 
3.2.2  The metabolome of multiple inflammatory macrophages 
3.2.2.1 Initial data analysis and filtering 
Once our culturing techniques and sample preparation were optimised, these 
methods were applied to interrogate the metabolome of M1 macrophages. 
Specifically the aim was to determine the relative contribution of IFNγ and LPS, 
either alone or in combination to immune-metabolism.  The conditions used 
were non-stimulated cells, IFNγ primed cells, LPS treated cells and cells that 
were both IFNγ primed and LPS treated. Note that IFNγ (100 U/mL) priming took 
place over night (16 h) and LPS (100 ng/mL) was added for 4 h the next day. 
Samples were prepared as described in 2.10.3 and LC-MS performed as 
described in 2.12. 
Initial data analysis was carried out using the IDEOM pipeline (2.12). Prior to 
statistical analysis putatively identified metabolites were filtered based on 
integrity of peak shapes (first column in IDEOM comparison tab). This includes 
annotated peaks that were shoulders or noisy peaks where statistical 
interpretation of peak area did not appear reliable. This approach reduces the 
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number of false negatives that typically affect large data sets. Next peptides, 
which are not reproducible in our system were filtered out. Finally, a 250-second 
retention time cut-off was used as most lipids elute from the column as a bolus 
during this time. This was done because lipids are not separated by retention 
time on our LC-MS method and thus, their identification is not reliable. 
Furthermore, the number of metabolites not attributed to any biological 
pathway is extremely high during this time window and could actually be a lipid 
or a fragment of one. 
Finally, β-alanine and L-alanine could be separated based on retention time but 
the gap was too small for standard settings within the Ideom pipeline (Creek et 
al. 2012). For these metabolites, a custom method was written in Xcalibur 
(Thermo) where an appropriate retention time window (±30 seconds of authentic 
standard) was used to obtain an accurate peak area measurement. The global 
application of the retention time window used here in the Xcalibur method to 
IDEOM would have been too restrictive and thus, was not done. The result of the 
filtering in IDEOM and the Xcalibur method was a list of 233 metabolites. The 
identity of 74 of these was confirmed using authentic standards (MSI level 1). 
PCA analysis was carried out on MetaboAnalyst and show that that conditions 
clearly separate (Figure 3-7b). 
We initially analysed the experiment using the commonly used one-way analysis 
of variance (ANOVA), with a false discovery rate (FDR: Benjamini–Hochberg) 
threshold of ≤0.05 on MetaboAnalyst. Note that the input files for additional 
analysis are in Supplementary File 3-(2-3) (Kegg IDs are shown, metabolite 
name is in Supplementary File 3-1). Several of the perturbed metabolites are 
in pathways that are important for immune function (Table 3-1), confirming the 
validity of our cell culture and LC-MS sample preparation protocol. The 
metabolites in this table are increased by one or both stimuli (Supplementary 
File 3-4). The contribution of both is discussed in more detail the following 
sections. 
Some of these are well known pathways such as oxidative stress response, the 
pentose phosphate pathway (PPP), CD38 calcium signalling and folate 
metabolism (Duch & Smith 1991; Haschemi et al. 2012; Qiao et al. 2007; 
Willmott et al. 1996). Upon up-regulating the production of reactive oxygen 
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species (ROS), macrophages utilise glutathione disulphide (GSSG) by reducing it 
to two molecules of glutathione with reducing equivalents from the coenzyme 
NADPH. Gluthathione (GSH) scavenges ROS, regenerating GSSG with water as a 
by-product. 
Inflammatory macrophages have enhanced glycolysis resulting in lactate 
accumulation (Tannahill et al. 2013). Central carbon metabolism has recently 
been the focus of much research into immune-metabolism and the previously 
reported increases in glycolysis and the TCA cycle are present in the data 
presented here. Accumulation of itaconate has been shown to inhibit succinate 
dehydrogenase leading to increased succinate levels (Lampropoulou et al. 2016). 
Thymidine degradation by thymidine phosphorylase leads to accumulation of 2-
Deoxy-D-ribose 1-phosphate. This is subsequently phosphorylated to yield 2 
Deoxy D-ribose-5-phosphate that is then cleaved by deoxy-D-ribose phosphate 
aldolase to acetoaldehyde and glyceraldehyde 3-phosphate ultimately leading to 
pyruvate production. 2-deoxy-D-ribose has previously been shown to cause the 
proteasomal degradation of HIF-1α in a human leukaemia cell line (Ikeda et al. 
2013). It is important to note that as we do not have an authentic standard we 
cannot preclude the possibility that 2 deoxy D-ribose-5-phosphate is instead 2 
deoxy D-ribose 1-phosphate. 
In the next section the results of our implementation of a general linear model 
(GLM), which was used as it allowed the incorporation of an interaction term, 
are discussed. 108 metabolites had a false discovery rate (Benjamini-Hochberg) 
of <(0.05) from the ANOVA while only 85 metabolites met the same threshold in 
the GLM (Supplementary File 3-4). Thus it is reasonable to consider both 
methods appropriately stringent considering the overlap in the metabolites 
found to be perturbed (Unique to the ANOVA are (R)-lactate (corrected GLM p 
value: 0.057) and 2 deoxy D-ribose-5-phosphate (corrected GLM p value: 0.07)).  
In conclusion, perturbations of metabolites, which have previously been shown 
to be essential for immune-metabolism were detected here, thus confirming the 
validity of our methodology. Furthermore, both approaches (ANOVA and GLM) 
detect significant changes in carnitine, pyrimidine and purine metabolism, which 
have not been interrogated in the context of M1 macrophage metabolism (see 
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Supplementary File 3.4 (GLM results were used for formal pathway analysis)). 
The nature of these perturbations is described in the following sections. In the 
next sections a GLM was used to determine the contribution of the inflammatory 
stimuli used here, alone and in combination, to perturbations both within and 
out with central carbon metabolism. 
Table 3-1: Key metabolites with altered abundance in inflammatory macrophages according 
to one-way ANOVA or GLM.  Shown here are the metabolites, their key immune specific 
pathways, their ANOVA-corrected p value (Benjamini-Hochberg false discovery rate (FDR) <0.05) 
and relevant citation. Most metabolites passed the GLM test with an FDR threshold of 0.05, the 
exception being metabolites highlighted in red ((R)-lactate (p.adjust (FDR) = 0.057) and 2 deoxy 
D-ribose-5-phosphate (p. adjust = 0.07)). 
Metabolite Pathway p.adjust (FDR) Reference 
L-Citrulline iNOS <0.001 (Jha et al. 2015) 
(R)-Lactate Glycolysis <0.001 (Jha et al. 2015; 
Tannahill et al. 2013) 
2-Oxoglutarate TCA cycle <0.001 (Rubic et al. 2008; Jha 
et al. 2015) 
Succinate TCA cycle <0.001 (Ji et al. 2016; 
Tannahill et al. 2013) 
(S)-Malate TCA cycle <0.001 (Tannahill et al. 2013) 
2 deoxy D-ribose-5-phosphate Pentose Phosphate pathway <0.001 (Ikeda et al. 2013)  
Ribose 5-Phosphate Pentose Phosphate pathway <0.001 (Jha et al. 2015; 
Haschemi et al. 2012) 
3-Phospho-D-glycerate Pentose Phosphate pathway <0.001 (Haschemi et al. 2012) 
ɣ-L-Glutamy-L-cysteine Oxidative stress response <0.001 (Qiao et al. 2007) 
Gluthathione disulphide (GSSH) Oxidative stress response <0.05 (Qiao et al. 2007) 
Cyclic-ADP-ribose CD38+ signalling <0.001 (Willmott et al. 1996) 
Dihydrobiopterin Folate biosynthesis <0.001 (Duch & Smith 1991) 
2-Amino-4-hydroxy-6-hydroxymethyl-
7,8-dihydropteridine 
Folate biosynthesis <0.001 (Duch & Smith 1991) 
Itaconate Anti-bacterial <0.001 (Jha et al. 2015) 
3.2.2.2 A generalised linear model incorporating the contribution of IFNγ and 
LPS stimuli 
For analysing this dataset a generalised linear model (GLM) as implemented in 
the R coding language (GLM) (Supplementary File 3-5) was used. GLM is a 
generalised instance of the linear model LM (e.g., ANOVA procedure) (McCullagh 
& Nelder 1989). Here the permutations are performed using a least squares 
regression approach to describe the statistical relationship between one or more 
predictors (in this case are the stimuli) and a continuous response variable (in 
this instance is a given metabolites intensity). 
GLM does not assume that residuals (data-points) are independent and applies 
one of several exponential family functions (Gaussian in our case). A Gaussian 
(Normal) distribution is assumed here (the default setting in this model in R), is 
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a limitation that is common to all datasets with small number of samples. As 
there were four replicates in each condition, it would not be reliable to try and 
test if the data fits another distribution. While using the LM function in R yields 
identical results, the GLM script (Supplementary File 3-5) is more flexible, with 
more available parameters (i.e. choice of distributions). 
We have incorporated an interaction term, which is used when two predictor 
variables affect the outcome variable in a way that is non-additive. In our case 
the example is whether one immune stimulus has an effect on the response of 
another. This is particularly appropriate for this experiment as it is widely 
accepted that the effect of IFNγ and LPS can be synergistic (e.g., Figure 3.5a). 
In general terms:  
model = lm( Y ~ X1 + X2 + X1:X2) 
In R this function regresses Y on X1 (IFNγ), X2 (LPS), and the X1-by-X2 (IFNγ-by-
LPS) interaction term. 
In Figure 3-8, not only are there stimuli specific signatures induced by IFNγ 
and/or LPS visible, it is denoted where the effects are additive, antagonistic or 
synergistic, and one can see where metabolites are increased or decreased when 
compared to the non-treated control (M0). An additive effect is where each 
stimulus on there own causes a change but there is no additional change caused 
by their interaction. If there was an interaction between stimuli, this change 
could be synergy (the result of two stimuli is greater than the sum of there 
parts). Antagonism would be where the change caused by one stimulus 
prevented by the presence of another stimulus. There is overlap of metabolites 
that are affected by IFNγ, LPS and the interaction of both as shown in the Venn 
diagram (Figure 3-8). An example of this is where both IFNγ and LPS perturb a 
metabolite on their own but the effect of them together is additive (in the Venn 
diagram this is the set with 16 metabolites).  
Here it is not distinguished whether one stimulus causes a greater effect than 
another (i.e., by comparing adjusted p values). An example would be if the 
largest increase is caused by one stimuli, and this increase is lessened when the 
other stimuli is present. We do not denote where the slight inhibition is 
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sufficient or not to cancel any biological effect of the overall increase that is 
present even in the presence of both stimuli. The reasoning behind this is to 
avoid the assumption that it is known what the thresholds (if any) at which 
metabolites may function in immune-metabolism. Nevertheless, the information 
necessary to do this (i.e., adjusted p values) is available in Supplementary File 
3-4. All of these metabolites are listed in Table 3-2. 
IFNγ causes a clear depletion of purine and pyrimidine related metabolites such 
as xanthine and uridine, and in some cases this is enhanced by the presence of 
LPS (hypoxanthine). In the case of L-citrulline, its increase can only be explained 
by the interaction term and this agrees with the result of Figure 3-5 A where 
iNOS activity requires the presence of both stimuli (note that with the exception 
of 1000ng LPS there is low nitrite levels when only one stimuli is present). 
It is notable that increases in many of the hallmark metabolites of immune-
metabolism can be explained by only one stimulus or a slight additive effect. For 
example, metabolites involved in glycolysis (fructose 1,6-bisphosphate and 3-
phospho D-glycerate), the TCA cycle (2-oxoglutarate), and the PPP (ribose 5-
phosphate and erythrose 4-phosphate), are all primarily driven by LPS. As these 
changes are relatively well known, the focus was switched to metabolites that 
were subject to either an additive or interaction term (Figure 3-9). 
Nevertheless, the list of metabolites, the levels of which are modulated by IFNγ, 
LPS or both is important in itself and this information is listed in Table 3-2. 
An important additional note is on the limitations of untargeted metabolomics. A 
major issue is confidence in identification of putative metabolites. To this end 
the Metabolomics Standards Initiative (MSI) has published a classification system 
driven by community-agreed reporting standards (Sumner et al. 2007). Level one 
identifications denote where a putatively identified metabolite matches an 
authentic standard in both accurate mass and retention time. Additionally, 
identifications can be obtained by fragmentation of mass spectral features and 
comparing to publically available databases (mZCLOUD). In Table 3-2, this 
information is listed. It is important to note that identifications without 
additional confirmation from authentic standards or fragmentation match, are 
putative. 
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Figure 3-8: Metabolites with significantly (p.ajust (FDR) ≤ 0.05) altered levels. Colour code 
beside metabolite name corresponds to Venn diagram. IFN refers to metabolites that are 
perturbed by IFNγ, LPS refers to metabolites that are perturbed by LPS, and IFN:LPS refers to 
metabolites where the perturbation is caused by an interaction of the two stimuli. There is some 
overlap so coloured lines are used on the Venn diagram and heat-map key to denote this. The 85 
metabolites shown here and additional information regarding confidence in identity can be found 
in Table 3-2. Andrew Pountain wrote the script used in this study. 
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Table 3-2: List of significantly altered metabolites from GLM.  For metabolites denoted 
NoKegg, this indicates that these metabolites do not have a Kegg ID. Metabolites in brackets in 
the Isomers column are alternative identifications in the case of a fragment or alternative 
adduct. Note that elaidiccarnitine and linoelaidylcarnitine had similar retention times and thus 
one may be an adduct of the other. The same applies to Hypotaurine and taurine The ‘Standard’ 
column denotes whether an authentic standard was available and the ‘Ms2’ column denoted 
where there was a confirmatory match in the mZCLOUD database (described in more detail in 
materials and methods). The colour coding in the Set column is colour coded to match the Venn 
diagram in Figure 3-9 while Π denotes an intersect between any of the groups (circles) and 
IFN:LPS refers to the interaction group. In order to avoid division by zero, missing values were 
replaced with a value that is 25% of the intensity threshold (250). N/A denotes metabolites found 
in one condition only. Andrew Pountain wrote the script used in this study. 
Kegg ID 
 
Name Standard Isomers MS2 Set Max FC 
C00299 Uridine Yes 3  IFN 10.2 
NoKegg28 Orotidine Yes 1  IFN 5.8 
C00487 L-Carnitine Yes 2 Yes IFN 2.4 
C00581 Guanidinoacetate  1  IFN 5.7 
C01035 4-Guanidinobutanoate  3  IFN 1.6 
C01210 N-Methylethanolamine phosphate  3  IFN 4.2 
C01950 Picolinamide  4  IFN 2.7 
C02376 5-Methylcytosine  4  IFN 2.3 
C13050 Cyclic ADP-ribose  1  IFN 2.6 
C02494 1-Methyladenosine  6  IFN 1.4 
C00559 Deoxyadenosine Yes 4  IFN 11.1 
C05570 Ergothioneine  2  IFN 1.6 
C05545 Ne,Ne dimethyllysine  1  IFN 2.0 
C08764 Glaucarubolone  4  IFN 2.5 
C00588 Choline phosphate Yes 1  IFN 2.1 
C02305 Phosphocreatine  1  IFN 1.9 
C00003 NAD+  1  IFN 2.13 
C00334 4-Aminobutanoate Yes 15  IFN 2.0 
C00506 L-Cysteate Yes 1  IFN 1.7 
C02636 3-Dehydrocarnitine  10  IFN 2.3 
C01233 sn-glycero-3-Phosphoethanolamine  1  IFN 1.5 
C02571 O-Acetylcarnitine Yes 1  IFN 1.6 
C00295 Orotate Yes 2  IFN 4.5 
C14168 3-(Dimethylamino)propyl benzoate  2  IFN 1.9 
C00049 L-Aspartate Yes 4  IFN 2.0 
NoKegg34 L-cysteine sulfinate  2  IFN 1.6 
C05829 N-Carbamyl-L-glutamate  5  IFN 1.6 
C00043 UDP-N-acetyl-D-glucosamine  3  IFN 1.9 
C00670 sn-glycero-3-Phosphocholine Yes 1  IFN 1.6 
C00212 Adenosine Yes 3  IFN 1.8 
C00491 L-Cystine Yes 2  IFN 1.6 
C00093 sn-Glycerol 3-phosphate Yes 3  IFN 2.1 
C13482 Phosphodimethylethanolamine  1  IFN 3.1 
C03850 Adenosine 2',5'-bisphosphate Yes 6 (choline phosphate)  IFN 2.2 
C14179 Sulfoacetate  1  IFN 2.8 
C00035 GDP Yes 1  IFN 2.1 
C00026 2-Oxoglutarate Yes 7  LPS 4.6 
C00117 D-Ribose 5-phosphate Yes 16  LPS N/A 
C00354 D-Fructose 1,6-bisphosphate  14  LPS 10.6 
NoKegg25 Hydroxybutyrylcarnitine  1  LPS 2.3 
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Kegg ID Name Standard Isomer Ms2 Set Max FC 
C00197 3-Phospho-D-glycerate Yes 3  LPS 7.3 
C00167 UDP-glucuronate  3  LPS 3.9 
C00294 Inosine Yes 1  LPS N/A 
NoKegg7 3-Hydroxy-11Z-octadecenoylcarnitine  2  LPS N/A 
C00279 D-Erythrose 4-phosphate  4 (Orotidine)  LPS N/A 
C00015 UDP  1  LPS 6.9 
C00270 N-Acetylneuraminate Yes 3-phospho-D-glycerate) 
(2 peaks?) 
 LPS 1.5 
C00029 UDP-glucose Yes 3 (S-MALATE)  LPS 2.9 
C00669 gamma-L-Glutamyl-L-cysteine Yes 2  LPS 10.2 
NoKegg6 Tetradecanoylcarnitine  2  LPS 1.9 
C02862 O-Butanoylcarnitine  3  LPS 3.0 
C00114 Choline Yes 1  LPS 1.4 
NoKegg22 S-D-mandeloylglutathione  1  LPS 3.9 
C00352 D-Glucosamine 6-phosphate  8  LPS 2.1 
C03943 (2R,4S)-2,4-Diaminopentanoate  6 (3-phospho-d 
glycerate) 
 IFN:LPS 7.4 
C00327 L-Citrulline Yes 3 Yes IFN:LPS 7.2 
C00099 beta-Alanine Yes 9  IFN Π LPS 2.8 
C00262 Hypoxanthine Yes 3 Yes IFN Π LPS 7.6 
C03592 5-Methyl-2'-deoxycytidine  1 (5-methyl-2'-
deoxycytidine) 
 IFN Π LPS 2.4 
C00881 Deoxycytidine  1  IFN Π LPS 3.8 
NoKegg30 &beta;-ketophosphonate  1  IFN Π LPS N/A 
C02230 3-Methylguanine  5  IFN Π LPS 12.0 
C00611 N-Acetyllactosamine  8 (dihydrobiopterin)  IFN Π LPS 9.8 
C00268 Dihydrobiopterin  4  IFN Π LPS 33.2 
C00300 Creatine  2 (Glutamine)  IFN Π LPS 1.4 
C00346 Ethanolamine phosphate Yes 2 (Taurine)  IFN Π LPS 1.8 
C00385 Xanthine Yes 3 Yes IFN Π LPS 2.8 
C00490 Itaconate Yes 7 Yes IFN Π LPS 17.7 
C00025 L-Glutamate Yes 14 Yes IFN Π LPS 2.0 
C00149 (S)-Malate Yes 4 Yes IFN Π LPS 3.3 
C00004 NADH Yes 1 (Picolinamide)  IFN Π LPS 4.3 
C00042 Succinate Yes 7 (itaconate?) Yes IFN Π LPS 2.2 
C00130 IMP Yes 3  IFN:LPS Π 
LPS 
N/A 
NoKegg4 trans-hexadec-2-enoylcarnitine  2  IFN:LPS Π 
LPS 
2.3 
C03406 N-(L-Arginino)-Succinate  6  IFN:LPS Π 
LPS 
N/A 
NoKegg2 Elaidiccarnitine  3  IFN:LPS Π 
LPS 
1.9 
C01959 Taurocyamine  1  IFN:LPS Π 
IFN 
2.5 
C00519 Hypotaurine  1 (Taurine)  ALL 2.8 
C01300 2-Amino-4-hydroxy-6-hydroxymethyl-7, 8-
dihydropteridine 
 1  ALL 5.0 
C00245 Taurine Yes 1 Yes ALL 1.8 
NoKegg12 2-Methylbutyroylcarnitine  4  ALL 2.5 
C00242 Guanine Yes 3  ALL 10.9 
C03017 O-Propanoylcarnitine  1  ALL 3.2 
NoKegg19 N-(octanoyl)-L-homoserine  4  ALL 3.3 
NoKegg3 Linoelaidylcarnitine  2 (elaidiccarnitine)  ALL 3.0 
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3.2.2.3  Interaction: additive, synergistic or antagonistic effects 
In Figure 3-9 the IFNγ depletion of purine and pyrimidine related metabolites 
and the synergistic production of citrulline is again apparent. Both LPS and IFNγ 
induce several classical inflammatory metabolites such as succinate, 
L-glutamate, (S)-malate and itaconate. While there is an additive effect from 
both stimuli, it is important that any strategy of inhibiting these metabolic 
pathways must account for the fact that unique to specific stimulus that may not 
be present in every disease.  
What is striking is the appearance of carnitine related metabolites in this 
section. These are trans-hexadec-2-enoylcarnitine elaidiccarnitine and 
linoelaidylcarnitine. Note that elaidiccarnitine and linoelaidylcarnitine had 
similar retention times and thus one may be an adduct of the other L-carnitine, 
which is increased in the presence of IFNγ has also been reported to be 
increased in M2 macrophages (Jha et al. 2015). While some of the carnitine’s 
production is maximised in the presence of IFNγ and LPS, there are 3 
metabolites that the inducement by LPS is inhibited by the presence of IFNγ. 
Accumulation of acylcarnitines can result from incomplete β-oxidation of fatty 
acids in mitochondria. Acylcarnitines can induce pro-inflammatory pathways so 
IFNγ may be acting to limit this. 
Inosine monophosphate (IMP) also displays a similar trend to the acylcarnitines in 
that it was increased in LPS treatment samples but not in samples treated with 
both IFNγ and LPS. Alterations in levels of purines and pyrimidines have largely 
been attributed to the cost of engaging expansive transcriptional programmes. 
Alternative roles of these pathways as well as Taurine and β-alanine metabolism 
are discussed further in section 3.2.3.2 where results of pathway analysis are 
presented. 
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Figure 3-9: Heatmap of metabolites that display an additive or interaction effect.  Colour key 
beside metabolite name corresponds to Venn diagram, which was made using Venny (Oliveros 
2015). 
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3.2.2.4 Pathway analysis reveals immune-metabolic drivers 
To formally categorise the contribution of LPS and IFNγ to biological pathways, 
pathway analysis was performed on log-transformed data using the pathway 
analysis module on MetaboAnalyst. A generalised logarithm transformation is 
used here. Generalized logarithm (glog) is a simple variation of ordinary log in 
order to deal with zero or negative values in the data set (where ‘a’ is a 
constant with a default value of 1). 
!"#!!! =  !"#! ! + !! + !!2  
 This allowed us to use the murine pathway library and upload a relevant 
background (all detected metabolites). The use of a background is important as 
it allows technical bias specific to the instrument used to be taken into account. 
Specifically, certain large pathways such as pyrimidine metabolite will not have 
every metabolite detected. If the metabolites with altered levels were 
subjected to enrichment analysis versus the entire pathway ignoring the fact 
that the status of many of these is unknown, this would not take into account 
the sampling bias that is present. Here a list of all detected metabolites was 
used as the background.  The pathway enrichment analysis used here is based on 
the GlobalTest algorithm (Xia & Wishart 2010). Here the null hypothesis is that 
none of the covariates in the tested group is associated with the response. The 
alternative is that at least one of the covariates has such an association. To 
estimate node importance, the Relative-betweeness Centrality algorithm was 
selected. This measures number of shortest paths going through the node, 
focusing more on global network topology. Thus changes in metabolites at 
central nodes within or between pathways are given more importance than those 
at the extremities as they are more likely to modulate flux through the 
pathway (s).  
First altered pathways either present exclusively in LPS or IFNγ affected subsets, 
the intersect/addition subset (LPSnIFN), or the set that contained any 
interaction effect was examined. Some of these pathways were exclusive to the 
following groups: LPS, IFNγ, the intersect of LPS and IFNγ sets, or interaction 
set. Some pathways were present in more than one of these groups i.e. there is 
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an impact of the interaction effect on arginine and proline metabolism but it is 
less than the additive effect (LPSnIFN). The results of this is summarised in 
Table 3-3. The entire list of significant hits from the GLM was also submitted to 
pathway analysis and used an impact score of ≥0.1 as a threshold to select a 
shortlist of pathways for further investigation. 
We detect an exclusive role of IFNγ in nicotinate and nicotinamide metabolism, 
specifically, its increasing of NAD+ levels. NAD+ serves an oxidizing agent while 
NADH is a reducing agent and these have roles in multiple pathways. The 
additive effects of IFNγ and LPS cause increased NADH levels.  Thus it appears 
IFNγ increases the oxidative potential of the macrophage, potentially to deal 
with increased glycolytic flux (Warburg shift). Other alternative uses of NAD+ 
include Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which is a key 
glycolytic enzyme, IMP dehydrogenase (discussed below) and the generation of 
cyclic–ADP-ribose generated by CD38. Cyclic–ADP-ribose is a metabolite, the 
increase of which is driven by IFNγ in our experiment. Glutathione is an 
important anti-oxidant and while it or its reduced equivalent (GSSG), does not 
show large perturbations, LPS treatment caused a large increase in its precursor 
Υ-L-Glutamyl-L-cysteine. Note that reliable detection of reduced versus oxidised 
metabolites such as these is a limitation of LCMS such as those used in this 
study. 
LPS induced accumulation of inosine and inosine monophosphate (IMP) and an 
IFNγ mediated increased guanine were among the most significant changes 
detected in our study. Upon activation a macrophage needs to engage an 
inflammatory transcriptional profile and it would not be unexpected that this 
could affect nucleotide metabolism. Macrophages are end-differentiated cells, 
which are mainly non-proliferative so these metabolites are not required for DNA 
synthesis. There are, however, instances where changes in specific parts of 
these pathways have been shown to have important functions independent of 
RNA/DNA synthesis. In purine metabolism, xanthine oxidase (XO) catalyses the 
conversion of hypoxanthine into xanthine, producing H2O2 as a by-product. The 
free radicals produced here have been shown to activate the p38-MAPK-NFAT5 
pathway and inhibiting XO via its inhibitor allopurinol limited inflammation in a 
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mouse model of arthritis (Kim et al. 2014c). Perturbations in the substrate and 
product of XO in stimulated cells were also observed. 
Table 3-3: Pathway analysis of inflammatory macrophages.  A background (all detected 
metabolites) was uploaded onto MetaboAnalyst and analysis carried out on metabolites unique to 
IFNγ, LPS or the interaction set. To avoid false positives from multiple comparisons, the entire 
list of significantly altered metabolites (according to the GLM) was analysis and this was used to 
set the 0.1 impact score threshold. The largest contributor (s) to pathway perturbation is 
indicated in the ‘Causative’ column and underlined values in the Impact summary denote the 
impact score obtained in the respective set. 
  Entire Pairwise Causative Impact Summary  
IFN exclusive FDR Impact FDR Impact  IFN LPS IFNn
LPS 
Interact 
Nicotinate and nicotinamide 
metabolism 
0.003 0.21 0.005 0.21 IFN 0.21    
LPS exclusive          
Glycolysis or Gluconeogenesis 0.001 0.1 0.001 0.1 LPS  0.1   
Pentose phosphate pathway 0.001 0.24 0.001 0.24 LPS  0.24   
Ascorbate and aldarate 
metabolism 
0.001 0.4 0.001 0.4 LPS  0.4   
Pentose and glucuronate 
interconversions 
0.001 0.47 0.001 0.47 LPS  0.47   
Starch and sucrose metabolism 0.001 0.25 0.001 0.25 LPS  0.25   
IFNnLPS          
Citrate cycle (TCA cycle) 0.001 0.14 0.001 0.07 IFNnLPS = 
LPS 
 0.07 0.07  
D-Glutamine and D-glutamate 
metabolism 
0.001 1 0.001 1 IFNnLPS   1  
Glutathione metabolism 0.009 0.13 0.001 0.06 LPS > 
IFNnLPS 
 0.08 0.06  
Pyrimidine metabolism 0.001 0.13 0.001 0 LPS  0.07   
Glycerophospholipid metabolism 0.005 0.18 0.002 0 IFN 0.16 0.02   
beta-Alanine metabolism 0.001 0.44 0.001 0.44 IFNnLPS   0.44  
Interaction          
Purine metabolism 0.001 0.2 0.001 0.13 Interaction 0.02  0.04 0.13 
Alanine, aspartate and glutamate 
metabolism 
0.001 0.65 0.001 0.02 IFN > 
IFNnLPS 
0.31 0.06 0.11 0.02 
Arginine and proline metabolism 0.001 0.19 0.001 0.05 IFNnLPS 0.04  0.11 0.05 
Taurine and hypotaurine 
metabolism 
0.001 0.71 0.001 0.71 Interaction    0.71 
Purine metabolism has previously been shown to be indispensable in the 
maturation of myeloid leukaemia cell lines (Knight et al. 1987). Knight et al 
observed that IMP was being diverted to guanine via increased IMP-
dehydrogenase (IMPDH) activity. Inhibiting IMPDH drove cell maturation towards 
a neutrophil phenotype. An key immune-modulatory role for IMPDH has been 
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proposed in the case of the IC-21 murine macrophage cell line (Jonsson & 
Carlsten 2002). In this study the authors found that the IMPDH inhibitor 
mycophenolate mofetil suppressed production of pro-inflammatory cytokines, 
nitric oxide, and lactate dehydrogenase in macrophages. Additionally, the 
inhibition of these inflammatory mediators was abrogated by guanosine 
supplementation. An increase in both IMP and inosine was detected in LPS 
treated macrophages, an increase that was inhibited in the presence of IFNγ. 
Whether these pathways and key enzymes such as IMPDH are valid targets in an 
inflammatory setting remains to be determined. 
Guanine levels have been shown to be required for the increase in cAMP induced 
by prostaglandin (PG) (Verghese & Snyderman 1983). PG are hormones, the 
levels of which are increased in activated macrophage. An increase in guanine 
was detected in this experiment but this was restricted to cells stimulated with 
IFNγ alone. While this may be a consequence of increased IMPDH activity (its 
catalysing the conversion of IMP to xanthosine monophosphate (XMP) is the first 
committed and rate-limiting step towards the de novo biosynthesis of guanine 
nucleotides), an increase in transcript abundance of the guanosine metabolising 
enzymes pnp and pnp2 has been detected in inflammatory macrophages (Jha et 
al. 2015). Pnp and pnp2 also catalyse inosine-hypoxanthine interconversions so it 
would be difficult to determine which, if any, of the multiple reactions are 
immune-modulatory. Nevertheless, it is apparent that the different stimulus are 
causing divergent perturbations to purine metabolism and it will be interesting 
to determine whether the metabolites have effector functions outwith 
nucleotide biosynthesis. 
β-alanine metabolism was significantly altered according to ANOVA, GLM and 
pathway analysis. It has been reported that the source of increased β-alanine is 
a by-product of increased flux through arginine metabolism via carnosine 
synthase 1 (Carns1) in anti-inflammatory macrophages (Jha et al. 2015). Carns1 
catalyses the conversion L-histidine and β-alanine to Carnosine. An alternative 
source of β-alanine is pyrimidine metabolism that was subject to stimuli specific 
perturbations. Furthermore, in the transcriptome data from Jha et al, there is 
an increase in transcript abundance of an enzyme (dpys) that carries out an 
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intermediate reaction in β-alanine synthesis from pyrimidine metabolism (5,6-
dihydrouracil to N-carbamoyl-β-alanine). 
There have also been some studies that have investigated the immune-
modulating capability of β-alanine (Prabha et al. 1988). Prabha et al reported 
that β-alanine caused similar effects to taurine in heart and adipose tissue. In 
adipose tissue the addition of these metabolites was shown to result in down-
regulation of lipoprotein lipase (LPL) activity and altered cholesterol 
metabolism. Harris et al found that IFNγ inhibits LPL at the level of transcription 
in macrophages (Harris et al. 2008). Interestingly, LPL has also been proposed to 
promote foam cell formation in macrophages (Babaev et al. 1999). As the 
increases presented here were present in all combinations of IFNγ treatment, it 
would be interesting to determine if β-alanine has a role modulating LPL 
activity. 
We also detected IFNγ-mediated increases in taurine and its related metabolites 
hypotaurine and taurocyamine. As previously mentioned, these metabolites have 
been shown to modulate cholesterol metabolism and LPL activity. Kim et al 
demonstrated that taurine inhibits nitric oxide induced apoptosis in murine 
RAW264.7 macrophages (Kim et al. 2009d). While taurine and taurine 
metabolites were increased in an IFNγ–dependent manner, whether this is a 
general protective process or if endogenous taurine production is sufficient to do 
the same remains to be determined. 
3.3 Discussion 
Development of a robust, high coverage metabolite extraction of macrophages 
has been established. In Chapter 1 phenomenon of immune-metabolism was 
introduced as well as some of the hallmarks of inflammatory macrophage 
metabolism. In Figure 3-10 the results of this chapter are shown in this context. 
Not only were well-known markers detected, it was possible to determine the 
relative contribution of each stimulus to these markers. Furthermore, there is a 
high-resolution readout of several perturbed modules the importance of which 
has not been interrogated in the context of immune-metabolism. 
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3.3.1 Classical markers: new insight 
Previous studies examining immune metabolism in inflammatory macrophages 
have used either LPS or IFNγ and LPS in combination (Tannahill et al. 2013; Jha 
et al. 2015). This is to our knowledge, the first study, which has examined the 
contribution and interaction of each of these factors in a systematic fashion. 
This is especially relevant physiologically as in vivo, prior encounter of a naïve 
immune cell with a pathogen can be simulated by LPS, pre-adaptation of 
immune cells caused by Th1 signalling by IFNγ, and interaction of a primed 
immune cell with a pathogen by the combination of both. In the context of 
disease, diagnosis often occurs after an immune response has been initiated, so 
any attempt to treat disease by modulating cell metabolism must take into 
account what these stimuli do in isolation and in combination. 
3.3.1.1 Glycolysis, PPP and TCA cycle: 
The detection of the Warburg effect was a key discovery in establishing the 
immune-metabolism field (Tannahill et al. 2013; Jha et al. 2015; Lampropoulou 
et al. 2016). Macrophages rapidly upregulate glucose uptake and several 
enzymes in glycolysis such as hexokinase and the highly active 
phosphofructokinase-1 isoform, u-PFK2 (Fukuzumi et al. 1996; Rodríguez-Prados 
et al. 2010). The Warburg effect offers cancer cells a means to utilise glucose 
for ATP production in the absence of oxygen. This is also the case for 
macrophages in hypoxic conditions. Increased glycolysis in the presence or 
reduced level of oxygen is also essential to generate NADPH (oxidative stress 
protection) and ribonucleotide precursors (possibly required for M1 
transcriptional programme) via the PPP. In order to sustain high glycolytic flux 
NAD+ must be increased NAD+ levels that are driven by IFNγ while increased 
fructose 1,6-bisphosphate and 3-phospho D-glycerate levels are induced by LPS. 
Lactate levels are increased but only in combination treatment so the source of 
increased NAD+ levels in IFNγ treated samples remains to be determined. 
Nevertheless, perturbations in these pathways is in agreement with previous 
studies (Tannahill et al. 2013; Jha et al. 2015) 
In the PPP, ribose 5 phosphate and erythrose 4-phosphate are increased in an 
LPS dependent manner indicating that a pathogen stimulus is critical for 
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increased production of NADPH and ribonucleotide precursors (Haschemi et al. 
2012). Recently reported perturbations of the TCA cycle are also observed in our 
data such as increases in both itaconate production and succinate accumulation 
(Tannahill et al. 2013; Lampropoulou et al. 2016). As expected the arginino-
succinate shunt requires synergistic activity from IFNγ and LPS to produce 
citrulline via iNOS. The effector metabolite of iNOS, NO, while not detectable 
using LC-MS, was measured using the Griess assay. 
3.3.1.2  Taurine, β-alanine and Carnitine related metabolites 
As mentioned in the results taurine and β-alanine have previously been shown to 
prevent apoptosis and modulate lipid metabolism and in some instances this 
involves signalling pathways modulated by IFNγ (Prabha et al. 1988; Harris et al. 
2008; Kim et al. 2009d). Lipid metabolism has previously been identified as 
important for M2 macrophages (Huang et al. 2014). A pro-inflammatory role has 
been suggested for incomplete lipid metabolism, which is a feature of 
incomplete β-oxidation of fatty acids in mitochondria in increased acylcarnitines 
and has been observed in insulin resistance and type 2 diabetes mellitus 
(Rutkowsky et al. 2014). Rutkowsky et al reported that acylcarnitines induced 
cyclooxygenase-2 (Cox-2) in a chain length-dependent manner but this study 
exclusively used cell lines such as RAW 264.7 cells. On the other hand, a 
previous study has examined in vivo the role of fatty acid oxidation and auto-
immune inflammation in the CNS in a murine multiple sclerosis (MS) model and 
found that fatty acid oxidation (FAO) was essential for disease progression. 
Furthermore, the authors found that FAO was essential for inflammatory T cell 
function and consequently disease progression (Shriver & Manchester 2011). 
A recent study using carnitine palmitoyltransferase 2 (Cpt2) deficient 
macrophages found that while the cells could not undergo FAO, this was not 
required for M2 polarisation (Nomura et al. 2016). Etomoxir inhibits another key 
enzyme in lipid metabolism, carnitine palmitoyltransferase 1A (Cpt1a). This is a 
mitochondrial enzyme that is responsible for the formation of acyl carnitines by 
catalysing the transfer of the acyl group of a long-chain fatty acyl-CoA from 
coenzyme A to l-carnitine. However, Etomoxir (200 µM), inhibited IL-4 target 
genes in Cpt2-/- macrophages, suggesting either an off-target effect or an 
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unknown additional function for Cpt1a and the authors proposed that localised 
deletion of Cpt1a will be require to elucidate possible functions outwith FOA.  
We observe perturbation of carnitine related metabolites, many of which were 
acylcarnitines. If these are pro-inflammatory effectors or a pro-inflammatory 
signature, it is possible that by reducing this, IFNγ has an important role 
regulating oxidation of β –fatty acids. Regulation of lipid metabolism will require 
further investigation in the context of inflammatory macrophages, taking into 
account the type-(s) of stimulus/stimuli used. 
3.3.1.3 Pyridines and purines 
The engagement of a transcriptional profile is expected to require increased 
nucleotide synthesis and consumption. Changes in these pathways were detected 
but it is noticeable that these changes are not unidirectional and stimulus 
specific increases are not uniform. Guanine and inosine have been shown to 
modulate cell function so it will be interesting to determine if they have a 
similar role in inflammation. Finally, there were two modified nucleotide 
analogues that had altered levels; 5’-methyl-2’deoxycytidine (marker of de-novo 
DNA methylation: decreased by all stimuli) and 3-methyguanine (altered in 
leukaemia, tumours and immunodeficiency: increased by all stimuli). Whether 
these metabolites are indicative of essential epigenetic modifications is 
currently unknown. Methylation in the context of inflammatory genes and/in 
disease has been reported but has not been detected at a global level 
(Bayarsaihan 2016). Interestingly, Adenosine, which is known to down-regulate 
classical macrophage activation via the A2A G-protein–coupled cell membrane 
receptor (Hasko & Pacher 2012), is increased in an IFNγ-dependent manner. 
Whether this is indicative of a regulatory mechanism remains to be determined 
3.3.2 Untargeted metabolomics: Strengths and weakness 
This study has given unparalleled coverage of the metabolome of inflammatory 
cells. Our choice of protocol and platform has allowed us to look within and 
outwith central carbon metabolism. This coverage comes at a cost. While 
confidence in metabolite identifications can be strengthened by use of authentic 
standard and fragmentation, many metabolites are solely identified by accurate 
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mass and predicted retention time and thus are only putatively identified. 
Further targeted analysis (IE isotope labelling studies) and validation studies 
(medium deprivation and inhibitors) will be required to verify these results and 
any biological importance. Nevertheless, a robust method has been established 
that performed admirably well here. Furthermore, this method further enabled 
meeting the aim of Chapter 4: to obtain the Leishmania-infected macrophage 
metabolome. 
 
Figure 3-10: Our results in the context of macrophage immune-metabolism. Note that 
location of metabolites does not refer to cellular location. 1: & 2: Some macrophages were 
primed with IFNγ overnight and then some were stimulated with LPS for four hours. 3: This 
causes increase in metabolites in glycolysis ((R))-Lactate) and the PPP (Ribose-5-Phosphate, not 
shown). 4: Previously reported perturbations in the TCA cycle are indicated including Itaconate 
production and Succinate accumulation. 5: L-Arginine is metabolised to L-Citrulline and effector 
molecule NO*. 6: Arginine and Glutamate metabolism are connected with N-L- (Arginino)-
Succinate and Aspartate (from Glutamate) allow for replenishment of the TCA cycle at the point 
of Fumarate. 7: Dihydrobiopterin is used to form the iNOS cofactor tetrahydrobiopterin by 
Dihydrobiopterin reductase. 8: Levels of select carnitine related metabolites are modulated by 
LPS and/or IFNγ. 9: Taurine metabolism is modulated by IFNγ. 10: Purine and pyrimidine 
metabolism displays as stimuli specific profile as did some modified analogues. 11: Levels of β-
alanine, which can originate from arginine, pyrimidine fatty acid or glutamate metabolism, were 
increased in M1 macrophages.
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4 A complementary metabolome and 
transcriptome of the infected macrophage 
4.1 Introduction 
Macrophages are a key part of the innate immune system and possess a wide 
range of potent effector functions such as the generation of reactive oxygen and 
nitrogen species. Furthermore, they can produce a plethora of chemokines and 
cytokines that can cause the recruitment and activation of other immune cells. 
Using classical techniques from molecular biology and immunology has revealed 
a great deal about how the Leishmania parasite can avoid, supress, and/or 
survive these responses. 
In Chapter 1 there an introduction to studies that showed how Leishmania 
species recruit macrophages and drive a M2 polarisation by secreting 
promastigote secretory gel (PSG) (Rogers et al. 2009), and how different 
parasite species activate different complement mediated opsonisation and 
uptake pathways (Mosser et al. 1986; Domínguez et al. 2003). Not all of these 
studies used the same parasite species/strains, and this, in combination with 
variation caused by differences in hosts (i.e. mouse strain), or host cell type 
used makes it difficult to have a single and unified overview of how specific 
parasite species modulate the host cell. Instead, a patchwork-like model of 
parasite-host interactions and modulation emerges that contains processes that 
may not apply to all Leishmania species. 
High throughput techniques such as transcriptomics and metabolomics are 
becoming increasingly important in this regard as they allow the systematic 
profiling of multiple biologically important processes simultaneously. These 
methods can be applied to multiple species and/or when multiple time-points 
are used, unprecedented insight into both pathogen and host biology can be 
obtained (Dillon et al. 2015; Fiebig et al. 2015; Fernandes et al. 2016). 
Metabolomics has already revealed important changes in parasite metabolism as 
they differentiate between life cycle stages. Saunders et al used targeted MS 
based metabolomics on a model of the L. mexicana intracellular parasite and 
found that there is a switch to a stringent profile where parasites consume fewer 
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substrates but also produce fewer partly oxidised products of metabolism 
(Saunders et al. 2014). Lamour et al used NMR to profile the L. major infected 
macrophage (Lamour et al. 2012). While several changes were detected, the 
coverage of NMR is much less than that of LC-MS. Furthermore, as an antigen or 
phagocytic control was not used in their study, it is not possible to differentiate 
between general responses associated with consumption of particulate matter 
and live parasite induced perturbations.  
Recently it was reported that L. infantum infected macrophages undergo a 
temporary shift to glycolysis (~6 hours post infection) before reverting to 
oxidative phosphorylation (~18 hours post infection) (Moreira et al. 2015). The 
focus of this study was, however, restricted to central carbon metabolism. 
Nevertheless, the findings were of interest hence the aim was to use as similar 
as possible time-points for the metabolic and transcriptomics profiling of 
L. mexicana-infected macrophages (Figure 4-1). Furthermore, flow-cytometry 
cell sorting was used to enrich for infected macrophages. The benefits of this 
are two-fold. Firstly, bystander cells are removed and secondly, intracellular 
parasites are synchronised. 
Integration of ‘Omics’ is a new and challenging area of research. This approach 
has the power to reveal emergent properties not obvious in the individual 
datasets (Jha et al. 2015). This will be increasingly useful in utilising 
metabolomics datasets by linking a specific transcriptional pathway to 
metabolites that can occur in multiple pathways and vice versa. Furthermore, 
while transcriptomics offers unparalleled coverage, not all transcripts are 
translated and post-translational modifications to proteins can affect cell 
function. As alterations in metabolite abundance occur downstream of such 
effects (i.e. changes in enzyme expression influence metabolism), metabolomics 
offers a readout that is closer to actual phenotype, in that it is the metabolite 
building blocks that are ultimately polymerised into the molecular structures 
defining cellular architecture. 
An antigen (or poly-antigen) control is commonly used in host-pathogen 
experiments. This control allows the detection of general responses that the live 
parasite may induce or supress as well as changes that only the live parasite may 
cause. The latter class of changes can include alterations caused by increased or 
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decreased levels of certain metabolites that are produced or consumed by the 
live parasite. In this chapter such a control was developed and utilised in both 
the transcriptomics and untargeted metabolomics profiling of L. mexicana-
infected macrophages.  
 
Figure 4-1: Experimental outline of Omics experiments in Chapter 4. Note that for the 
metabolomic experiments that did not involve FACs, there were M1 and M2 controls for each 
time-point.  
4.2 Results 
4.2.1 Establishing a heat-killed control and enrichment strategy  
4.2.1.1 Heat-killed control 
Several studies have used heat-killed parasites as an antigen control with heat-
killing conditions ranging from 56ºC for 5 minutes to kill L. amazonensis to 65ºC 
to 45 minutes heat-killing of L. donovani (Morehead et al. 2002; Marr et al. 
2014). The lowest temperature that reproducibly yielded non-live parasites in 
our hands was 48ºC for 12 minutes as characterised by growth curves 
(Figure 4-2) (see 2.6.4). While different parasite strains have different 
sensitivities to heat (i.e. cutaneous stains die at 37ºC), and higher temperature 
could be used with the aim of denaturing enzymes, our objective was to heat-
kill the parasite using the least harsh treatment possible in a controlled and 
reproducible manner. While Moreira et al used gamma-irradiated parasites 
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(Moreira et al. 2015), our X-ray source would have taken several hours to deliver 
an equivalent dose, which was unsuitable for our experimental design. 
 
Figure 4-2: Growth curves comparing heat-killed parasites with control. Metacyclic 
promastigotes were heated to 48ºC for 12 minutes in a water bath then seeded at a density of 
10^6 cells/mL in cRPMI, and growth at 32ºC, 5% CO2 monitored. Results are representative of 
three independent experiments. 
4.2.1.2 Flow cytometry enrichment of infected cells 
To enrich for infected cells, metacyclic promastigotes (5 day old culture) were 
first labelled with EF670 (eBioscience) similarly to Moreira et al. 2015 (see 
2.7.2). This was done prior to heat killing to avoid subjecting the heat-killed 
parasites to multiple centrifugation steps. Infection was allowed to proceed for 
four hours before proceeding to the FACS protocol. After the protocol, cells 
were re-plated and subsequently processed samples at 7 hours (3 hours post 
infection end) and 24 hours (18 hours post infection end) after starting initial 
infection. 7 (3) hours and 24 (18) hours were chosen as previous studies have 
reported that important changes to metabolite and transcript levels occur at or 
near these time-points (Moreira et al. 2015; Dillon et al. 2015; Fernandes et al. 
2016).  
Additionally, our lab has observed a dramatic reduction in cells present in the 
non-treated groups (quantified by Clément Regnault, unpublished data, using 
the post-extraction protein measurement protocol described in Chapter 3) at 
later time-points (48hrs or later) severely reducing its suitability as a 
comparable control. 
In Figure 4.3, the gating strategy is shown. Briefly cells were first gated based 
on size vs. granularity (forward scatter (FSC)-area vs side scatter (SSC)-area) 
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then singlets were selected (SSC-Area VS SSC-Height). Finally, the EF670+ 
population was selected (final row of panels, right two panels, second peak). In 
the second row of panels, the small particles positive for EF670 may correspond 
to extracellular parasites or debris of parasites or infected cells. Note that the 
Aria I (BD bioscience) was used to sort sample D while samples A and C on the 
Aria III (BD bioscience) in order to obtain sufficient cells. Identical samples were 
used for setting gates, and identical flow rate (cells/min) were used for each 
machine. Furthermore, after the procedure, all sample counts were verified 
using a haemocytometer (Greiner) and cell viability confirmed to be >95% using 
Trypan blue (Sigma). While this does not completely exclude that the different 
instruments are contributing to changes seen in a metabolite’s level, given the 
similarity of results in sorted and non-sorted experiments, this is assumed to be 
minimal. 
 
Figure 4-3: FACs enrichment strategy. The gates were set as denoted. Note that in Chapter 3, 
the ‘lymphocyte’ population was shown consistently to comprise of Cd11b and F4/80 positive 
cells (macrophages). The samples shown were as follows- A: Non-infected, B: Infected with non-
labelled parasites, C: Infected with live parasites, D: Infected with heat-killed infected. These 
are the results of the Aria-III sort on which samples A and C were collected. The same samples 
were run on the Aria-I and similar results obtained (Supplementary Figure 4-1). Sample D was 
collected on the Aria-I. The second row of panels shows populations corresponding to infected 
and non-infected macrophages while the top left population comes from the debris/extracellular 
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parasite gate. The bottom row of panels shows the final gating used on the “Lymphocyte’ 
(Macrophage) population shown in the first row. 
4.2.2 The metabolome of the infected macrophages 
We used a 46-minute protocol for our LC step to differentiate between 
L-citrulline and L-argininic acid, similar to that described in a recent publication 
(Westrop et al. 2015). L-citrulline and L-argininic acid are discussed in more 
detail in Chapter 5. 
4.2.2.1  Validation of method; M1 immune metabolism 
The experiment was executed as described in 3.1. This section pertains to 
results obtained from samples not subjected to FACs sorting. Due to the limited 
number of cells obtained from FACs enrichment, 200,000 cells/replicate were 
used while 250,000 cells/replicate were used in non-sorted samples. In order to 
ensure that profiling method performed with less cells, M1 (IFNγ and LPS) and 
M2 (Il-4) controls were included. This allowed the testing of the reproducibility 
of some of the previous chapter’s findings  (IFNγ and LPS vs. M0) as well. 
Additionally, this allowed the interrogation of whether macrophages infected 
with live or heat-killed parasites were polarised in a similar manner to classical 
M1 or M2 models. The latter is discussed in the following section as well as the 
justification for conducting statistical analysis on each time-point separately. 
Data filtering was conducted as in 3.2.2.1 but with the addition of an Xcalibur 
method to distinguish between L-argininic acid and L-citrulline. The result of 
this filtering in IDEOM and the Xcalibur method was a list of 280 metabolites. 
The identity of 76 of these was confirmed using authentic standards (MSI level 
1). For statistical analysis one-way ANOVA was carried out a (using 
MetaboAnalyst) for both time-points independently with Fisher’s least significant 
difference method (Fisher’s LSD) being used for post hoc analysis as 
implemented in MetaboAnalyst. Note that the parasite specific samples were 
included in this analysis.  
Naive samples for the first time-point were omitted, as there were only two 
replicates. Note that the input and output of this analysis are available in 
Supplementary Files 4-(2-3) (Kegg IDs are shown, metabolite name is in 
Supplementary File 4-1). 
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In Table 4.1, a summary of metabolites that had altered levels caused by M1 or 
M2 stimuli is presented. There were more metabolites with significantly altered 
levels (30 with FDR <0.05 and 4 with FDR <0.1) at the earlier time-point despite 
the lack of a naive control. At the later time-point there were 4 metabolites 
with an FDR <0.05 and 4 with a FDR <0.1. Most changes were M1 driven. The fact 
that the M1 stimulus used is quite strong/enriched is a possible explanation for 
this. Additionally, IL-4 treated macrophages are primed to have an anti-
inflammatory response to pathogens (LPS). Thus there may be a more divergent 
phenotype if they were co-treated with LPS to be effector M2 cells. A similar 
approach taken in Chapter 3 could also be used to dissect the immune and 
pathogen driven anti-inflammatory phenotypes. 
We compared these results with those presented in Chapter 3. The time-point of 
choice was 7 hours as it is nearer to the 4 hours used in the M1 macrophage 
study in the previous chapter.  A total of 24 metabolites were in common in both 
experiments  (in bold in Table 4-1) with only 2 of these outside the FDR <0.5 
cut-off. For all of these metabolites, the direction of change (vs. M0) was 
identical. Additionally, other metabolites such as UTP and uracil have a FDR <0.5 
in Chapter 3 when using an ANOVA instead of a GLM. Thus some discrepancies 
may be due to the different statistical method used. 
Finally, three metabolites (D-fructose 6-phosphate, D-glyceraldehyde 
3-phosphate, 4-methylene-L-glutamine) from the dataset presented in this 
chapter were found on the rejected list within the Ideom data processing 
pipeline (2.12). Differences in the identification process here may have been 
caused by increased separation during a long LC protocol used in this chapter. 
Another example of a limitation of data processing that is not unique to Ideom is 
that it can be difficult to differentiate between metabolites of which there are 
multiple isomers e.g. glyceraldehyde 3-phosphate and dihydroxyacetone 
phosphate. These limitations could potentially overcome by using authentic 
standards for the metabolites of question in combination with a different LC 
method that would separate them better. 
Nevertheless, our protocol preforms well even with 12 fold fewer cells, and 
shows good concordance with some of the key findings of Chapter 3. Increased 
noise at the later time-point in conjunction with the lower number of replicates 
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(n=3 vs. n=4) limits the chances of determining if earlier perturbations are 
sustained. However, O-acetylcarnitine, which was increased in M1 macrophages 
at 7 hours, is higher in M2 macrophages at 24 hours. A detailed understanding of 
the role/regulation of carnitine metabolism will be required to interpret the 
biological relevance of these metabolites in M1 and M2 macrophages. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4-1: Metabolites, the levels of which are altered in the presence of immune stimuli.  
Significance was determined by one-way ANOVA for each time-point with Fisher’s LSD used for 
post-hoc analysis. Samples were analysed alongside infected samples. As KEGG IDs are less 
ambiguous, the equivalent KEGG IDs are in column 1. As certain metabolites are not in KEGG, 
arbitrary IDs are used for these. Metabolites whose alterations match those seen in Chapter 3 
have names in bold. For the 24 hour time-point there were sufficient samples to include the M0 
sample for analysis. In the ‘Change’ column, the altered condition is indicated and unless 
otherwise stated, the change is an increase. A match with an authentic standard, number of 
alternative isomers, match with mZCLOUD fragmentation database and maximum fold change 
(FC) are indicated in the last four columns. Maximum FC refers to the largest FC between any 
condition at denoted time-point. In order to avoid division by zero, missing values were replaced 
with a value that is 25% of the intensity threshold (250). 
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7 hrs ANOVA Name  FDR Change Std Iso MS2 Max FC 
C00490 Itaconate 6.44E-09 M1 Yes 7 Yes 73.1 
NoKegg30 Hydroxybutyrylcarnitine 2.72E-06 M1  1  4.8 
C05933 N-(omega)-Hydroxyarginine 2.72E-06 M1  2  172.5 
C02305 Phosphocreatine 3.89E-06 M1  1  2.5 
C03017 O-Propanoylcarnitine 3.89E-06 M1  1  4.6 
C00149 (S)-Malate 3.88E-05 M1 Yes 4  2.8 
C00085 D-Fructose 6-phosphate 4.18E-05 M1 Yes 46  188.5 
C02230 3-Methylguanine 5.22E-05 M1  5  1133.0 
C01300 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine 7.62E-05 M1  1  691.0 
C00669 gamma-L-Glutamyl-L-cysteine 7.62E-05 M1 Yes 2  391.2 
C00581 Guanidinoacetate 7.97E-05 M1  1  4.8 
C00118 D-Glyceraldehyde 3-phosphate 0.0002 M1  7  24.6 
C00099 B-Alanine 0.0005 M1 Yes 1  3.4 
C00670 sn-glycero-3-Phosphocholine 0.0005 M1 Yes 1  3.4 
C00519 Hypotaurine 0.0006 M1  1  3.3 
C00327 L-Citrulline 0.0008 M1 Yes 1  7.3 
C02862 O-Butanoylcarnitine 0.001 M1  3  2.8 
NoKegg32 Orotidine 0.0012 M1 Yes 1  2.3 
C01109 4-Methylene-L-glutamine 0.0014 M1  2  7.5 
C00019 S-Adenosyl-L-methionine 0.0014 M1  1  5.5 
C00093 sn-Glycerol 3-phosphate 0.0018 M1 Yes 3  2.4 
C01233 sn-glycero-3-Phosphoethanolamine 0.0018 M1  1  2.2 
C00075 UTP 0.0031 M1  1  3.1 
C00026 2-Oxoglutarate 0.0043 M1 Yes 7  3.3 
C00042 Succinate 0.0056 M1 Yes 7  2.6 
C00588 Choline phosphate 0.0056 M1 Yes 1  2.5 
C00051 Glutathione 0.0078 M1 Yes 3  3.0 
C00346 Ethanolamine phosphate 0.021 M1 Yes 2  1.8 
C02571 O-Acetylcarnitine 0.033 M1 Yes 1  1.5 
C00002 ATP 0.04 M1/2 
(noisy) 
 4  2.1 
C00036 Oxaloacetate 0.068 M2 
lower 
 3  1.5 
NoKegg34 DL-2-Aminooctanoicacid 0.07 M1  4  1.6 
C00245 Taurine 0.079 M1 Yes 1  1.5 
C02990 [FA] O-Palmitoyl-R-carnitine 0.09 M2 
down 
 1  1.6 
C00299 Uridine 0.12 M1 
down 
Yes 3  1.8 
C00106 Uracil 0.12 M1 Yes 2  2.0 
24 hrs ANOVA Name FDR Change Std Iso MS2 Max FC 
C00669 gamma-L-Glutamyl-L-cysteine 0.015 M1 Yes 2  303.4 
C01109 4-Methylene-L-glutamine 0.029 M1  2  28.9 
C00085 D-Fructose 6-phosphate 0.038 M1 Yes 46  563.8 
C00149 (S)-Malate 0.047 M1 Yes 4  3.2 
C00327 L-Citrulline 0.058 M1 Yes 1 Yes 29.9 
C02571 O-Acetylcarnitine 0.061 M2 Yes 1  3.3 
C02427 L-Homocitrulline 0.076 M1  1  1284.7 
C02230 3-Methylguanine 0.076 M1  5  1825.7 
C00118 D-Glyceraldehyde 3-phosphate 0.081 M1  7  717.1 
C03771 2 keto arginine 0.081 M2  1  3.1 
C05933 N-(omega)-Hydroxyarginine 0.084 M1   2  1256.2 
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4.2.2.2 PCA and clustering analysis 
It was immediately obvious that time of extraction had a large impact on 
metabolite levels as time accounted for the majority of the most significantly 
changed metabolites, with the magnitude of changes of these metabolites being 
greater between time-points when compared to those between the different 
conditions at each time-point. Firstly metabolites of each replicate were 
normalised to the median of that metabolite in the naïve macrophage for the 
relevant time-point (M0-normalised). While the median and mean should be the 
same in a normal distribution, the median is more accurate than the mean. 
Furthermore, with three-four replicates, it is not possible to see if a metabolite 
fits a normal distribution. The overall aim of this approach was to see if 
infecting the macrophages with either live or heat killed Leishmania skewed 
polarisation towards an M1 or M2 phenotype. Principal components analysis was 
conducted using MetaboAnalyst as it facilitates 3-D rotations. This was 
particularly useful as the first 2 components only explained a combined 43% of 
variation (Figure 4-4a). 
It is apparent that replicates from the same sample groups at the earlier time-
point cluster more tightly together with a larger spread obvious for some 
samples at the 24-hour time-point. Additionally, three of the 24-hour conditions 
(M1, M2 and Infected) used only three replicates. Rotating to view the third 
component shows that M1 macrophages are the most divergent with M2 and 
Infected (Live or heat-killed) showing minor separation (Figure 4-4b).  
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Figure 4-4: Principal components analysis (PCA) of naive, live or heat-killed parasite-infected 
macrophages, M1 and M2 macrophages. These results are for the experiment where samples 
were not subjected to FACS protocol. Values are M0-normalised (median) for the respective 
time-point. Note that M0 samples for the first time point was not included in constructing the 
graphs, as there was only two replicates. A: 2-D view. 95% confidence intervals are highlighted 
by the respective background colour. B: rotated 3D-PCA (of A) showing third component. 
We next decided to conduct clustering analysis on these samples using the 
MetaboAnalyst clustering module to see how they separated. For this Euclidian 
distance measure and the Ward clustering algorithm (clustering to minimize the 
sum of squares of any two clusters) were used. A major factor driving clustering 
is time of extraction with a clear separation between time-points. For the seven-
hour time-point the infected (live and heat-killed) macrophages were separate 
from both M1 and M2 groups. The second time-point was more variable with 
macrophages infected with heat-killed parasites, M2 and naive macrophages 
showing some overlap. While macrophages infected with live parasites seem to 
cluster near to the M1 samples, the variance in these groups and small number 
of replicates may be responsible.  
As the effect of time of extraction was not removed from the data even after 
normalising each time-point to its respective naive control statistical analysis 
was conducted on each time-point separately. While time in culture is expected 
to have some effects, possibly due to cell death or increased cell size, 
alternative explanations include different efficiency of extraction at each time-
point or minor variations in execution of protocol. Finally, while there are 
currently available resources for time-course analysis that take advantage of 
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linear model functions with a time factor incorporated, these require more than 
2 time-points (Xia et al. 2015). 
 
Figure 4-5: Clustering analysis of time resolved metabolome of infected, M1 and M2 
macrophages. These results are for the experiment where samples were not subjected to FACS 
protocol. Values for each metabolite were normalised to the median of the M0 sample of the 
relevant time-point. For this analysis the two M0 samples from the 7 hours time-point are 
removed. The default MetaboAnalyst settings; Euclidian distance measure and Ward clustering 
algorithm were used. 24 hours time-point samples are as indicated, otherwise they are 7 hours. 
4.2.2.3 Parasite driven changes 
In agreement with PCA and clustering analysis, there were fewer significantly 
altered metabolites due to infection vs. M1 stimuli according to ANOVA. Some of 
these metabolites were only found in the infected macrophage and may be 
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unique to parasites Table 4.2; indeed several clearly were. While more changes 
were detected at the early time-point, this may be due to the increased 
variance present in the later time-point as well as there being only three 
replicates in the live-infection group. The magnitude of changes here was less 
than that detected in M1 macrophages with a maximum (of all pairwise 
comparisons) fold change range of 1.3-3.8 (metabolites where this is the case 
are indicated in column M1/2 in Table 4.2). Note that this is part of the analysis 
was presented in Table 4-1, but only parasite-perturbed metabolites are shown 
here. Thus it seems that there are fewer metabolic perturbations induced in the 
macrophage by parasites when compared to classical M1 stimuli. This is perhaps 
expected when considering the M1 stimulus used here is essentially an enriched 
and highly potent immunogenic component. This should be considered when 
investigating if the major increases and breaks in metabolic flux observed in 
classical model systems apply to models of infectious diseases. It is important to 
note that there were several MS features with no i.d. assigned that were not 
detected in non-infected macrophages. These could be further interrogated to 
see if they are novel parasite metabolites 
 
 
 
 
 
 
 
 
Table 4-2: Metabolome of the infected macrophage.  These results are for the experiment 
where samples were not subjected to FACS protocol. Significance was determined by one-way 
ANOVA for each time-point with Fishers LSD used for post-hoc analysis. Samples were analysed 
alongside M0 (for 24 hour samples only), M1 and M2 samples. As KEGG IDS are less ambiguous, 
the equivalent KEGG ID are in column 1. As certain metabolites are not in KEGG, arbitrary IDs 
are used for these. If a metabolite was altered by M1 or M2 stimuli, this is indicated in the ‘M?’ 
column. In the ‘Change’ column, other than parasite specific metabolites, the altered condition 
is indicated. Unless otherwise stated, the change is an increase. A match with an authentic 
standard, number of alternative isomers, match with mZCLOUD fragmentation database and 
maximum fold change are indicated in the last four columns. Maximum FC refers to the largest 
FC between any condition at the denoted time-point. In order to avoid division by zero, missing 
values were replaced with a value that is 25% of the intensity threshold (250). * Imidazole lactic 
acid: see text (4.3.2.1). 
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7 hrs  anova Name FDR M? Change Std Iso MSn Max FC 
NoKegg41 Argininic acid 3.6E-16  Parasite Yes 1 Yes N/A 
C03680 4-Imidazolone-5-propanoate* 4.6E-11  Parasite  4   N/A 
C00408 L-Pipecolate 4.6E-11  Parasite  9  N/A 
C03170 Trypanothione disulphide 6.1E-09  Parasite  1  N/A 
NoKegg37 1-deoxyxylonojirimycin 1.6E-07  INF>HK  4  4.2 
C00380 Cytosine 2.4E-07  INF>HK Yes 1  4.3 
NoKegg36 Ovothiol A 8.4E-05  Parasite  1  N/A 
C00670 sn-glycero-3-Phosphocholine 0.00054 M1 HK>INF Yes 1  1.5 
C03771 2 keto-arginine 0.00057    1  1.9 
C02728 N6-Methyl-L-lysine 0.0014  HK>INF  6  1.8 
C00093 sn-Glycerol 3-phosphate 0.0018 M1 HK>INF Yes 3  1.8 
C01233 sn-glycero-3-Phosphoethanolamine 0.0018 M1 HK>INF  1  1.5 
C01181 4-Trimethylammoniobutanoate 0.0043  HK>INF Yes 4  1.3 
C00588 Choline phosphate 0.0056 M1 INF>HK Yes 1  1.9 
C03916 1-Oleoylglycerophosphocholine 0.112   HK>INF  12  1.5 
24 hrs anova Name FDR  M? Change Std Iso MSn Max FC 
C03170 Trypanothione disulphide 0.00028  Parasite  1  N/A 
NoKegg41 Argininic acid 0.0018  Parasite Yes 1 Yes N/A 
C00408 L-Pipecolate 0.012  Parasite  9  N/A 
NoKegg36 Ovothiol A 0.081  Parasite  1  N/A 
C03680 4-Imidazolone-5-propanoate 0.098  Parasite  4   N/A 
C00588 Choline phosphate 0.098 M2 INF>HK Yes 1  3.8 
  
4.2.3 Enriching the metabolic signal 
In 4.2.1.2 the strategy for enriching for infected cells is outlined. According to 
FACs, roughly 40-45% of macrophages were infected in the experiment presented 
here. The presence of non-infected cells could dilute any parasite-induced 
alterations. Thus parasites were labelled so non-infected cells could be 
removed. The data presented here is not expected to be free from FACs-derived 
artefacts due to the prolonged time in PBS, multiple centrifugations and cell 
straining, and the FACs itself. To reduce this non-infected cells, as well as cells 
infected with live or heat-killed parasites were subjected to the same 
procedure. 
4.2.3.1 PCA and clustering analysis 
Clustering analysis and PCA was performed as described above. Again, time was 
a major factor in driving separation despite normalising metabolites in each 
replicate to the median of the M0 group for the respective time-point. 
Macrophages infected with either live or heat-killed parasites clustered together 
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with overlap for both time-points with the exception being the 24-hour time-
point for macrophages infected with heat-killed parasites. Some parasite 
specific metabolites were present in the live or heat-killed groups at the earlier 
time-point but were near or below the detection limit in the heat-killed group 
for the 24-hour time-point. This can be explained when examining the loading 
plots for the PCA which shows L-argininic acid, L-pipecolic acid, 4-imidazolone-
5-propanoate and ovothiol A were in the top 12 contributors to variance (data 
not shown). Note that an isomer of imidazolone-5-propanoate, imidazole lactic 
acid has been found in Leishmania species, and confirmed by authentic standard 
(Emily Armitage: L. donovani, personal communication) and fragmentation (MS2 : 
L. donovani, L. major and L. mexicana) (Westrop et al. 2015) and thus may be a 
more likely identification. However these do not seem to be solely driving the 
clustering results.  When these metabolites were omitted, the only major 
change in clustering analysis was that 24_SOR_INF (Live-infected, 24 hours) and 
SOR_UN_1 (M0, 7 hours) switched clades. 
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Figure 4-6: A: Principal components analysis (PCA) of naive, live or heat-killed parasite-
infected macrophages that were put through our FACs protocol to enrich for infection.  
Values for each metabolite were normalised to the median of the M0 sample of the relevant 
time-point. 95% confidence intervals are highlighted by the respective background colour. B: 
Clustering analysis of time resolved metabolome of macrophages that were enriched for 
infection. The default MetaboAnalyst settings; Euclidian distance measure and Ward clustering 
algorithm were used here. 
4.2.3.2 Data filtering and ANOVA 
Data filtering was conducted as in 4.2.2.1. The result of this filtering in IDEOM 
and the Xcalibur method was a list of 252 metabolites. The identity of 83 of 
these was confirmed using authentic standards (MSI level 1). 
As above, ANOVA was performed on each time-point separately. Note that the 
input files for additional analysis are in Supplementary Files 4-(5-6) (Kegg IDs 
are shown, metabolite name is in Supplementary File 4-4). There were more 
metabolites with altered levels at both time points when compared to the non-
sorted experiment. Again, some of these were only found in the infected 
macrophage only and may be unique to parasites (Table 4.3). While there are no 
M1 or M2 samples that were put through the FACs procedure, the M1/2 column 
has been added for reference (for changes also caused by M1 or M2 in Table 
4-1). Notable for the 7-hour time-point itaconate and 4-aminobutanoate were 
increased in the heat-killed groups, but not with live parasites but this pattern 
was reversed at the second time-point. 
Itaconate as mentioned previously, is a key metabolite associated with 
inflammation, and inhibits the glycoxylate shunt in certain bacteria as well as 
inhibiting the TCA cycle at the point of succinate dehydrogenase (Michelucci et 
al. 2013; Lampropoulou et al. 2016). 4-aminobutanoate, which is better known 
as GABA, is present in multiple pathways but is role in the GABA shunt has been 
shown to be essential for inflammatory macrophages (Tannahill et al. 2013). 
While GABA was not detected in the non-sorted samples, these samples were 
part of a different LC-MS run, and additionally, GABA found to be increased by 
IFNγ in Chapter 3.  
In summary, these perturbations may be indicative of live parasites 
suppressing/failing to induce an M1 response, which, by contrast, is triggered 
when cells encounter heat-killed parasites. While this control has not been used 
in the context of metabolomics, this is in line with several previous studies 
Chapter 4  147 
 
(Buchmüller-Rouiller & Mauël 1987; Banerjee et al. 2016). These studies found 
that heat-killed parasites, in contrast to the live parasites induce the respiratory 
burst and an inflammatory cytokine profile. 
At the 24 hour time-point the macrophages infected with heat-killed parasites 
have increased levels of D-glyceraldehyde 3-phosphate and (S)-malate. 
Interestingly, (R)-2-hydroxyglutarate, which can be an incidental by-product of 
malate dehydrogenase activity is also increased; further supporting the presence 
of a perturbation in the TCA, perhaps in response to itaconate. The use of 
stable-isotope labelling of glucose will be required to get a better idea of what 
the live or heat-killed parasite does to flux through central carbon metabolism. 
We next compared the results of both sorted and non-sorted experiments in 
order to obtain a list the most reproducible findings. A summary of this is 
presented in Table 4-4. For both time-points, and for two experimental groups 
that were extracted and run on the LC-MS platform at both times, parasite 
specific metabolites were reproducibly detected only in samples containing 
parasites. 
It is possible that these metabolites might be present in serum samples of non-
infected individuals either originating from different cell types or from the 
micro-biome. It will however, be interesting to see if these metabolites could 
potentially be used as novel biomarkers of infection. This will be explored 
further in Chapter 5. Furthermore, for other metabolites detected in both 
experiments, the direction/pattern of change was identical. 
 
Table 4-3: Metabolome of the macrophage enriched for infection.  Significance was 
determined by one-way ANOVA for each time-point with Fisher’s LSD used for post-hoc analysis. 
As KEGG IDS are less ambiguous. The equivalent KEGG IDs are in column 1. As certain 
metabolites are not in KEGG, arbitrary IDs are used for these. Changes that pass the 0.05 FDR cut 
off have their FDR in bold. If a metabolite was altered by M1 or M2 stimuli, this is indicated in 
the M? column (Note that this refers to the results of a separate experiment that is summarised 
in Table 4-1). In the Change column, other than parasite specific metabolites, the altered 
condition is indicated. Unless otherwise stated, the change is an increase. A match with an 
authentic standard, number of alternative isomers, match with mZCLOUD fragmentation 
database and maximum fold change are indicated in the last four columns. Maximum FC refers to 
the largest FC between any condition at the denoted time-point. In order to avoid division by 
zero, missing values were replaced with a value that is 25% of the intensity threshold (250). * 
Imidazole lactic acid: see text (4.3.2.1). * means that this metabolite may be an incidental 
product of malate dehydrogenase activity. 
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7 hr Name FDR M? Change STD MS2 Isomers Max 
FC Nokegg23 Argininic acid 2.0E-11  Parasite Yes Yes 1 N/A 
Nokegg15 Ovothiol A 2.0E-10  Parasite   1 N/A 
C03170 Trypanothione disulphide 6.7E-10  Parasite Yes  1 N/A 
C00408 L-Pipecolate 2.1E-05  Parasite   9 N/A 
C03680 4-Imidazolone-5-propanoate* 0.0002  Parasite   4  N/A 
C00490 Itaconate 0.0005 M1 HK Yes Yes 7 2.92 
C00669 gamma-L-Glutamyl-L-cysteine 0.0016 M1 HK>INF>M0 Yes  2 2.69 
C01233 sn-glycero-3-Phosphoethanolamine 0.0016 M1 HK>INF>M0   1 1.94 
C00418 [FA methyl, hydroxy (5:0)] 3R-methyl-3,5-
dihydroxy-pentanoic acid 
0.0024  INF>HK>M0   14 6.08 
C03274 Glycerophosphoglycerol 0.0042  INF>HK>M0   3 2.35 
C02291 L-Cystathionine 0.0042  INF>HK>M0 Yes  4 N/A 
C00559 Deoxyadenosine 0.0049  HK (lower) Yes  4 2.03 
C00334 4-Aminobutanoate 0.0076  HK Yes  15 1.39 
C00093 sn-Glycerol 3-phosphate 0.061 M1 HK Yes  3 1.68 
C01077 O-Acetyl-L-homoserine 0.062  INF and HK   10 1.53 
C00670 sn-glycero-3-Phosphocholine 0.067 M1 HK Yes  1 1.68 
C00354 D-Fructose 1,6-bisphosphate 0.12 M1 HK Yes  14 1.74 
C03771 2-Keto-Arginine 0.12  HK   1 2.75 
C00588 Choline phosphate 0.12 M1 INF Yes  1 1.37 
24 hr Name FDR M? Fisher's LSD STD MS2 Isomers Max FC 
C03680 4-Imidazolone-5-propanoate* 2.5E-06  Parasite     4 N/A 
C03170 Trypanothione disulphide 2.5E-06  Parasite Yes  1 N/A 
Nokegg23 Argininic acid 9.1E-06  Parasite Yes Yes 1 N/A 
C00408 L-Pipecolate 0.0002  Parasite   9 N/A 
C13482 Phosphodimethylethanolamine 0.0002  M0>INF>HK   1 1.72 
C00118 D-Glyceraldehyde 3-phosphate 0.0009 M1 HK>M0>INF   7 1.27 
C02291 L-Cystathionine 0.0016  INF>HK>M0 Yes  4 N/A 
C00149 (S)-Malate 0.0023 M1 HK>M0>INF Yes  4 1.39 
C01233 sn-glycero-3-Phosphoethanolamine 0.0023  HK (lower)   1 1.58 
C01087 (R)-2-Hydroxyglutarate 0.0028  HK>M0>INF Yes  1 * 1.21 
Nokegg15 Ovothiol A 0.0048  Parasite   1 N/A 
C00093 sn-Glycerol 3-phosphate 0.0072  INF Yes  3 1.63 
C00900 2-Acetolactate 0.016  INF   16 1.23 
Nokegg19 [FA dioxo(8:0)] 4,7-dioxo-octanoic acid 0.03  INF   4 1.44 
C01210 N-Methylethanolamine phosphate 0.03  INF>M0>HK   3 1.64 
C10660 Dictamnine 0.03  HK   2 1.18 
C00270 N-Acetylneuraminate 0.037  HK (lower) Yes  5 1.41 
C06455 Hydroxymethylphosphonate 0.045  HK   2 1.15 
C00212 Adenosine 0.047  HK Yes Yes 3 1.18 
C01181 4-Trimethylammoniobutanoate 0.053  INF Yes  6 1.43 
C00670 sn-glycero-3-Phosphocholine 0.053  INF Yes  1 1.53 
C00334 4-Aminobutanoate 0.063  INF>M0>HK Yes  15 1.43 
Nokegg22 HEPES 0.063  HK (lower) Yes  1 1.09 
C03894 Propane-1,2-diol 1-phosphate 0.082  HK   2 2.44 
C02728 N6-Methyl-L-lysine 0.082  INF and HK   6 1.07 
C01042 N-Acetyl-L-aspartate 0.082  INF  Yes 4 1.28 
C02928 2-Dehydro-D-xylonate 0.13  INF (lower)     2 1.32 
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Table 4-4: Summary of metabolites that were significantly altered in both sorted and non-
sorted experiments.  Parasite specific metabolites are underlined while glycerophospholipid 
metabolites perturbed in both sets are in bold. These samples were extracted separately and 
analyses on independent LC-MS runs. * Imidazole lactic acid: see text (4.3.2.1). 
Non-sort 7h 7h common Sort 7h Non-sort 24h 24h common Sort 24h 
1-
deoxyxylonojirimycin 
Argininic acid Itaconate Choline 
phosphate 
Argininic acid D-Glyceraldehyde 3-
phosphate 
Cytosine 4-Imidazolone-5-
propanoate* 
gamma-L-Glutamyl-L-
cysteine 
 4-Imidazolone-5-
propanoate* 
(S)-Malate 
N6-Methyl-L-lysine L-Pipecolate 
 
[FA ***pentanoic acid  L-Pipecolate (R)-2-Hydroxyglutarate* 
4-Trimethyl-
ammoniobutanoate 
Trypanothione disulphide 
 
Glycerophospho-
glycerol 
 Trypanothione 
disulphide 
 
2-Acetolactate 
1-Oleoylglycero-
phosphocholine 
Ovothiol A 
 
L-Cystathionine  Ovothiol A 
 
L-Cystathionine 
 2 Keto-Arginine 
 
4-Aminobutanoate   4-Aminobutanoate 
 sn-glycero-3-
Phosphocholine 
Deoxyadenosine   sn-glycero-3-
Phosphocholine 
 sn-Glycerol 3-phosphate O-Acetyl-L-homoserine   sn-Glycerol 3-phosphate 
 sn-glycero-3-
Phosphoethanolamine 
D-Fructose 1,6-
bisphosphate 
  sn-glycero-3-
Phosphoethanolamine 
 Choline phosphate    [FA dioxo (8:0)] 4,7-dioxo-
octanoic acid 
     N-Methylethanolamine 
phosphate 
     Dictamnine 
     N-Acetylneuraminate 
     Phosphodimethyl-
ethanolamine 
     Hydroxymethylphosphonate 
     Adenosine 
     4-Trimethyl-
ammoniobutanoate 
     HEPES 
     Propane-1,2-diol 1-
phosphate 
     N6-Methyl-L-lysine 
     N-Acetyl-L-aspartate 
     2-Dehydro-D-xylonate 
 
Other than parasite specific metabolites, glycerophospholipid metabolites made 
up the majority of significantly altered metabolites that were present in both 
experiments. Interestingly, these metabolites were also increased (albeit much 
more) in M1 macrophages. While these are not large changes (FC<2.0) it is 
notable that their patterns are nearly identical in both sorted and non-sorted 
data sets at the 7-hour time-point (Figure 4-7). At the 24-hour time-point, 
except for choline phosphate, these metabolites were slightly higher but only in 
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the sorted samples. Both sn-glycero-3-phosphocholine and choline phosphate 
have previously been reported to be increased in L. major infected macrophages 
(Lamour et al. 2012). Lipid metabolism will be discussed further in 4.2.5. 
 
Figure 4-7: Metabolites involved in glycerophospholipid metabolism at the 7-hours time-point 
from A: samples not subjected to FACs protocol or B: cells subjected to FACs protocol. ** and * 
denotes metabolites that met the 0.05 and 0.01 FDR cut-offs respectively. Note that samples in 
A and B were made separately and run on independent LC-MS runs. 
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4.2.4  Transcriptome of infected macrophage 
For differential expression analysis of transcriptomics data the DESeq2 package 
was used in conjunction with tool available on the Galaxy server that is hosted 
by Glasgow Polyomics (2.13). Briefly quality reports were generated on the 
forward and reverse fastq files by FASTQC (Andrews 2010) while alignment to 
the Ensemble mm10 version of the mouse genome (Aken et al. 2016) was carried 
out using HISAT2 (Kim et al. 2015b). The HTSeq-count Python package was used 
to generate raw count files (Anders et al. 2015). Once all these steps were 
completed on Galaxy (Afgan et al. 2016; Blankenberg et al. 2014), the count 
files were downloaded and differential analysis carried out on a local instance of 
DESeq2 (Love et al. 2014). Within DESeq2, the results function automatically 
performs independent filtering based on the mean of normalized counts for each 
gene. The idea of this is to avoid submitting genes with little or no chance of 
being called differentially expressed (DE) and thus set a more suitable FDR cut-
off. Venny was used to classify overlap between pairwise comparisons and 
likelihood ratio model (LRT) (Oliveros 2015). A LRT inspects two models for the 
counts, a full model with a particular number of terms and a reduced model, in 
which some of the terms of the full model are removed. This is similar to the 
general linear model (GLM) used in Chapter 3 with the main difference being 
that a GLM uses calculation in linear regression, while the LRT implements a 
Negative Binomial GLM, which utilises analysis of deviance (ANODEV), where the 
deviance captures the difference in likelihood between a full and a reduced 
model. 
We subsequently utilised principal components analysis (PCA) and Euclidean 
distance heatmap analysis to visualize the relationship between experimental 
datasets (Figure 4.8). The PCA plots demonstrated that samples from the same 
experimental condition grouped together demonstrating a high level of 
reproducibility between replicates. The main contributor to variation is infection 
status while the viability of the parasite contributes only 12%. The dendrograms 
associated with the Euclidean distance heatmaps further showed this point, with 
like samples clustering most closely with one another, the exception being one 
heat-killed infected sample. 
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Figure 4-8: Global gene expression profiles of murine macrophages that are non-infected, 
infected with live or dead (heat-killed) parasites. Principal components analysis (PCA) plots (A) 
and heatmaps (B) of hierarchical clustering analyses on rLog transformed counts using Euclidean 
distance are shown. The analyses were performed using all annotated protein-coding genes 
following filtering for low counts. In the PCA plots, the first two principal components are shown 
on the X and Y-axes, respectively, with the percentage of total variance associated to that PC 
indicated. 
Pairwise comparisons were carried out using the contrast function with a FDR 
cut-off of 0.05. Here a Wald test is used whereby the estimated standard error 
of a log2 fold change was used to test if it was equal to zero. The results of this 
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are summarised in Figure 4-9:A-C. Here the output of Plot-MA demonstrates 
that, within the DESeq2 pipeline, only genes with a large average normalized 
count contain sufficient information to be called as significant. Additionally, it 
supports the results of the PCA, as the majority of changes occur between the 
naive macrophage group and either infection group while relatively few genes 
are differentially expressed between the INF and HK group. To avoid false 
positives caused by multiple comparisons, results from the pairwise comparisons 
were intersected with the results for LRT (FDR cut-off of 0.05).  
There were 26 genes unique to the LRT (Supplementary Table 4-1) so these 
were excluded from further analysis yielding the final groups shown in Figure 
4.9. This resulted in a list of 4183 DE genes, which is ~87% of found DE using the 
various pairwise comparisons. In Supplementary Table 4-1 these genes, the 
Venn subset information, Log2 fold change, normalised counts and gene 
description are available. 
Use of an antigen control (killed parasites) allows investigating responses that 
the live parasite actively suppresses or induces. For example, the subset of 365 
genes in Figure 4-9 (D-E) could potentially be normal responses seen in response 
to killed parasites that are suppressed by the live parasite. Likewise the subset 
of 1343 could be considered to be antigen specific responses as the viability of 
the parasite is not important. 
The subset containing 254 genes is particularly challenging as it affected by both 
antigen presence and parasite viability. Here the author does not attempt to 
differentiate between the relative contributions of each by the size of the 
adjusted pairwise p-values, as this would be oversimplifying cases where there is 
almost equal contribution. Furthermore, it would ignore the possibility that for 
certain pathways, there are thresholds for activation. A hypothetical example of 
this could be where a pathway requires a 2-fold increase of a particular enzyme 
for activation. If the heat-killed parasite activated a pathway by causing a 2.5 
fold increase in an enzyme but the live parasite suppressed this to a 1.5-fold 
increase, using a binary cut-off described above would not capture this. 
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Figure 4-9: MA-Plots generated from the pairwise comparisons of A: Live infection (INF) vs M0, 
(B) Heat killed infection (HK) vs M0 and C: INF vs HK. These plots show the log2 fold changes 
from the treatment over the mean of normalized counts, i.e. the average of counts normalized 
by size factors. Here the points that are coloured red have an adjusted p value of less than 0.1. 
D: Intersect of differentially expressed genes obtained from pairwise comparisons (contrasts) 
that were contained in LRT Note that the 26 genes were unique to the LRT were excluded from 
further analysis. The Venn diagram was made with Venny (Oliveros 2015). E: Heatmap of 254 
genes (normalized counts subjected to DESEQ2’S variance stabilising transformation) that are DE 
between all three conditions. The Heatmap was generated using Heatmap2 with hierarchal 
clustering method set to "average", Spearman distances and scaling used. Only rows were 
clustered. 
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In Table 4-5 a list of genes that are DE (FC >2.15 ) between macrophages 
infected with live parasites (INF) versus macrophages infected with heat-killed 
parasites (HK). As some of this subset (254, 444, 365: Figure 4-9) were DE 
between INF or/and HK and Control (M0), this is denoted by the ‘±.’ Symbol. In 
section 4.2.4.1 the results of this study are compared with those of (Fernandes 
et al. 2016). Genes in our study that have identical expression profiles with 
human orthologs in the previous study are marked by the ‘§’ symbol in the log2 
FC (M0) column. The human study was chosen as the authors subtracted the 
effect of phagocytosis by using latex beads. 
Notable in the INF vs M0 subset are Il-4, which is upregulated by live parasites 
relative to the antigen control, and Cxcl3, the upregulation of which is inhibited 
by the live parasite. Other immunity related genes not shown in Table 4-5 
(these are not within fold-change cut-off selected here) include the Il-7 receptor 
(Il-7r) and Ccrl2, which were found to be similarly upregulated by Fernandes et 
al. While Ccrl2 was upregulated by both L. amazonensis and L. major, only the 
latter upregulated Il-7r. 
Genes related to peroxisome proliferator-activated receptors (PPAR) signalling 
were also strongly up regulated (Fabp4 and Angptl3) with other members of the 
pathway down regulated (Angptl4 and Olr1). PPARs are a group of nuclear 
receptor proteins that function as transcription factors regulating the expression 
of genes. They have essential roles in regulating of cellular processes such as 
differentiation, and metabolism (Feige et al. 2006).  
While Fernandes et al found no perturbation in PPAR signalling pathway in 
L. major or L. amazonensis infected human macrophages either before or after 
subtracting the effect of phagocytosis, Dillon et al reported identical results for 
Fabp4 and Angptl4 in L. major infected murine macrophages and this difference 
was restricted to the 4 hour time-point (Dillon et al. 2015). Fernandes et al did 
observe an increase in Angptl4 at the four hours time-point in both species in 
contrast to the decrease seen here.  
Possible explanations include the host cell type used (peritoneal versus 
monocyte derived) or host-species specific responses (human versus mouse). 
Nevertheless, Angptl4 has previously been shown to inhibit fatty acid uptake 
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into mesenteric lymph node macrophages (Lichtenstein et al. 2010). It is 
interesting that the live parasite decreases the transcript of this inhibitor of 
fatty acid uptake relative to the heat-killed parasite as this makes sense for the 
intracellular stage of the parasite, which is dependent on lipid metabolism 
(Saunders et al. 2014). 
Ppargc1b, which is a key member of PPAR signalling, is downregulated by the 
heat-killed parasite (-1.84 FC) but not by the live parasite (Supplementary 
Table 4-2). Interestingly Moreira et al found that live L. infantum increase 
Ppargc1a (albeit after 14 hours infection) but not Ppargc1b relative to their 
irradiated control. While the current study does not have later time-points, 
Dillon et al did not detect perturbations to Ppargc1a at any time-point. This may 
be due to differences between parasite species. Nevertheless, PPAR signalling 
and downstream, related pathways were found perturbed in our pathway 
analysis (4.2.4.2). These perturbations and how they might be linked with the 
alterations that were detected in glycerolipid and glycerophospholipid 
metabolisms are discussed in more detail later in this chapter. 
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Table 4-5: Top DE genes that are antigen-independent.  The FC threshold is >2.15. The FC 
presented are expression levels from live parasites infected macrophages (INF) either relative to 
heat-killed infected cells (Log2 FC (HK)) or to non-infected cells (Log2 FC (M0)). The adjusted p 
value (p.adjust) is from the LRT If INF or HK was DE from M0, this is also indicated by “±” in the 
‘Other FC’. Genes displaying the same expression pattern as reported in Fernandes et al is 
denoted by ** (see 4.2.4.1).  
ENSEMBLE ID Description Name log2 FC (HK) padj log2 FC (M0) Other FC 
ENSMUSG00000022469 Rap guanine nucleotide exchange 
factor (GEF) 3 
Rapgef3 1.86 5.4E-06 1.12 ± 
ENSMUSG00000000869 interleukin 4 Il4 1.62 1.9E-04 0.39  
ENSMUSG00000019845 epsilon-tubulin 1  Tube1 1.55 6.7E-03 0.21  
ENSMUSG00000062470 F-box and leucine-rich repeat 
protein 12, opposite strand  
Fbxl12os 1.51 4.3E-03 0.95  
ENSMUSG00000028496 myeloid/lymphoid or mixed-lineage 
leukemia; translocated to 3 
Mllt3 1.43 3.1E-04 0.49  
ENSMUSG00000089665 Foxo1 corepressor Fcor 1.33 4.7E-02 0.23  
ENSMUSG00000062515 fatty acid binding protein 4, 
adipocyte 
Fabp4 1.21 3.1E-41 1.57 ± 
ENSMUSG00000028553 angiopoietin-like 3 Angptl3 1.12 1.1E-02 0.89 ± 
ENSMUSG00000032014 out at first homolog  Oaf -1.18 2.8E-17 0.45 HK>Inf>M0 
ENSMUSG00000048537 pleckstrin homology like domain, 
family B, member 1 
Phldb1 -1.21 6.9E-35 0.92 § HK>Inf>M0* 
ENSMUSG00000026475 regulator of G-protein signalling 16 Rgs16 -1.23 1.5E-06 0.29 HK up 
ENSMUSG00000027962 vascular cell adhesion molecule 1 Vcam1 -1.24 8.4E-08 0.83 HK up 
ENSMUSG00000054675 transmembrane protein 119 Tmem119 -1.26 3.9E-07 -0.68 ± 
ENSMUSG00000032420 5' nucleotidase, ecto Nt5e -1.27 2.4E-02 -0.40  
ENSMUSG00000029379 chemokine (C-X-C motif) ligand 3 Cxcl3 -1.29 1.3E-12 1.57 § HK>Inf>M0± 
ENSMUSG00000002289 angiopoietin-like 4 Angptl4 -1.30 3.6E-03 -0.56  
ENSMUSG00000060639 histone cluster 1, H4i Hist1h4i -1.31 1.4E-15 0.88 HK up± 
ENSMUSG00000029287 transforming growth factor, beta 
receptor III  
Tgfbr3 -1.36 2.0E-02 -0.68  
ENSMUSG00000024912 fos-like antigen 1 Fosl1 -1.39 4.1E-23 1.67 § HK>Inf>M0± 
ENSMUSG00000032724 ankyrin repeat and BTB (POZ) 
domain containing 2 
Abtb2 -1.42 1.5E-14 0.97 § HK>Inf>M0± 
ENSMUSG00000021806 nidogen 2 Nid2 -1.43 7.6E-03 -0.32  
ENSMUSG00000030162 oxidized low density lipoprotein 
(lectin-like) receptor 1 
Olr1 -1.48 1.5E-31 1.17 § HK>Inf>M0± 
ENSMUSG00000090877 heat shock protein 1B Hspa1b -1.49 4.8E-09 0.69 HK up 
ENSMUSG00000091971 heat shock protein 1A Hspa1a -1.50 3.1E-26 1.31 HK>Inf>M0± 
ENSMUSG00000003545 FBJ osteosarcoma oncogene B  Fosb -1.50 3.3E-22 1.07 § HK>Inf>M0± 
ENSMUSG00000003070 ephrin A2  Efna2 -1.71 2.4E-15 1.56 HK>Inf>M0± 
ENSMUSG00000038418 early growth response 1 Egr1 -1.74 2.0E-23 -0.29  
ENSMUSG00000041481 serine (or cysteine) peptidase 
inhibitor, clade A, member 3G 
Serpina3g -1.96 2.1E-03 -0.42  
ENSMUSG00000032487 prostaglandin-endoperoxide 
synthase 2 
Ptgs2 -2.28 3.3E-34 2.07 § HK>Inf>M0± 
ENSMUSG00000022602 activity regulated cytoskeletal-
associated protein 
Arc** -2.30 8.0E-40 3.73 § HK>Inf>M0± 
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In Table 4-6 genes that are DE between macrophages infected with either live 
(INF) vs. heat-killed parasites (HK) or INF vs. M0 with a FC >3.2 are presented. As 
in Table 4-5, genes in our study that have similar expression profiles with human 
orthologs in the previous study are marked by a § in the log2 FC (M0) column. 
This set is specific to effects of infection that are independent to parasite 
viability. The Slc7a11 transporter was one of the most upregulated genes in this 
study. Slc7a11 is a cystine-glutamate antiporter that couples the uptake of one 
molecule of cystine with the release of one molecule of glutamate. Related to 
this, GABA was increased in samples infected with heat-killed parasites, but was 
higher in the samples containing live parasites at the later time-point. The 
increase of this transcript has been reported to be essential for T-cell 
proliferation (Levring et al. 2012), but has not been investigated in the context 
of macrophage activation or infection.  
Interestingly, the anti-inflammatory interleukin 1 receptor antagonist Il1rn is 
upregulated. Both of these results are in agreement with the results from Dillon 
et al where this change was restricted to an early time-point (Dillon et al. 2015). 
This was also found to be the case in L. amazonensis and L. major infected 
human macrophages (Fernandes et al. 2016).  Reports on the role for IL-1 in 
leishmaniasis have pointed to a negative contribution by this inflammatory 
cytokine. In the murine model (susceptible model: Balb/C) of L. major infection, 
IL-1 (α or β) caused earlier disease progression, while a negative association for 
IL-1β with disease severity caused by L. mexicana has also been reported 
(Voronov et al. 2010; Fernández-Figueroa et al. 2012). The mechanisms of how 
Leishmania eventually supresses Il1rn, remains to be determined. 
Inflammatory chemokines such as Ccl3, 4 and 5, Cxcl1 and 16 were among other 
notable upregulated immunomodulatory mediators that are typical of a general 
inflammatory response while IL-4 and IL-6 receptors, IL-16, chemokines Ccl7 and 
chemokine receptor Cxcr3 were down regulated (these are not within fold-
change cut-off selected here). Arginase (Arg2) was upregulated in infected 
macrophages. Of all these Cxcl1 and Il-6 showed similar expression profiles in 
infected human macrophages. 
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Table 4-6: Top DE genes that are antigen-dependent.  The FC threshold is >3.2. The FC 
presented are expression levels from live parasites infected macrophages (INF) relative to non-
infected cells (Log2 FC (M0)). The adjusted p value (p.adjust) is from the LRT. Genes displaying 
the same expression pattern as reported in Fernandes et al is denoted by “§” in the ‘Log2 FC 
(M0)’ column (see 4.2.4.1). 
ENSEMBLE ID Description Name padj log2 FC M0 
ENSMUSG00000019817 pleiomorphic adenoma gene-like 1 Plagl1 1.0E-05 3.98 § 
ENSMUSG00000027737 solute carrier family 7 (cationic amino acid transporter, y+ 
system), member 11  
Slc7a11 3.2E-94 3.23 § 
ENSMUSG00000048329 major facilitator superfamily domain containing 6-like Mfsd6l 8.5E-04 2.83 § 
ENSMUSG00000109864 EP300 interacting inhibitor of differentiation 3 Eid3 2.1E-12 2.45 § 
ENSMUSG00000028517 phospholipid phosphatase 3  Plpp3 3.6E-37 2.40 
ENSMUSG00000034472 RASD family, member 2 Rasd2 2.4E-05 2.40 
ENSMUSG00000038508 growth differentiation factor 15 Gdf15 2.0E-33 2.29 
ENSMUSG00000048108 transmembrane protein 72 Tmem72 1.1E-07 2.26 
ENSMUSG00000021997 leucine rich repeat containing 63 Lrrc63 1.3E-02 2.20 
ENSMUSG00000027313 ChaC, cation transport regulator 1 Chac1 2.8E-04 2.06 
ENSMUSG00000002100 myosin binding protein C, cardiac Mybpc3 1.4E-03 2.04 
ENSMUSG00000026981 interleukin 1 receptor antagonist Il1rn 3.1E-29 2.04 § 
ENSMUSG00000030142 C-type lectin domain family 4, member e Clec4e 9.6E-47 2.03 
ENSMUSG00000037887 dual specificity phosphatase 8 Dusp8 2.8E-10 1.95 § 
ENSMUSG00000020178 adenosine A2a receptor Adora2a 2.0E-03 1.94 
ENSMUSG00000074647 family with sequence similarity 83, member C Fam83c 7.9E-08 1.93 
ENSMUSG00000102037 B cell leukemia/lymphoma 2 related protein A1a  Bcl2a1a 2.0E-09 1.90 
ENSMUSG00000040329 interleukin 7  Il7 2.6E-03 1.90 § 
ENSMUSG00000024334 histocompatibility 2, O region alpha locus H2-Oa 2.2E-03 1.89 
ENSMUSG00000026873 PHD finger protein 19 Phf19 4.7E-03 1.86 
ENSMUSG00000039646 vasorin Vasn 1.4E-04 1.85 
ENSMUSG00000024486 heparin-binding EGF-like growth factor  Hbegf 4.3E-07 1.78 § 
ENSMUSG00000024014 proviral integration site 1 Pim1 1.4E-25 1.78 § 
ENSMUSG00000028214 GTP binding protein (gene overexpressed in skeletal muscle) Gem 2.5E-10 1.75 § 
ENSMUSG00000000730 DNA (cytosine-5-)-methyltransferase 3-like Dnmt3l 1.1E-04 1.75 
ENSMUSG00000022534 Mediterranean fever Mefv 5.2E-18 1.72 
ENSMUSG00000034842 ADP-ribosyltransferase 3  Art3 2.0E-02 1.68 
ENSMUSG00000051043 G protein-coupled receptor, family C, group 5, member C Gprc5c 1.3E-23 -1.71 
ENSMUSG00000055782 ATP-binding cassette, sub-family D (ALD), member 2  Abcd2 2.8E-36 -1.72 
ENSMUSG00000020669 Sh3 domain YSC-like 1  Sh3yl1 3.6E-02 -1.83 
ENSMUSG00000067199 frequently rearranged in advanced T cell lymphomas  Frat1 1.3E-16 -1.90 § 
ENSMUSG00000056476 mediator complex subunit 12-like Med12l 3.3E-06 -2.22 
ENSMUSG00000054850 small integral membrane protein 10 like 2A Smim10l2
a 
1.8E-02 -2.27 
ENSMUSG00000039783 kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) Kmo 1.8E-05 -2.57 
  
4.2.4.1 Comparison with previous studies 
Two recent studies carried out RNAseq of Leishmania infected macrophages at a 
similar time-point to us (Dillon et al. 2015; Fernandes et al. 2016). In the first 
study, L. major infection of murine macrophages was tracked over several time-
points. In the second study, L. major and L. amazonensis infected human 
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macrophages as well as an additional phagocytic control were traced. 
Additionally, the authors composed a list of human genes that were DE after 
subtracting the phagocytosis effect and had a corresponding DE mouse orthologs. 
This list is comprised of ~50% of total murine DE genes. The list of all DE genes 
from the LRT were compared with DE genes that Fernandes et al subtracted the 
effect of phagocytosis from.  
To this end, our list of DE genes was converted to human orthologs on Biomart 
(Durinck et al. 2009), obtaining 3613 hits that compared with DE genes from 
Fernandes et al.  (Figure 4-10, Supplementary Table 4-3). 32% of our DE genes 
overlapped with either L. amazonensis or L. major DE genes or 20% to 
L. amazonensis. Note that Figure 4-10 does not state that these genes are DE 
between species IE while the 945 genes and 233 genes unique to L. major and 
L. amazonensis are DE relative to the naïve macrophage; they are not DE to each 
other. Fernandes et al conducted separate analysis between L. major and 
L. amazonensis and found only four genes to be DE (4hours post infection only). 
Interestingly 8 of the 30 genes most DE due to the live parasite and 10 of the 34 
genes most DE due to infection, were among this set, having an identical FC 
directionality.  
Next a Hypergeometric distribution test was used to check if overlap in Figure 
4-10 was random. This distribution is typically associated with urn models, i.e. 
there are n balls in an urn, y are painted red, and m balls are drawn from the 
urn. Then if X is the number of balls in sample of m that are red, X has a hyper-
geometric distribution. Essentially nA, denote DE genes from this study (L. 
mexicana), nB denote DE genes from Fernandes et al (L. major or 
L. amazonensis), n C denote the total number of genes (24850 genes in the mm10 
Ensemble genome), and nAB denotes the overlap between AA and B. Then 
nAB∼HG(nA,nC,nB) 
This was implemented in R using the following code: 
n_Mex = 3613;n_Major = 3118; n_Transcriptome = 24850; n_Mex_Major = 1062 
phyper(n_Mex_Major - 1, n_Mex, n_Transcriptome-n_Mex, n_Major, lower.tail = FALSE) 
n_Mex = 3613;n_Amaz = 2057; n_Transcriptome = 24850; n_Mex_Amaz = 713 
phyper(n_Mex_Amaz - 1, n_Mex, n_Transcriptome-n_Amaz, n_Amaz, lower.tail = FALSE) 
For L. mexicana vs. L. major or L. mexicana vs. L. amazonensis the p values 
were 5.4e-195 and 3.4e-142 respectively, which is highly significant. 
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Furthermore, when repeating the above using 14402 as the ‘transcriptome’ that 
contains orthologs mapping one to one between mouse and human, the results 
were still significant. (1.97e-37; vs. L. major, 5.6e-41; vs. L. amazonensis). 
Note that Fernandes et al accounted for phagocytosis, by contrasting infected 
samples to both bead-containing macrophages and uninfected control cells. 
Subsequently, for each gene, the authors selected the maximum p-value from 
these two contrasts for input into the BH multiple-testing adjustment. This 
selection process does not allow the prediction of appropriate responses that the 
parasite might suppress to some extent. Additionally, these differences may be 
due to the fact a different species of parasite was used (we used L. mexicana) or 
that their control was phagocytic while ours was antigenic). 
 
Figure 4-10: Comparison of DE genes from current study compared to DE genes (after 
accounting for phagocytosis) from Fernandes et al. The time-point in question from the latter 
study was 4 hours post infection. Note that Figure 4-9 does not state that these genes are DE 
between species IE while the 945 genes and 233 genes unique to L. major and L. amazonensis 
are DE relative to the naïve macrophage; they are not DE to each other. Venny was used to make 
diagram (Oliveros 2015). 
4.2.4.2 Pathway analysis 
For pathway analysis the aim was to differentiate between general immune 
responses to antigen and those induced by the live parasite. To this end DE 
genes from the three pairwise comparisons were analysed (Figure 4-9). Some of 
the resulting DE genes were pseudo/predicted, had no gene description, coded 
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for micro, small nucleolar or mitochondrial RNAs. While these are potentially 
interesting, they were filtered out prior to further analysis. Additionally, the 
library prep used was not designed to target these classes (there are custom 
library preparation for them), so coverage or bias could be an issue.  
Furthermore, this was necessary as many pathway analyses tools convert input 
to ENTREZ gene formatting. The conversion of ENSEMBLE (used here) to ENTREZ 
is not straightforward with each type having unique hits as well as some genes 
mapping to multiple loci, thus preventing one to one conversions. Pathway 
analyses tools do not accept datasets with a high percentage of non-ENTREZ 
mapping genes. Thus our filtering allowed us to lower non-mapping to a level 
permissible by analysis tools. This led to a reduction of DE genes from 4209 to 
3729. Pathway analysis was carried out using Graphite using the Mus musculus, 
species and KEGG pathways (Sales et al. 2013).   
Graphite Web also allows incorporation of Log2 fold change values as well as 
allowing the user to supply a background (all genes detected by the platform) 
and a list of DE genes. This is particularly important when one considers that 
different types of mammalian cell have different expression profiles, with 
certain genes unique to a single cell type. In this instance the background was a 
list of genes that had at least one condition that contained two samples with a 
non-zero number of reads. When considering the coverage of RNAseq, it is 
reasonable to assume that this background is well representative of the subset 
of the transcriptome that is utilised by macrophages. As described above, 
entries that were pseudo/predicted, had no gene description, coded for micro, 
small nucleolar or mitochondrial RNAs were filtered as above. Note that an 
arbitrary LFC threshold was not set as this tended to lead to a bias towards 
genes with low read counts.  
There are several options available in Graphite that allows the user to supply a 
list of pre-calculated DE genes alongside a platform background. These are the 
Hypergeometric test (used in 4.2.4.1), and Signalling Pathway Impact Analysis 
(SPIA). Here the Hypergeometric test (used above) generates an estimate of the 
chance probability of observing a given number of genes from a pathway among 
the pre-selected differentially expressed genes. SPIA encapsulates key aspects of 
the data combining the fold change of the DE genes, the pathway enrichment 
and the topology of pathways (Tarca et al. 2009). Specifically, SPIA first 
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computes the Hypergeometric enrichment p-values (pND). As well as this, SPIA 
computes a perturbation factor as a linear function of the perturbation factors 
of all genes in a given pathway, whose significance is calculated through a 
bootstrap approach, pPERT. The combination of the two independent p-values 
(pNDE and pPERT) yields pG. Finally, pGs are then adjusted for multiple testing 
using either the false discovery rate (FDR) algorithm (pGFdr). 
 Our method of choice was SPIA as it takes into account all supplied information 
and not only lists effected pathways, but also predicts the nature of the impact, 
i.e. is it activation or inhibition? The database options available were the KEGG 
and Reactome databases. These databases contain pathway information that is 
bases on experimental work. For example, the Leishmaniasis KEGG pathway 
highlights genes and interactions (and relevant citations) that are associated 
with various species of Leishmania, some of which are mentioned in the 
introduction (i.e. gp63 protease). The results of this are presented in Table 4-7 
(detailed results is available in Supplementary Table 4-4). Here the results 
contain hits with a minimum (pGFdr<0.1). The first column (INF) shows what 
happens in macrophages infected with live parasite in comparison to naïve 
macrophages. The second column (HK) shows what happens in macrophages 
infected with heat-killed parasites in comparison to naïve macrophages. The 
third column (LIVE) shows what happens in macrophages infected with live 
parasites in comparison to macrophages infected with heat-killed parasites. 
It is important to state that while the live parasite might either increase or 
decrease pathway activation or inhibition relative to the heat killed parasite, 
this does not mean that it is sufficient to cancel out or reverse its affect (see 
KEGG: NF-kappa B signalling pathway for such an example). 
Table 4-7: SPIA analysis of L. mexicana infected macrophages. INF refers to DE genes in the 
pairwise comparison of macrophages infected with live parasites versus non-infected 
macrophages. HK refers to DE genes from pairwise comparison of macrophages infected with 
heat-killed parasites versus non-infected macrophages. LIVE refers to DE genes from pairwise 
comparison of macrophages infected with live parasites versus heat killed parasites 
macrophages. The colour key is red for inhibition, green for activation and grey for either not 
detected at false discovery rate (FDR) algorithm (pGFdr)<0.1. Note that R-HSA-163200 
(Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by 
uncoupling proteins), R-HSA-174178 (APC/C:Cdh1 mediated degradation of Cdc20 and other 
APC/C:Cdh1 targeted proteins in late mitosis/early G1) and R-HSA-72662 (Activation of the mRNA 
upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S) are stable 
REACTOME IDS used for the sake of abbreviation. 
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KEGG INF HK LIVE REACTOME INF HK LIVE 
Insulin signaling pathway    R-HSA-163200    
Neurotrophin signaling pathway    Respiratory electron transport     
p53 signaling pathway    M/G1 Transition    
Viral myocarditis    DNA Replication Pre-Initiation    
Jak-STAT signaling pathway    SCF(Skp2)-mediated degradation of p27/p21    
Transcriptional misregulation in cancer    Regulation of activated PAK-2p34 by proteasome mediated degradation    
Antigen processing and presentation    Ubiquitin-dependent degradation of Cyclin D    
Alzheimer's disease    Ubiquitin-dependent degradation of Cyclin D1    
NOD-like receptor signaling pathway    Signaling by Wnt    
Prostate cancer    CDK-mediated phosphorylation and removal of Cdc6    
Type II diabetes mellitus    p53-Dependent G1/S DNA damage checkpoint    
T cell receptor signaling pathway    Regulation of ornithine decarboxylase (ODC)    
Notch signaling pathway    SCF-beta-TrCP mediated degradation of Emi1    
GnRH signaling pathway    Stabilization of p53    
Vascular smooth muscle contraction    Degradation of beta-catenin by the destruction complex    
PPAR signaling pathway    Autodegradation of the E3 ubiquitin ligase COP1    
Measles    p53-Dependent G1 DNA Damage Response    
B cell receptor signaling pathway    Autodegradation of Cdh1 by Cdh1:APC/C    
Chagas disease (American trypanosomiasis)    CDT1 association with the CDC6:ORC:origin complex    
Leishmaniasis    APC/C:Cdc20 mediated degradation of Securin    
NF-kappa B signaling pathway    APC/C:Cdc20 mediated degradation of mitotic proteins    
Toll-like receptor signaling pathway    Assembly of the pre-replicative complex    
Epstein-Barr virus infection    Destabilization of mRNA by AUF1 (hnRNP D0)    
Osteoclast differentiation    Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins    
Toxoplasmosis    p53-Independent DNA Damage Response    
Adipocytokine signaling pathway    p53-Independent G1/S DNA damage checkpoint    
Herpes simplex infection    Ubiquitin Mediated Degradation of Phosphorylated Cdc25A    
Hepatitis B    R-HSA-174178    
Cell adhesion molecules (CAMs)    Cdc20:Phospho-APC/C mediated degradation of Cyclin A    
Apoptosis    Regulation of APC/C activators between G1/S and early anaphase    
Legionellosis    S Phase    
HIF-1 signaling pathway    APC/C-mediated degradation of cell cycle proteins    
Influenza A    Regulation of mitotic cell cycle    
Small cell lung cancer    Mitotic G1-G1/S phases    
Glioma    G1/S Transition    
Hepatitis C    Cyclin D associated events in G1    
Melanoma    G1 Phase    
Chronic myeloid leukemia    Eukaryotic Translation Elongation    
Cell cycle    Peptide chain elongation    
Bacterial invasion of epithelial cells    GTP hydrolysis and joining of the 60S ribosomal subunit    
Colorectal cancer    Nonsense-Mediated Decay    
Leukocyte transendothelial migration    Nonsense Mediated Decay Enhanced by the Exon Junction Complex    
Cholinergic synapse    Cap-dependent Translation Initiation    
Salmonella infection    Eukaryotic Translation Initiation    
    The citric acid (TCA) cycle and respiratory electron transport    
    R-HSA-72662    
    Meiosis    
    Interferon Signaling    
    Meiotic Recombination    
    Interferon gamma signaling    
    Interleukin-1 signaling    
    RNA Polymerase I Transcription    
    RNA Polymerase I Promoter Opening    
    RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription    
    RNA Polymerase I Promoter Clearance    
    Telomere Maintenance    
    MAP kinase activation in TLR cascade    
    Signaling by Robo receptor    
    MAPK targets/ Nuclear events mediated by MAP kinases    
    Nuclear Events (kinase and transcription factor activation)    
    Glucose metabolism    
    PPARA Activates Gene Expression    
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Note that as there was varying numbers of DE genes in each set (2935 in INF, 
2557 in HK and in 1351 LIVE) and this will have some consequence as well. 
Fernandes et al used a Hypergeometric test separately on genes either 
upregulated or down regulated by the parasite (and independent of 
phagocytosis) (Fernandes et al. 2016). This approach was not taken as it would 
not connect cases where down-regulation of inhibitors of pathways with the 
upregulation of activators. Fernandes et al restricted their pathway analysis to 
genes that were DE due to L. major infection and had mouse orthologs. 
Nevertheless, as reported by Fernandes et al, there is upregulation/activation of 
NF-kappa B signalling pathway, and Toll-like receptor signalling pathways. 
Interestingly, while induced by both the live and heat-killed parasite, the former 
does this to a significantly lesser extent. There were no down-regulated 
pathways in our study in common with Fernandes et al. 
Inflammatory macrophages are reported to upregulate glycolysis and down 
regulate mitochondrial respiration. When taking this into consideration, it is 
notable in the Reactome section that the live parasites activate the TCA cycle 
and within it the respiratory electron response while heat killed parasites 
upregulate glucose metabolism. This would suggest that even at an early time-
point the live parasite, unlike its “antigen” equivalent, polarises macrophages 
away from an inflammatory phenotype. As immune-metabolism is a relatively 
new field and as such is absent from databases, this was explored in more detail 
(Figure 4-11). The inset image in Figure 4-11 (a) shows the Reactome map of 
TCA related pathways. The example highlighted is cytochrome complex somatic 
(cycs) that is upregulated by the parasite. As cycs is an essential part the 
electron transport chain it is assigned a high impact score.  
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Within the TCA cycle, there are several enzymes, of which the up- or –down 
regulation of which is essential for the M1 polarisation of macrophages (Jha et 
al. 2015). In M1 macrophages idh1 expression is down-regulated leading to 
citrate accumulation. In M1 macrophages itaconate production from citrate is 
massively upregulated via irg1 (acod1). In our dataset, both live and killed 
parasite cause slight down-regulation of both idh isoforms and a ~5 fold increase 
in the transcript of acod1. In our metabolomics data while there was a slight 
increase in itaconate in cells infected with killed parasites, this was only in the 
FACS group. In non-sorted samples, M1 macrophages massively upregulated 
Itaconate levels. While this TCA signature seems present in infected cells, it is 
not as potently induced as when LPS is used to trigger a response. Thus it 
remains to be determined if this feature is functionally important or if the live 
parasite has to suppress it. Other enzymes in the TCA cycle had slightly altered 
levels, but a complete understanding of the effects of this will require stably 
labelled isotope experiments (e.g.. 13C-glucose). 
Another characteristic of inflammatory macrophages is increased uptake of 
glucose by up-regulating expression of transporters. There is some evidence of 
this with an infection driven 1.9-fold increase (heat-killed caused slightly larger 
increase than live parasite) of the glucose transporter Slc2a1 in our dataset. 
Furthermore, live and heat-killed parasites have divergent affects on hexokinase 
isoforms. HK1 exclusively promotes glycolysis, whereas HK2 has a more 
multifaceted role, driving glycolysis when bound to mitochondria and glycogen 
synthesis when located in the cytosol (John et al. 2011). The upregulation of hk1 
and pfkp in cells infected with killed parasites points towards a higher glycolytic 
rate. 
Figure 4-11: Overview of immune-metabolic related pathways perturbed in infected macrophages. 
 A :Inset shows Cytoscape TCA Reactome network produced by Graphite. As an example cytochrome S is 
highlighted and the normalised counts from Deseq2 shown. In light blue is the TCA cycle and an enzyme 
from Gluconeogenesis in pink. Reaction direction or reaction inhibition is as indicated and, multistep 
reactions are shown as dashed lines. Gene names and maximum fold change (in brackets) are shown in 
count plots In red arrows are reactions that have been shown to be critical for M1 macrophages. 
Specifically, Itaconate production by Acod1 (Irg1) and down-regulation of Idh expression have been 
reported to be essential for M1 macrophages. B: Glycolysis is shown in detail. Reaction direction or 
reaction inhibition is as indicated, and multistep reactions are shown as dashed lines. Gene names and 
maximum fold change (in brackets) are shown in count plots In red arrows are reactions that have been 
shown to be critical for M1 macrophages while in blue arrows denote those to be essential in M2 
macrophages. Arginine and glucose transporters are shown on cell periphery. TCA and arginine 
metabolism are highlight in light blue shading 
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Arginine metabolism is key to both M1 and M2 macrophages. In murine cells, it 
can be taken up via transporters SLC7A1-3. SLC7A1 is constitutively expressed 
while SLC7A2 is cytokine inducible and is important for both M1 and M2 
macrophages (Yeramian et al. 2006). Surprisingly there is an up-regulation of 
SLC7A1 only.  In the Fernandes et al study, SLC7A1 was increased at all time-
points for both parasite species but the increase was only larger than that 
induced by latex beads for L. major at 4 hours post infection (Fernandes et al. 
2016). Both live and heat-killed parasites cause up-regulation or Arginase 2 
(Arg2), which did not occur in the study by Fernandes et al. The role of Arg2 in 
macrophages, which is localised in the mitochondria is less well known than its 
cytosolic equivalent and classical M2 marker, Arg1 (Yang & Ming 2014) and 
interestingly, in Chapter 3, if anything, it is upregulated in M1 macrophages 
(after 24 hours). A microarray based study on L. amazonensis amastigote 
infected BMDM (24 hour infection Balb/c) reported an increase in Arg2 and 
confirmed this using qPCR (Osorio y Fortea et al. 2009). It will be interesting to 
see if these alterations in host arginine metabolism are important in the context 
of L. mexicana. 
Not shown in Figure 4-11 is the down-regulation of Deptor by live (0.62 FC) and 
killed (0.48 FC) parasites. Deptor inhibits both mTORC1 and 2. This is interesting 
as Leishmania release the gp63 protease, which cleaves it (Halle et al. 2009). 
Deptor has been shown to upregulate glycolytic metabolism by preventing 
mTORC1 blocking the PI3K-Akt pathway signal transduction pathway (Meng et al. 
2013). While this is an example of a gene being DE between all three conditions, 
whether there is a functional consequence caused by the live parasite down-
regulating the Deptor to a significantly lesser extent than its antigen control 
remains to be determined. 
4.2.5  Integration of Metabolomics and Transcriptomics Datasets 
Integration of omics is a new and challenging area of research. While 
transcriptomics offers unmatched coverage, the fact that a gene is DE does not 
necessarily mean higher protein levels. Furthermore, as metabolites can occur in 
multiple pathways, transcriptomics can help elucidate the responsible enzymes. 
The integration module of MetaboAnalyst, which uses a Hypergeometric test for 
enrichment analysis and Betweeness Centrality topology analysis was used (Xia 
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et al. 2015). This was the method of choice here as this module accepts not only 
ENSEMBLE and KEGG IDs, but their fold change as well, outputting interactive 
images of maps that show metabolites, transcripts and whether they are up or 
down regulated. As there weren’t sufficient cells to conduct RNAseq on cells 
subjected to the FACs protocol, integration of the transcriptomics data is 
restricted here to its non-sorted samples. Here the live versus heat-killed 
infection comparison was used due to insufficient replicates of non-infected 
samples in the metabolomics set. Excluding obvious parasite specific metabolites 
argininic acid, ovothiol A and trypanothione disulphide, this led to a list of 9 
metabolites versus 1197 DE genes that had equivalent Mus musculus KEGG and 
Entrez hit. 
Table 4-8: Significantly altered pathways containing both metabolites and transcripts from 
integration analysis.  Total refers to sum of genes and metabolites present in pathway while 
expected refers to number of hits expected by chance. 
Pathway Total hits Expecte
d 
Metabolite name Kegg ID P.Value Topology 
Glycerolipid 
metabolism 
72 2.9 sn-glycerol 3-phosphate C00098 0.02 1.6 
Glycerophospholipid 
metabolism 
119 4.8 sn-glycerol 3-phosphate                
sn-glycero-3-Phosphocholine         
sn-glycero-3-Phosphoethanolamine 
Choline phosphate 
C00098        
C00670      
C01233      
C0588    
 
0.1 0.6 
In Table 4-8 the results of this analysis are presented. Glycerolipid and 
glycerophospholipid metabolism were the top pathways but this is expected as 
the majority of metabolites with altered abundance were from these pathways. 
Nonetheless, the related PPAR and Adipocytokine signalling pathways were 
perturbed in transcriptome pathway analysis so this was examined in more 
detail. In Figure 4-12 the KEGG maps are presented alongside the 
transcriptional profile. Metabolite nodes are simply coloured red (increased) or 
green (decreased), comparing the live infected with heat-killed infected 
samples. 
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Notable among the altered transcripts are lipoprotein lipase (Lpl). Lpl has been 
demonstrated to have a role in atherosclerosis and foam cell formation in 
macrophages, a processes that is associated with inflammation (Takahashi et al. 
2013).  Here the live parasite does not display the marked increase in transcript 
induced by the heat-killed parasite. As previously mentioned, the live parasites 
suppress the decrease in Ppargc1b caused by the heat-killed parasite. Ppargc1b 
has previously demonstrated to be required for oxidative fatty acid metabolism, 
which is associated with M2 metabolism (Vats et al. 2006). In this study Lpl and 
carnitine palmitoyltransferase 1A (Cpt1a) were associated with anti-
inflammatory processes. Cpt1 is a key enzyme in lipid metabolism, catalysing 
formation of acyl carnitines. As mentioned in Chapter 2, the association of fatty 
acid oxidation (FAO) with M2 macrophage function is not fully understood, and 
Cpt1a may have additional immunomodulatory functions (Nomura et al. 2016). 
The transcript level of Cpt1a was decreased ~1.8 fold by the live parasite only in 
our data. Further work should be done on fully determining the extent to which 
parasite’s modulate macrophage lipid metabolism and which of these are 
immunomodulatory and which are needed to meet the parasites requirement for 
lipids. 
4.3 Discussion 
This is to our knowledge, the first application of integrative omics approaches to 
Leishmania infection. Here the high coverage of transcriptomics is combined 
with a robust metabolomics protocol and an heat-killed antigen control to gain a 
detailed insight into host-pathogen interactions. At a metabolite level, potential 
parasite specific metabolites stood out while glycerolipid and 
glycerophospholipid metabolism displayed a highly reproducible profile. These 
perturbations, in combination with transcriptome alterations in the same 
pathways as well as PPAR signalling can be used to inform further experiments of 
the key targets and processes to target. 
Figure 4-12: Overlay of KEGG metabolite and transcripts that are altered in infected macrophages.  
Metabolites are represented by round nodes and enzymes/transcripts by square nodes. Transcripts and 
their fold change are shown. Colour of metabolites refers to comparison of macrophages infected with 
live parasites versus macrophages infected with heat-killed parasites; red referring to metabolites or 
transcripts increased in Live-infected cells, green refers to metabolites or transcripts decreased in Live-
infected cells. 
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4.3.1 Building on and expanding from previous omics studies 
4.3.1.1 Parasite specific metabolites: potential biomarkers 
Among the most significantly altered metabolites were, unsurprisingly, parasite 
specific metabolites. However, this is the first instance of 
Leishmania-macrophage samples being subjected to untargeted metabolomics. 
L-argininic acid has previously been reported to be produced by multiple 
parasites species (Westrop et al. 2015). Not only is this finding confirmed in the 
current study but it is shown that it also takes place within the macrophage and 
that the naive macrophage or polarised (M1 or M2) macrophages do not make it. 
Similar results were found for L-pipecolic acid, ovothiol A, 4-imidazolone-5-
propanoate (Imidazole lactic acid: see text (4.3.2.1)) and trypanothione 
disulphide. Further in vivo studies will be required to confirm if these are 
parasite specific as it is not possible to rule out of other cell types or 
components of the micro-biome might produce them. 
4.3.1.2  Comparison with the literature: Transcriptomics 
This study is the first example of a matched metabolomic and transcriptomics 
approaches. In comparison to previous transcriptomics studies, there are some 
similarities, but difference in library preparation and sequencing platforms, data 
processing pipelines, time-points, parasite or host species, or host cell type are 
compounding factors that will limit overlap. Previous studies have used heat-
killed controls. For instance Rabhi et al conducted a time-course analysis of 
L. major infected murine BMDM (Balb/c) (Rabhi et al. 2012). A detailed 
comparison with this study was not possible as only a select list of 97 DE genes 
was published. While of 40 of the 47 genes that were detected as DE were in 
agreement with FC (Supplementary Table 4-3), the microarray technology used 
in this study does not offer the resolution of RNAseq. Furthermore, a description 
of the heat-killing protocol was not available. 
For this reason the results of this study were compared with those of Fernandes 
et al to not only compare overlap but to potentially have a shortlist of genes 
that are DE in human and mice specific model-in vitro systems (Fernandes et al. 
2016). Additionally, this publication had a comprehensive supplement containing 
all DE genes before and after subtracting phagocytosis for both species. The 
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combination of these studies will allow differentiating between perturbations 
induced by the parasite metabolism and antigenic repertoire as well as its 
phagocytosis. The author of the current study is of the opinion that antigenic 
and phagocytic events should not simply be discounted as artefacts and 
subtracted, as it is likely that it is the combination of these alongside the live 
parasites metabolism that dictates macrophages responses. 
4.3.1.3  Comparison with the literature: Immune-metabolism 
A key study in integrating metabolomics and transcriptomics (Jha et al. 2015) 
used activated macrophages as their model system. This was used as a basis on 
which to examine our data to see if there were any similarities. Based on the 
Reactome pathway analysis, it seems that the live parasite activates the TCA 
cycle while the heat-killed parasite up-regulates glucose metabolism. Itaconate 
is a metabolite whose importance in the context of immune-metabolism is only 
recently being appreciated. It is produced by M1 macrophages causing succinate 
accumulation that ultimately results in the production of the inflammatory 
cytokine IL-1β. Additionally, it has an important role in inhibiting ROS produced 
by increased flux through succinate dehydrogenase and has been proposed to 
impose a limit on inflammation (Lampropoulou et al. 2016; Chouchani et al. 
2014).  
Both live and killed parasites caused an increase in Acod1 (Irg1), which is the 
enzyme that produces itaconate. While there was an increase in itaconate at the 
early time-point, this was only in FACs enriched samples. Whether the live 
parasite suppresses itaconate, and thus succinate accumulation, remains to be 
determined. Nevertheless, the increase in Acod1 transcript in conjunction with 
the increase in the glucose transporter is more in line with an M1 macrophage. 
On the other-hand, the increase in Arg2 could potentially benefit the parasite. A 
possible explanation for these somewhat conflicting results is that the parasites 
engage multiple receptors on the macrophage surface, as well as differences 
between using parasites and supraphysiological dose (s) of immune stimulus (i). 
Studies using macrophages from Irg1/Acod1 deficient mice for Leishmania 
infections could help shed some light on these the role of these perturbations. 
Chapter 4  174 
 
4.3.1.4  Lipid metabolism and host-parasite interactions. 
As L. mexicana parasites enter into a stringent metabolic state, up-regulating 
the uptake of fatty acids, (Saunders et al. 2014), it is interesting that perturbed 
lipid metabolism was a consistent result across both ‘Omics’ experiments. In the 
context of the L. major-infected macrophages, alterations in 
glycerophospholipids have been reported but these studies did not have the 
coverage seen here (Lamour et al. 2012). Lipid metabolism in the context of 
fatty acid oxidation has been associated with M2 macrophages but recent studies 
using macrophages deficient in key enzymes have shown that FAO and 
macrophage polarisation may be more complex than previously thought (Nomura 
et al. 2016). 
Using both unbiased and comprehensive pathway analysis utilising KEGG and 
Reactome databases, PPAR signalling was perturbed in both. Furthermore, when 
examining genes with the largest FC values, members of this pathway including 
fatty acid binging proteins were present. There are readily available inhibitors 
for some of these such as FABP4 inhibitor CAS 300657-03-8 (Merck), which will 
facilitate further interrogation of the importance of these pathways. 
4.3.2  Limitations and benefits of integrated Omics 
A limitation of the integration approach here is the limited coverage that afflicts 
even untargeted metabolomics in comparison to transcriptomics. This is 
compounded by the uncertainty in metabolite identity. In comparison to models 
of macrophage M1 activation, parasites induce a much smaller repertoire of 
perturbed metabolites and the magnitude of these changes is of orders less. 
Furthermore, further studies based on the transcriptomics data presented here 
and elsewhere will first require validation such as time- course resolved qPCR, 
which is considered the gold standard with respect to confirming transcript 
changes. Nevertheless, as can metabolites can occur in multiple pathways, the 
ability to link a perturbed metabolite to a perturbed transcriptional network is 
invaluable.  
An important role for lipid metabolism has previously been implicated in both 
the activated macrophage and intracellular parasite. Both ‘Omics’ approaches 
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here show perturbations in these and related pathways. Further targeted 
validation of these pathways will be required. For instance, the role of Cpt1a, 
and PPAR related enzymes reported here should be investigated in the context 
of L. mexicana. The novel parasite metabolites observed here in an infected host 
setting are promising and their potential as biomarkers must be investigated. 
While LC-MS is not a practical diagnostic tool, simple and cheap assay can be 
developed. 
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5 Arginine metabolism in Leishmania mexicana 
5.1 Introduction 
Arginine and arginine metabolism sits at the interface of Leishmania – 
macrophage interactions. Parasites of the Leishmania species are unable to 
synthesise the essential amino acid arginine (Vincendeau et al. 2003). Arginine is 
hydrolysed by the parasites arginase into L-ornithine and this is subsequently 
decarboxylated into putrescence by ornithine decarboxylase (ODC). Putrescine, 
together with an aminopropyl group from decarboxylated S-adenosyl-
methionine, is converted by spermidine synthase to form the polyamine, 
spermidine. Spermidine is essential for growth and survival of Leishmania and 
other members of the trypanosomatid family. Additionally, spermidine along 
with glutathione is a substrate for trypanothione synthase, which synthesises the 
essential parasite-unique antioxidant, trypanothione. Trypanothione and 
trypanothione disulphide function similarly to the glutathione-glutathione 
disulphide redox system by neutralising the ROS produced by macrophages 
during infection (Fairlamb et al. 1985) and playing more general roles in cellular 
redox metabolism. While the parasite’s arginase is essential to its viability, the 
growth defected observed in Arginase-/-mutants can be rescued by 
supplementing with ornithine or polyamines (Gaur et al. 2007). Alternatively, 
Leishmania can scavenge polyamines from their environment using specific 
transporters (Naderer & McConville 2008). 
It has been reported that for L. mexicana, while the polyamines generated by 
arginase are essential for in vitro growth, depletion of intracellular 
(macrophage) arginine levels is also necessary for infectivity and proliferation in 
its host cell (Gaur et al. 2007). In this study, the authors reported that arginase 
deficient parasites (Arg-/-) had lower infection rates and lower growth rates in 
murine bone marrow derived macrophages (BMDM). The authors found higher 
levels of nitric oxide in cells from lymph nodes of mice infected with Arg-/- 
parasites. This difference was abrogated in BMDM from mice deficient in iNOS 
implying that parasites use arginase to divert arginine away from NOS. A similar 
conclusion was reached from a study using Arg-/- L. major (Reguera et al. 2009). 
However a later study using the same mutant reported that while infectivity was 
slightly decreased, that infection development was delayed, and the parasites 
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were auxotrophic for polyamines, their requirement for polyamines seemed to 
be met by scavenging from the host (Muleme et al. 2009). These discrepancies 
may be due to a species-specific role for arginase or the use of the susceptible 
Balb/c mice in the last study versus the C57BL/6 used in the first two. A recent 
study reported that Leishmania parasites possess a sensor for extracellular L-
arginine and can activate a specific arginine transporter (LdAAP3) in response or 
L-arginine deprivation, revealing a role for stage in the parasite life-cycle. 
(Goldman-Pinkovich et al. 2016).  
It is well established that arginine has an essential role in host cell immunity. In 
inflammatory (M1) macrophages, arginine is utilised to generate NO via iNOS. 
This is an important effector molecule that is required for the controlling of 
pathogens, including Leishmania. On the other hand, anti-inflammatory (M2) 
macrophages upregulate arginase thereby diverting arginine to ornithine, 
ultimately resulting in increased levels of L-proline and polyamines. L-proline 
can be used in collagen formation while polyamines can help support cell 
proliferation, both of which are required for wound healing (Yang & Ming 2014). 
Preliminary time course LC-MS data from our group suggested that L. mexicana 
procyclic promastigotes were producing and secreting a metabolite of the same 
mass and retention time of L-citrulline (Julie Kovářová, unpublished data). As 
this phenomenon was not present in Trypanosoma brucei brucei, this inferred 
that this latter parasite would lack a candidate enzyme capable of metabolising 
citrulline. Sources from L-citrulline include various nitric oxide synthases (NOS), 
the urea cycle, arginine deiminase (ADI) and dimethylarginase (DDAH). 
ADI is a hydrolase that catalyses conversion of L-arginine to L-citrulline while 
DDAH positively regulates NOS by degrading its endogenous inhibitor, 
asymmetric dimethylarginine (ADMA). The presence of an ADI has been reported 
in several bacteria and parasite species such as Mycoplasma arginini and Giardia 
intestinalis (Takaku et al. 1992; Knodler 1998). In the case of the M. arginini, 
enzyme, its activity has been proposed to have anti-tumour properties (Takaku 
et al. 1992). While mammals use DDAH to regulate NOS, this enzyme has been 
found to be present in the bacteria Pseudomonas aeruginosa and a crystal 
structure obtained (Murray-Rust et al. 2001).  
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Interestingly, a previous study reported the existence of NOS in Trypanosoma 
cruzi, which served to protect the parasite from apoptosis-induced DNA damage 
(Piacenza et al. 2001) while a more recent paper reported this NOS was down-
regulated upon attachment to the host extracellular matrix (Pereira et al. 2015). 
Certain bacteria have been shown to have endogenous NOS activity, with the 
responsible gene being identified (Gusarov et al. 2009). Ablating expression of 
the enzyme in bacteria revealed that these bacteria use NOS to protect against 
oxidative stress by inducing superoxide dismutase and to detoxify antibiotics 
either produced by other microorganisms or used as a treatment. Several studies 
have reported measuring NOS activity in L. donovani and L. mexicana extracts 
and using affinity chromatography to purify an enzyme with NOS activity (Basu 
et al. 1997; Genestra et al. 2006).  However, these studies failed to identify a 
gene encoding NOS and several groups have subsequently failed to corroborate 
its presence (Steve Beverley, personal communication). Leishmania do not have 
an intact urea cycle as they lack an ornithine transcarbamoylase (OTC) and 
arginosuccinate lysase (ASL) (Camargo et al. 1978). 
Although a compound of the mass of L-citrulline was clearly identified in 
Leishmania, it is noteworthy that other compounds, for example, L-argininic 
acid, have the same formula and thus exactly the same mass.  As this work was 
proceeding, a study utilising metabolic profiling of various Leishmania species 
reported the presence of L-citrulline and L-argininic acid (Westrop et al. 2015). 
It has previously been suggested that this metabolite is made from L-arginine via 
2 keto-arginine. Specifically, Westrop et al proposed that 2-keto arginine is 
formed via a transaminase reaction and in turn, converted by dehydrogenase 
enzymes to L-argininic acid. The authors further proposed that this was 
analogous to the mechanism in which tryptophan is degraded to indole 3-lactate. 
Finally, the authors reported that some L-citrulline was produced that was 
utilised to synthesise L-arginosuccinate via arginosuccinate synthase (ASS). 
Lakhal-Naouar et al used a L. donovani cell line that overexpressed a dominant-
negative mutant ASS to demonstrate that the enzyme is important for virulence 
(Lakhal-Naouar et al. 2012). The authors reported that L-citrulline and 
L-aspartate were not sufficient to replace L-arginine in cell medium, which is 
consistent with the absence of an ASL in the Leishmania genome. The authors 
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were, however, unable to generate a knock out due to a combination of 
apparent genomic instability and they’re being three copies of the gene. Sardar 
et al managed to generate a mutant parasite with two of these copies deleted, 
which resulted in ASS protein levels being reduced below the detection limit of a 
western blot (Sardar et al. 2016). The authors reported that free thiol levels in 
this mutant cell line were decreased and that in L-arginine depleted medium the 
viability of the mutant cell line was attenuated on exposure to oxidative stress. 
This combined with the fact that the mutant parasite was less able to infect 
mice led the authors to propose that ASS has a role in the parasites anti-oxidant 
defence. 
As arginine is essential to both the parasite and appropriate macrophage immune 
responses, it was hypothesised that by diverting arginine towards L-citrulline, 
the parasite might deprive the host NOS of its substrate. Bioinformatic analysis 
revealed a potential candidate protein for L-citrulline synthesis. As this gene is 
absent from T. brucei brucei, and quite divergent from other orthologs, it may 
also a candidate for an L-argininic synthesis. Concurrently stable –labelled 
isotope metabolomics were employed to trace the fate of arginine in in vitro 
models of both procyclic promastigotes and the intracellular amastigotes. 
5.2 Results 
5.2.1  A putative “Dimethylarginase” and arginine metabolism 
To search for possible Leishmania orthologs of NOS, ADI and DDAH, The BLASTP 
function in Tritrypdb was used to search for hits of protein sequences with 
confirmed functions (Aslett et al. 2009). While no hit obtained for NOS, a match 
was obtained for a putatively identified DDAH. This gene, Lmxm.08.1225 is 
annotated as a DDAH in Tritrypdb. However as DDAH and ADI are quite similar 
proteins and the Leishmania sequence is quite divergent from each, it is not 
possible to rule out either one, and a robust annotation based on the sequence 
alone is not feasible 
5.2.1.1 Phylogenetic and structural analysis 
An alignment was built using Clustal Omega (Sievers et al. 2011) taking the 
protein sequence of Lmxm.08.1225 and known candidate genes for either ADI 
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and DDAH from BRENDA (Schomburg et al. 2004) (2.14). The alignment was 
manually corrected by me using CLC genomics (Qiagen) to ensure that 
experimentally confirmed catalytic and binding residues aligned and were 
annotated (Figure 5-1A). While Lmxm.08.1225 (241 amino acids (aa) was shorter 
than most of the DDAH sequences (289-342 aa) other than the canine DDAH 
(185aa), it was much shorter than the ADIs (419-593aa). In Figure 5-1 the 
analysis pertaining to DDAH is presented while that for ADI is available in 
Supplementary Figure 5-1.  
Phylogenetic trees were made on Clustal Omega using the above groups with one 
example from the opposite group as an out-group. Nexml files were imported 
into Dendroscope (Huson & Scornavacca 2012) to give the final tree shown in 
Figure 5-1 C. Structural analysis was conducted using Phyre2 (Kelley et al. 
2015). 
Phyre2 a web based suite of tools that uses homology detection methods to take 
advantage of protein structure databases to predict and analyse protein 
structure. The top 10 results of this analysis are presented in Table 5-1  
(Full results are in Supplementary File 5-1) and the top hit shown in 
Figure 5-1B. The top hits of this analysis are as expected, DDAH and ADI though 
the percentage identity is slightly higher for DDAH. This is probably due to ADI 
being longer and thus will have lesser proportion covered by the alignment.  
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Table 5-1: Results of Phyre2.  The first column refers to PDB id for structure that was used as 
template. The next column is 'Confidence'. This represents the probability (from 0 to 100) that 
the match between input sequence and a given template is a true homology. It does not 
represent the expected accuracy of the model - although the two are intimately related. The 
percentage identity between a input sequence and the matching template is in the %id column 
and relevant functional PDB information is in the final column. 
Template (PDB) Confidence % i.d. Template information Species 
d1h70a 100 33 Fold: Pentein, beta/alpha-propeller  
Superfamily: Pentein  
Family: Dimethylarginine dimethylaminohydrolase DDAH  
Pseudomonas 
aeruginosa 
c3i4aA 100 33 PDB header: hydrolase  
Chain: A:  
PDB Molecule: n(g),n(g)-dimethylarginine dimethylaminohydrolase 1 
PDB Title: crystal structure of dimethylarginine dimethylaminohydrolase-1 (ddah-2 1) 
in complex with n5-(1- iminopropyl)-l-ornithine  
Human 
c2ci6A 100 31 PDB header: hydrolase  
Chain: A:  
PDB Molecule: n(g),n(g)-dimethylarginine dimethylaminohydrolase 1;  
PDB Title: crystal structure of dimethylarginine2 dimethylaminohydrolase i bound 
with zinc low ph  
Cow 
d1s9ra 100 20 Fold: Pentein, beta/alpha-propeller 20  
Superfamily: Pentein  
Family: Arginine deiminase  
Mycoplasma 
arginini 
c4e4jJ 100 21 PDB header: hydrolase 
Chain: J:  
PDB Molecule: Arginine deiminase; 
PDB Title: crystal structure of arginine deiminase from mycoplasma penetrans 
Mycoplasma 
penetrans 
d1rxxa 100 24 Fold: Pentein, beta/alpha-propeller 
Superfamily: Pentein  
Family: Arginine deiminase  
Pseudomonas 
aeruginosa 
d1bwda 100 16 Fold: Pentein, beta/alpha-propeller 
Superfamily: Pentein 
Family: Amidinotransferase (Inosamine-phosphate amidinotransferase) 
Streptomyces 
griseus 
c4bofA 100 17 PDB header: hydrolase  
Chain: A:  
PDB Molecule: Arginine deiminase; 
 PDB Title: crystal structure of arginine deiminase from group a streptococcus  
Streptococcus 
pyogenes 
c8jdwA 100 16 PDB header: transferase  
Chain: A:  
PDB Molecule: protein (l-arginine: glycine amidinotransferase);  
PDB Title: crystal structure of human l-arginine: glycine amidinotransferase in 
complex with l-alanine  
Human 
c1jdwA 100 17 PDB header: transferase  
Chain: A:  
PDB Molecule: l-arginine: glycine amidinotransferase;  
PDB Title: crystal structure and mechanism of l-arginine: glycine2 
amidinotransferase: a mitochondrial enzyme involved in3 creatine biosynthesis  
Human 
The best match according to Phyre2 is the P. aeruginosa DDAH followed by 
human, then cow. Interestingly glycine amidino-transferases (AGAT) had some 
homology. AGAT catalyses the transfer of an amidino group from L-arginine to 
glycine producing products L-ornithine and guanidinoacetate, the immediate 
precursor of creatine. This analysis largely matches the phylogenetic analysis 
and P. aeruginosa and other DDAH enzymes cluster together even when all ADIs 
are included with human NOS2 as an out-group (Supplementary Figure 5-2). 
While a DDAH seems slightly more likely than an ADI, Lmxm.08.1225 is quite 
divergent limiting the conclusions that can be drawn from this analysis. 
Nevertheless, an arginine metabolising enzyme is a likely function. 
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 Figure 5-1: Clustering, structural and phylogenetic analysis of Lmxm.08.1225. 
 A: Alignment was generated using Clustal Omega and minimally edited to ensure experimentally 
validated active (red) and substrate (green) binding sites are aligned. Blue denotes the lid region 
present in bovine DDAH. B: Top hit (P. aer ddah) generated from Phyre2 using Lmxm.08.1225 as a 
template C: Phylogenetic tree was generated in Clustal Omega, and out-group set as Giardia 
intestinalis ADI in Dendroscope. Scale bar represents nucleotide substitutions per site. In 
Supplementary Figure 5-2, some ADI sequences are included with the above sequences, with human 
iNOS set as the out-group. 
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5.2.1.2 Assaying dimethylarginine and arginine utilising proteins 
As the two top candidates were DDAH and ADI, the activity of these enzymes was 
assayed for (2.9). As a positive control for ADI commercially available enzyme 
was used. As there was no commercially available DDAH, the P. aeruginosa DDAH 
was cloned and overexpressed it in E. coli as carried out by (Wang et al. 2009b) 
(Figure 5-2A). Next enzyme was purified using nickel affinity chromatography 
(Figure 5-2B). The same approach was attempted with Lmxm.08.1225 but was 
unsuccessful. As the Rosetta strain (DE3), which contains a plasmid coding for 
rare codons was used, it is unlikely that this is due to the use of these by the 
L. mexicana gene. 
 
Figure 5-2: Overexpression in E. coli of DDAH from P. aeruginosa and putative DDAH/ADI 
from L. mexicana. A: Genes from L. mexicana (Lmxm.08.1225) and P. aeruginosa were cloned 
into the pET28a (+) vector as described in material and methods. IPTG (1mM) was used to induce 
overexpression at 37ºC for 4 hours with shaking once cultures reached an OD600 of 0.4-0.5.  Pre 
indicates pre-induction, T indicates total culture post induction, S indicates soluble fraction and 
Ins indicates insoluble fraction. B: Nickel-affinity chromatography of P. aeruginosa DDAH. L 
indicates sample that was loaded into column, F indicates the flow through and E indicates the 
fraction that was eluted in imidazole. 
The commercial ADI and purified DDAH were then assayed alongside Leishmania 
cell extract using relevant substrates L-arginine (ADI) or asymmetric 
NG,NG-dimethylarginine (ADMA) and urease (Sigma) to remove urea (Figure 5-3 
A-C). The assay used here relies on diacetyl monoxime (DAMO) derivatization of 
the ureido group in L-citrulline to form a coloured product. This assay is limited 
by the fact that it is discontinuous and relies on hazardous strong acids for 
colour development (Prescott & Jones 1969). An additional limitation is a lack of 
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absolute specificity as other ureido containing compounds such as urea and 
carbamyl asparte will be detected. While it was possible to control for the 
interference of urea by use of a urease, it is not possible to preclude the 
presence and interference of carbamyl aspartate. No detectable activity was 
observed in Leishmania extract even though protease inhibitors were used and 
commercial ADI was active within cell extract (we have not tested the same for 
P. aeruginosa DDAH).  
With regards to the possibility of a Leishmania NOS, nitrite was not detectable 
using the Griess assay in spent medium from Leishmania cultures. Finally, we 
were unable to reproduce results that were obtained using affinity (2’5’ ADP 
agarose) chromatography purification (Supplementary Figure 5-3) in two 
previous studies (Basu et al. 1997; Genestra et al. 2006). While ideally there 
would have been more replicates of these experiments, the results seen here, 
and in 5.2.1-3 do not support the presence of a L-citrulline producing enzyme. 
 
Figure 5-3: Results from colorimetric assay that is specific for L-citrulline. Note that A and B 
were carried out in 1mL cuvettes while C was carried out in 96 well format. See material and 
methods for further information on differences in protocol. The ADI protein functioned in two 
independent experiments with different conditions but this exact experiment was executed only 
once so results are indicative of one replicate A: Increasing amounts of ADI lead to increasing 
amounts of L-citrulline production. B ADI produces L-citrulline in dialysed cell extract. C: 
Recombinant DDAH from P. aeruginosa produces L-citrulline. Both readings in C were normalised 
to substrate control and measurements were carried out in triplicate. 
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5.2.1.3  Pilot Overexpression in OPPF 
As overexpression work shown above, as well as with the use of a maltose 
binding protein solubilising tag and attempts of refold the protein using various 
combinations of L-arginine and NaCl was unsuccessful, an application as made to 
work at the Oxford Protein Production Facility-UK (OPPF-UK, Research Complex 
at Harwell, University of Oxford). This is a high-throughput protein over-
expression screening facility based at the Harwell research complex. Briefly 12 
plasmids (pOPINEneo, pOPINE-3C-HALO7, pOPINF, pOPINS3C, pOPINHALO7, 
pOPINMSYB , pOPINTRX, pOPINH , pOPINGM, pOPINP ,pOPINTolB and pOPING) 
were used in combination with native Leishmania sequence, or gene blocks 
(synthesised sequences) that were codon optimised for E. coli, HEK293 cell line 
or baculovirus / Drosophila melanogaster system.  
All of the resulting 48 plasmids were used in E. coli, the HEK293 cell line or 
baculovirus / Drosophila melanogaster systems. The E. coli or the baculovirus / 
Drosophila melanogaster system failed to yield soluble protein. The HEK293 
system did yield soluble protein, while one (6) was secreted (Figure 5-4). As the 
stable isotope labelled data did not support the presence of an L-citrulline 
producing enzyme, and creating stable over-expressing HEK293 clones is a time-
consuming process, no further work was done with these plasmids. Note that the 
author was supervised and assisted by Dr. Louise Bird (Strategy, primer and gene 
Figure 5-4: Results of overexpression of Lmxm.08.1225 carried out that the OPPF-UK. 
 The results shown here are from the HEK293 system after a 3-day transient transfection. HEK 293, 
Bac/Ins, and E.coli refer to the codon-optimized sequence used. 1 = C terminal His, 2 = N terminal His, 
3= Tol-B SS, 4= Sumo, 5 = SS-N terminal His, 6 = SS-N-HIS-3C-POI, + = GFP positive control. +, 1 - 5 are 
soluble intracellular proteins and 6 is secreted. 
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block design, plasmid generation and E. coli screening), Dr. Joanne Nettleship 
(HEK293 system), Prof. Ray Owens (Strategy). Additionally, the facility carried 
out the Drosophila melanogaster system after the authors two-week visit. 
5.2.1.4  Overexpression in Leishmania and metabolic profiling 
In parallel to the above experiments, overexpression in L. mexicana was 
conducted using an episomal overexpressing plasmid with either no tag or a 
3’ terminal his tag (pGL1002 Prof. Jeremy Mottram, originally pXG; Prof. Steve 
Beverly’s lab) (Ha et al. 1996). A control using wild type parasites cultured in 
parallel was also used. In order to detect overexpression, RT-qPCR was used and 
this showed a large increase in transcript (Figure 5-5a). However attempts to 
detect an increase or presence of the 3’-tagged protein using either Coomassie 
blue or immuno-blotting (anti- his-tag) were unsuccessful. 
Figure 5-5: RT-qPCR of episomal over-expressors and PCA of metabolomics data. A: RT-qPCR was 
conducted on episomal over-expressors. The D-Delta method was used, normalising to LmxmGPI8. Data 
is representative of three biological replicates. B: PCA analysis was conducted on log transformed using 
MetaboAnalyst 95% confidence intervals are highlighted by the respective background colour. 
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Untargeted metabolomic profiling was carried out to investigate if there was a 
perturbation at the metabolic level. Data filtering was conducted as in 4.2.2.1. 
The result of this filtering in IDEOM and the Xcalibur method was a list of 231 
metabolites. The identity of 91 of these was confirmed using authentic standards 
(MSI level 1). 
There was marked separation according to PCA between both over-expressor cell 
lines and wild-type control (Figure 5-5b).  A one-way ANOVA was used to test 
for significance. In Table 5-2 significantly altered metabolites (FDR <0.05) as 
well as 2 other arginine metabolism-related metabolites (FDR <0.1) are 
presented. The initial hypothesis tested here was that over-expression might 
lead to increased L-citrulline (or isomer L-argininic acid) production but levels of 
this metabolite (s) were not markedly altered.  
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Table 5-2: Metabolic alterations in parasites overexpressing Lmxm.08.1225.  Significance was 
determined by one-way ANOVA for each time-point with Fishers LSD used for post-hoc analysis. 
As KEGG IDS are less ambiguous, the equivalent KEGG ID is in column 1. As certain metabolites 
are not in KEGG, arbitrary IDs are used for these. In the ‘Change’ column, the direction change 
of either one or both of the over-expressors to wild-type control is indicated. A match with an 
authentic standard, number of alternative isomers, match with mZCLOUD fragmentation 
database and maximum fold change are indicated in the last four columns. There were 3 peaks 
with the mass of L-homocitrulline, one of which was rejected by the Ideom pipeline due to its 
proximity to L-homocitrulline (first one). All three of these peaks were increased in terms of 
area in the episomal over-expressors. 
Name KEGG ID FDR Std Isomer MS2 FC Change 
5-Methyl-2'-deoxycytidine C03592 4.4E-05  1  8.5 Up 
Deoxycytidine C00881 5.0E-04 Yes 1  5.0 Up 
Fagomine C10144 7.3E-03  2  5.5 Down 
1-Oleoylglycerophosphocholine C03916 7.3E-03  12  7.5 Up 
L-4-Hydroxyglutamate semialdehyde C05938 7.3E-03  14  2.0 Down 
(S)-Carnitine C15025 7.3E-03  2  5.1 Down 
L-Threonine C00188 9.7E-03 Yes 11  3.5 Down 
L-Homocitrulline.1 C02427 9.7E-03  1  28.4 Up 
sn-Glycerol 3-phosphate C00093 9.7E-03 Yes 1  6.2 Up 
L-Phenylalanine C00079 1.1E-02 Yes 7 Yes 2.6 Up 
PC(16:0/5:0(COOH)) NoKegg24 1.1E-02  1  6.0 Up 
(R)-2,3-Dihydroxy-3-methylbutanoate C04272 1.3E-02  8  1.7 Down 
Pantothenol C05944 1.3E-02  1  3.8 Down 
phosphinomethylmalate NoKegg17 1.3E-02  3  3.3 Up 
7-chloro-L-tryptophan NoKegg11 1.3E-02  2  2.7 Down 
Diethanolamine C06772 1.3E-02  2  2.3 Up 
Cytosine C00380 1.3E-02 Yes 1  3.1 Up 
Maltose C00208 1.5E-02 Yes 42  2.9 Down 
L-Valine C00183 1.5E-02 Yes 17 Yes 1.8 Up 
L-Arginine C00062 1.6E-02 Yes 2 Yes 1.7 Up 
Stachydrine C10172 1.6E-02  2  2.7 Down 
Phosphodimethylethanolamine C13482 1.9E-02  1  2.5 Up 
N-Methylethanolamine phosphate C01210 1.9E-02  3  1.8 Up 
L-Proline C00148 1.9E-02 Yes 4 Yes 1.5 Up 
3-(4-Hydroxyphenyl)lactate C03672 1.9E-02  13  2.2 Up 
N-&alpha;-acetyl-DL-norvaline NoKegg2 1.9E-02  10  3.0 Down 
D-Ribulose 1,5-bisphosphate C01182 1.9E-02  3  3.6 Up 
Maltotriose C01835 2.4E-02  22  3.1 Down 
Caffeic aldehyde C10945 2.5E-02  12  3.9 Up 
L-Homocitrulline C02427 2.6E-02  1  5.2 Up 
1-5-diazabicyclononane NoKegg21 2.7E-02  2  2.5 Down 
4-Guanidinobutanoate C01035 2.8E-02  3  2.1 Up 
N-Acetyl-L-leucine C02710 2.8E-02  5  2.9 Up 
Daminozide C10996 2.9E-02  4  5.4 Up 
sn-glycero-3-Phosphocholine C00670 2.9E-02 Yes 1  2.2 Up 
L-Glutamine C00064 2.9E-02 Yes 6 Yes 1.5 Down 
beta-Alanyl-L-arginine C05340 2.9E-02  2  1.7 Down 
L-Ornithine C00077 3.0E-02 Yes 6 Yes 1.7 Up 
L-Tyrosine C00082 3.1E-02  11  2.4 Up 
Acetyl-maltose C02130 3.1E-02  1  2.7 Down 
D-Glucose C00221 3.1E-02  57  1.5 Up 
Succinyl proline C11711 3.1E-02  1  2.7 Up 
S-Methyl-L-methionine C03172 3.1E-02  6  2.1 Up 
p-Coumaroyl quinic acid C12208 3.2E-02  4  1.6 Up 
Xanthine C00385 3.4E-02 Yes 3  2.1 Up 
2-Dehydro-3-deoxy-L-rhamnonate C03979 3.4E-02  24  1.4 Up 
L-Pipecolate C00408 3.4E-02  9 Yes 1.6 Up 
Carnosine C00386 3.4E-02  3  2.2 Up 
Choline phosphate C00588 3.7E-02 Yes 1  1.2 Up 
Iminodiacetate NoKegg23 3.9E-02  4  2.0 Up 
N-dimethylethanolamine NoKegg25 3.9E-02  1  2.3 Up 
2 keto-arginine C03771 7.4E-02  1  1.7 Up 
L-Argininic acid NoKegg26 9.4E-02 Yes 1 Yes 1.5 Up 
Chapter 5  189 
 
Note that the input files for additional analysis are in Supplementary Files 
5-(3-4) (Kegg IDs are shown, metabolite name is in Supplementary File 5-2). 
L-citrulline levels were very low in all samples, and in fact its peak resembled a 
slight shoulder beside the L-argininic acid peak. The data is presented in 
heatmap format in Figure 5-6. While there are decreases and increases in 
several general pathways, 5 of these belong to arginine metabolism. Ideally an 
empty vector control would have been used to subtract the effect of growing the 
episomal over-expressors in antibiotic which influence cannot be ruled out.  
 
Figure 5-6: Heatmap analysis of significantly altered metabolites present in parasites 
overexpressing Lmxm.08.1225  
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While by its name, L-Homocitrulline would seem to be part of L-arginine 
metabolism, it instead is formed by a carbamoyl-phosphate: L-lysine carbamoyl-
transferase in an orphan reaction. This reversible reaction is as follows: 
Carbamoyl phosphate + L-Lysine <=> Orthophosphate + L-Homocitrulline. 
A metabolite of this mass was detected by a previous publication (Westrop et al. 
2015). A dataset of L. mexicana grown in U13C-Lysine (Snezhana Akpunarlieva, 
unpublished data) was examined and there was no evidence of a labelled version 
of L-Homocitrulline. A peak of this mass was not present in infected, M1 or M2 
macrophages. Additionally, there was no labelled version of the L-homocitrulline 
formula in U13C-Arginine labelled samples. If Lmxm.08.1225 is responsible for 
the increases in these peaks, it is independent of these two amino acids (L-lysine 
and L-arginine). Additionally it is possible that this is an adduct of the G418 
antibiotic that the over-expressing parasites are maintained in. 
(S)-carnitine was markedly decreased in our data. Checking the retention time 
of the authentic (R)-carnitine confirmed that this was a separate metabolite. 
There were no other identified metabolites (or masses) that had both a similar 
trend and retention time so unlikely this peak is an adduct. Note that (R)-
carnitine, was detected and it matched the authentic standard in retention time 
and a MS2 Spectra in mZCLOUD.  The identity of ‘(S)-carnitine’ could be 
investigated by obtaining and running an authentic (S)-carnitine with some of 
the samples mentioned here. Finally, while other metabolites with marked 
perturbations, such as deoxycytidine and 5-methyl-2’-deoxycytidine, there 
immediate relationship to Lmxm.08.1225 is not immediately obvious.  
For some of the metabolites presented here, especially L-argininic acid, the 
intensity was extremely high so dilutions of the QC were run to find a dilution 
factor that would get samples in the linear range. While these samples were run 
on the Fusion MS (Thermo), and the previous run were on the qExactive 
(Thermo), the results for arginine related metabolites are comparable. 
L-arginine, L-ornithine and 2 keto-arginine were increased in both 
over-expressor lines (Figure 5-7). Dimethyl-arginine was unchanged and while 
L-argininic acid was slightly higher, this trend did not reach statistical 
significance. Thus it seems that while Lmxm.08.1225 may have some role in 
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L-arginine metabolism, it is not clear from the current data what this role might 
be. Given the diversity in sequence in this gene with other ADI and DDAH 
sequences from other species, this enzyme may have an alternative role. The 
role of this enzyme in infection of could be investigated by using the cell lines 
generated in this study (alongside an empty vector control) to infect BMDM. 
Additionally, the enzyme could be investigated further by generating a knockout 
cell line. This was attempted by using both a traditional homologous 
recombination replacement strategy and inducible Di-Cre system (Duncan et al. 
2016) but were unsuccessful due to limited time. Further attempts using this 
approach or similar methods may be successful. 
 
Figure 5-7: Arginine metabolism in cell lines over-expressing Lmxm.08.1225. One in ten 
dilutions were made of samples which were run on the Fusion (Thermo) MS. A method was 
written in Xcalibur (Thermo) In order to ensure that argininic acid was correctly chosen. 
Statistical significance was determined in Prism 6 (Graphpad) using a one-way ANOVA with 
Tukeys correction for multiple comparisons. 
5.2.2 Arginine metabolism in procyclic promastigotes 
While the essentiality of L-arginine to Leishmania species is well known, how the 
parasite utilises this amino acid is not fully understood. As a recent publication 
reported the synthesis of L-argininic acid and L-citrulline by multiple Leishmania 
species (Westrop et al. 2015), this was investigated further using stable isotope 
labelled-metabolomics. This approach was first applied in the procyclic 
promastigote form of the fly. Briefly, procyclic promastigotes were grown in 
medium containing 50% U13C-L-arginine (Cambridge isotope laboratories, 
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enrichment 99%, cat: CLM-2265-H-0.1) until they reached mid-log stage (48 
hours) at which point samples were made for LC-MS (See materials and 
methods). The key reasoning behind this approach that the same metabolite 
with various proportions of a labelled amino acid will have the same retention 
time but different masses. 
Data analysis (for all stable isotope experiments) was conducted in conjunction 
with Fiona Achcar using mzMatch-ISO (Chokkathukalam et al. 2013). In this 
experiment a 26-minute LC protocol was used, which is unable to differentiate 
between L-argininic acid and L-citrulline. As the stable isotope labelled here is 
expected to give 6-13C-labelled L-argininic acid and L-citrulline, these are 
treated as one in this section. 
As Leishmania are confirmed to have an arginase, and the reaction from 
L-arginine to L-ornithine involves the loss of one carbon, it would be expected 
expect that L-ornithine would be 5-13C-labelled and that is what happens (Figure 
5-8). An OTC catalyses the conversion of from L-ornithine to L-citrulline and this 
reaction involves the incorporation of a carbon (non-labelled in this experiment) 
in the form of carbamoyl aspartate. If there is an OTC present in Leishmania, 
and this was responsible for L-citrulline formation, it would be expected that 
some L-citrulline to be 5-13C-labelled and this is not the case (Figure 5-8). Thus 
it is obvious that this metabolite be it L-argininic acid or L-citrulline is formed by 
the reaction that acts on L-arginine without exchanging any carbons. Based on 
these results, ADMA could still be a substrate for an L-citrulline-forming DDAH as 
it 6-13C-labelled. In positive mode, 2 keto-arginine was 6-13C-labelled so it 
potentially could be converted to L-argininic acid.  
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Figure 5-8: Stable isotope labelling of U-13C-arginine metabolism in L. mexicana 
promastigotes. Data is from negative mode and panel on right represents the peak that has the 
denoted number of labelled carbons. These samples are from the procyclic promastigote (48 
hours). As it was not possible to differentiate between L-argininic acid and L-citrulline in this 
experiment, the two names have been assigned to the same peak. Note that is not possible to 
differentiate between symmetric and asymmetric dimethylarginine on our LC-MS platform. 
5.2.2.1 Origin of intracellular proline 
A previous study has reported that L. donovani parasites preferentially import 
L-proline to use as an intracellular energy reservoir (Mazareb et al. 1999). This is 
thought to be necessary in promastigotes as L-proline is reported to be more 
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abundant in the fly, which uses it for flight (Mazareb et al. 1999). However, 
evidence for abundance of L-proline has only been reported in Tsetse fly (Bursell 
1966). In our data, however it is apparent that the majority of L-proline 
originates from L-arginine. Previous studies used Earl’s balanced salt solution in 
contrast to the rich medium (HOMEM) used here, which might explain some 
differences. Additionally, if the ratio of L-arginine to L-proline were different 
i.e. as reported in the fly, this might be expected to change the uptake of each. 
Nevertheless, when both amino acids are present, L-arginine is the consumed 
amino acid for Leishmania promastigotes. 
5.2.3  Arginine metabolism in axenic amastigotes 
In order to determine if arginine metabolism was similar in intracellular 
amastigotes as in promastigotes the above approach was applied to axenic 
amastigotes. Briefly parasites were transformed and cultured according to a 
well-established protocol (Bates et al. 1992) (2.6.3). Axenic amastigotes were 
grown for 72 hours in medium containing 50% U13C-L-arginine. In addition to this, 
medium samples as well as fresh medium samples were analysed by LC-MS. The 
latter samples allowed us to confirm previous findings as well as demonstrate 
that the activity responsible for generating L-argininic acid is not present in 
serum though there is a small fraction of this mass present in labelled fresh 
media. 
An example of such a reaction can be seen in Figure 5-9 where arginase activity 
present in the serum is responsible for the generation of 5-(U13C)-labelled 
L-ornithine. In the case of axenic amastigotes, less L-proline is derived from 
L-arginine when compared to promastigotes. Whether this reflects increased 
L-proline uptake or the axenic amastigotes generally less profligate metabolic 
state remains to be determined. Finally fresh and spent media samples from the 
5.2.2 were re-run using the longer LC protocol to determine if the parasites do 
or do not make L-citrulline and no difference were detected (Supplementary 
Figure 5-4). 
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Figure 5-9: Arginine metabolism in axenic amastigotes. L-argininic acid is generated from 
L-arginine in this life stage and is not explained by serum activity. Less L-proline is labelled when 
compared to promastigotes. Dashed lines represent hypothetical (?) or multi-step reactions. The 
abbreviations used are as follows; Solvent blank = Blank, Labelled fresh medium = LFM, Labelled 
spent medium = LM, Labelled intracellular content = LT, Pool sample= Pool, Un-labelled fresh 
medium = UFM Un-labelled intracellular content = UT, Un-labelled spent medium = UM, and Un-
labelled intracellular content = UT. Cells were cultured for 72 hours. 
5.2.4 A stable labelled metabolomics separates isomers 
While it was possible to separate L-argininic acid and L-citrulline using a longer 
LC method, and confirm this using authentic standards, the L-argininic acid was 
ordered as a one off custom synthesis and thus not widely applicable. To address 
this, (guanido15N2)-L-arginine (Cambridge Isotope Laboratory, Inc, enrichment 
98%, cat: NLM-395-0.5), which is commonly used as a tracer of iNOS activity, was 
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purchased. The reasoning behind this is that if L-arginine were converted to L-
argininic acid, oxygen exchange would occur at the opposite end of the amino 
acid, thus the product would retain two-labelled nitrogens. On the other hand, 
the conversion of L-arginine to L-citrulline occurs at the guanido-end of L-
arginine and thus L-citrulline should be single nitrogen labelled. The net result 
of this is that the two metabolites can be separated by mass. Mid-log procyclic 
promastigotes were grown in 50% labelled medium in combination the long LC 
method here to see if naturally abundant 1-15N-labelled-L-argininic acid masked 
1-15N-labelled-L-citrulline or vice versa. 
Approximately 50% of L-argininic acid was not labelled which reflects roughly the 
expected 50% labelling (Figure 5-10). As mentioned above in 5.2.2, some 
L-citrulline may be formed by serum.  It is likely that a protein such as NOS, that 
is present in the heat-inactivated serum, retains enough activity to do this. It is 
important to state that the different peak height observed for L-argininic acid 
was much larger and L-citrulline either is at a low intensity or hidden by the 
much larger L-argininic acid peak. Therefore is seems that the vast majority of 
L-arginine is metabolised to L-argininic acid. Note, however, that though when 
examining the authentic standards for both (100 µM each), the peak for 
L-argininic acid is much larger than that of L-citrulline (Supplementary Figure 
5-5) so differences in peaks need not necessarily correspond to differences in 
concentrations but reflecting differential ionisation. Nevertheless, as mentioned 
above, L-citrulline production is not different between fresh and spent medium 
(Supplementary Figure 5-4) so it seems unlikely the parasites produce any. 
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Figure 5-10: 5-11: 50%-(guanido15N2)-L-arginine LC-MS profiling of L. mexicana procyclic 
promastigotes. Averages from three biological replicates are shown. Purple is 2 x 15N-labelled, 
Blue is 2 x 15N-labelled and grey is non-labelled metabolite matching the L-argininic acid in 
retention time. Graph was made using mzMATCH-ISO (from Fiona Achcar). 
5.2.5 Fragmentation analysis of Leishmania infected macrophages 
with authentic L-citrulline and L-argininic acid standards 
L-argininic acid was purchased (American Custom Chemical Corporation) and 
rerun with labelled samples and with the samples described in Chapter 4. 
Authentic standard mixes are routinely run as part of Glasgow Polyomics services 
and L-citrulline is one of these. Fragmentation (MS2) was carried out on the 
standards and pooled samples.  The result of this analysis on infected 
macrophage (FACS enriched) samples is shown in Figure 5-11. This sample is 
chosen as L-citrulline from the macrophage and L-argininic acid from the 
parasite is present. The fragmentation spectrum for these peaks is shown and 
expected fragments are indicated. In the case of the blue coloured formula, it 
points to the first fragment while the red coloured formula is a subsequent 
fragment of this. 
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Figure 5-12: MS2 analysis of L-argininic acid and L-citrulline present in pooled sample from 
FACs enriched infected macrophages experiment (Chapter 4). Samples and authentic 
standards are as indicated (note that L-citrulline is part of a standard mix routinely run by 
Glasgow Polyomics). MS2 spectra are shown for the parent mass (bold) from the indicated peaks. 
The formula in blue coloured font is an instance where a fragment was subsequently fragmented 
to yield the formula in red coloured font. 
5.2.6 Multiplex cytokine profiling of L-argininic acid treated M1 
macrophages 
One hypothesis about a function for L-argininic acid is that its synthesis results in 
the depletion of the substrate of iNOS, L-arginine. Given the importance of 
arginine metabolism for M1 macrophages it is possible that a metabolite that is 
produced by the degradation of L-arginine could interfere with general M1 
effector functions. It is also of interest whether the product of L-lysine 
degradation that were found in macrophages infected with parasites only, 
L-pipecolic acid might also be immunomodulatory. In order to test these 
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hypotheses, the Luminex murine multiplex assay (Invitrogen) was used to see if 
either pre- or simultaneous incubation of BMDM with L-argininic acid or 
L-pipecolic acid could inhibit the LPS mediated increase of pro-inflammatory 
cytokines (2.8.2). Some of the M0, M1 and M2 controls in this assay were 
presented in Chapter 4. Note that an MTT assay (2.8.4) was first used to ensure 
that compounds were not toxic at levels tested (Supplementary Figure 5-6). As 
4 biological replicates were used, a repeated measure one-way ANOVA with 
Dunnett's multiple comparisons test was used in Prism6 (Graphpad). No such 
inhibition was observed. Unexpectedly an increase was seen in the case of 
monocyte chemoattractant protein 1 (MCP-1 (CCL2), denotes P ≤ 0.01, FC = 
~1.7) (Figure 5-12). In the introduction it was mentioned how certain 
pathogenic strains of Leishmania (including L. mexicana) release the gp63 
protease which causes an NF-κB cleavage resulting in a novel heterodimer that 
translocate to the nucleus, driving expression of pro-inflammatory cytokines 
such as CXCL2, CCL2, CCL3 and CCL4 (Gregory et al. 2008). A potential 
explanation would be that the parasites use L-argininic acid to recruit further 
macrophages to infect. However, further work will need to be done such as 
seeing if L-argininic acid on its own can increase CCL2 levels. Whether L-
argininic acid can efficiently (if at all) traverse the macrophage membrane 
remains to be determined. Unfortunately at the concentrations used here, L-
argininic acid is detected in the Griess assay (possibly due to contaminating L-
arginine in commercial sample) while no effect was seen at lower 
concentrations. 
 
Figure 5-13: Luminex profile of MCP-1. Matching paired values from 4 biological replicates are 
shown. BMDM were incubated overnight with the indicated amount of L-argininic acid prior to 6 
hour stimulation with LPS (100 ng/mL) Significance was determined using a repeated measure 
one-way ANOVA with Dunnett's multiple comparisons test was used in Prism6 (Graphpad). ** 
denotes P ≤ 0.01. 
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5.3 Synthesis of 2 keto-arginine 
As it was not possible to purchase 2 keto-arginine, it was synthesised in order to 
confirm the identity of the metabolite in our LCMS data. This metabolite has 
quite low intensity so identification by MS2 is not suitable.  Furthermore, this 
compound may be useful if it is an intermediate in L-argininic acid synthesis, and 
a candidate enzyme is isolated, it will be required as a substrate. Synthesis was 
carried out based on a method described by (Wellner & Meister 1960) (2.9.1). 
Briefly; dried snake venom (Sigma) from the Crotalus adamanteus (Eastern 
diamondback rattlesnake) was used as a source of L-amino oxidase alongside its 
cofactor FAD. Catalase (Sigma) was used to prevent 2 keto-arginine being 
attacked by the reactions by-product, hydrogen peroxide. L-amino oxidase 
catalyses the following reaction: 
L-amino acid + H2O + O2 <-> A 2 oxo-acid + NH3 + H2O2 
In Figure 5-13, the LC-MS analysis of the product of this reaction is shown as 
well as an enzyme-only and solvent blank controls. The mass spectrum on the 
bottom panel shows masses present in the indicated retention time in the 
enzyme plus substrate sample. There is only one peak with this mass and it is 
apparent in the total ion chromatograph (TIC) for positive mode that this mass is 
the most abundant mass in the sample. The naturally present 1-C13 secondary 
peak is also visible in the spectrum (mass = 174.0872 + 1.00335 = 175.08055). 
Additionally, this peak is 6.56% as abundant as the parent peak which matches 
well with the expected abundance (1.109% [C13 abundance] x 6 = 6.65%). When 
run alongside Leishmania samples the synthesised 2 keto-arginine was shown to 
co-elute with a peak of the same mass indicating that indeed this molecule is 
present in Leishmania (Clement Regnault: L. mexicana and Emily Armitage: 
L. donovani, personal communication).   
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Figure 5-14: LC-MS analysis of synthesised 2 keto-arginine. Samples are as indicated and the 
total ion chromatograph (TIC), mass ranges, and mass spectrum are all positive mode. Figure was 
made using Xcalibur (Thermo). The peak at retention time 13.06-13.09 (minutes) is 2 keto-
arginine. L-arginine (not shown) had a retention time of 21.3 (minutes). 
5.4 Discussion 
While it well established that L-arginine is both essential to Leishmania parasites 
and is indispensible to the pro-inflammatory M1 macrophage, its fate in the 
parasite is not fully understood. The reporting of L-argininic acid synthesis by 
multiple Leishmania species by Westrop et al and the work here shows that 
there is much more research needed on this subject. While previous studies have 
reported NOS activity in Leishmania (Basu et al. 1997; Genestra et al. 2006), the 
use of stable isotope labelling here strongly indicate that detected L-citrulline is 
an incidental artefact of bovine NOS present in serum. 
Amino acids can be used in energy metabolism and it has been reported that 
L. mexicana promastigotes have several amino acid transporters that 
preferentially import L-proline to use it as an intracellular energy reservoir 
(Mazareb et al. 1999). It is shown here that L-arginine is preferentially taken up 
by L. mexicana promastigotes and that it is the main source of L-proline in our 
culture conditions. This does not occur to the same extent in axenic amastigotes 
but whether is due to increased L-proline uptake or the amastigotes lipid-
dependent and generally less profligate metabolic state (Saunders et al. 2014) is 
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not clear. It is important to mention that L-proline use was previously thought to 
be more relevant to promastigotes due to supposed L-proline abundance in the 
tsetse fly (Bursell 1966). Whether the same for the sandfly remains to be tested. 
Based on the experiments presented in this chapter the current model of 
arginine metabolism in Leishmania has been expanded (Figure 5-15). Some new 
pathways are shown in Figure 5-15 involve enzymes that should be studied 
further to determine their importance and possible therapeutic targeting. 
 
Figure 5-15: Summary of utilisation of L-argininic acid by L. mexicana. In black are previously 
experimentally validated pathways. In red are pathways that have been validated by the stable-
labelled isotope experiments described in the current chapter. Dashed lines indicate multistep or 
hypothetical (?) reactions. 
5.4.1 Argininic acid, waste, effector or biomarker 
Argininic acid has most commonly being referred to in the context of human 
disease where there are defects in known arginine-metabolism related enzymes 
(C. G. da Silva et al. 1999; Livesay et al. 2008). These defects are arginase 
deficiency and have been confirmed using arginase knockout mice. These studies 
proposed that a transamination reaction produces 2 keto-arginine from 
L-arginine and that the 2 keto-arginine is subsequently hydrogenated to 
L-argininic acid. However, the enzymes that are responsible for these reactions 
are unknown. While argininic acid may be an incidental product of L-arginine 
degradation, it has been reported that L-argininic acid can inhibit iNOS activity 
(IC50 388.0 ± 46.5 µM) (Grant et al. 1998). It will be interesting to know whether 
L-argininic acid produced by Leishmania parasites can reach these levels and if 
its synthesis, in combination with host and parasite arginase activity, lowers 
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L-arginine levels enough to affect iNOS efficiency. The detection of this 
metabolite in a previous study (Westrop et al. 2015) and detailed and robust 
analysis presented here show that it exists in the context of pathogenic 
infections. Finally, as it is shown here that, host cells do not produce this 
metabolite; the possibility of its use as a biomarker should be explored further. 
5.4.2  Future directions 
Given that so little is known about L-argininic acid, it will require substantial 
work to elucidate the enzyme responsible for its synthesis. Additionally, there is 
no evidence that 2 keto-arginine is an intermediate in its synthesis. While it 
would be possible to add 2 keto-arginine to cell extract, it is quite possible that 
the transaminase reaction that makes it is reversible. Thus 2 keto-arginine would 
be converted back to L-arginine and if another enzyme was responsible, it would 
convert it to L-argininic acid. Interestingly 2 keto-arginine and other keto-acids 
have been reported to be able to scavenge reactive oxygen species (Nath et al. 
1995) and this itself warrants further work. The current study is limited by the 
fact that the only way of detecting L-argininic acid is by LC-MS, which is time-
consuming and expensive, so ideally a cheap and quick colorimetric assay would 
aid future work. If L-argininic acid has potential to be used biomarker, pilot 
studies using murine infection models should be carried out. 
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6 General discussion 
6.1.1 The Omics, future applications 
The advent of Omics techniques has seen an exponential growth in the amount 
of biological data at a systems level. This includes genomics, transcriptomics, 
proteomics and metabolomics. Additionally, there is a myriad of ‘-Omics’ terms 
used to describe the different levels of regulation of the above such as the 
methylome and epigenome. These approaches offer unprecedented ability to 
capture detailed information across the different levels that make up complex 
biological systems.  
The application of these techniques has moved beyond examining single species  
(i.e. DNA sequencing of different species) to complex disease scenarios such as 
host-pathogen interactions in isolated cellular systems or even whole organisms. 
Examples of this include studies searching for single nucleotide polymorphisms 
(SNPS) that are associated with disease or disease susceptibility, or studies 
searching for metabolites that can serve as biomarkers/ risk factors of disease. 
An even more complex application is the use of the Omics to detect/model the 
mechanisms of disease. These diseases range from infectious disease such as 
Leishmaniasis to autoimmune diseases such as rheumatoid arthritis. The starting 
point for such studies is simple in vitro systems that use limited and well-
defined inputs and outputs. The overarching aim of this protect was to apply 
Omics techniques to a classical systems (the M1 macrophage), building on 
previous studies in order to use the established techniques to detect/model the 
mechanisms of Leishmania manipulation of its host cell, the macrophage. 
6.1.2 Metabolic profiling of classical M1 macrophages: new 
insight 
In this project a robust protocol for the extraction of macrophages that offers 
high coverage of the macrophage metabolome was developed. In Chapter 1 the 
phenomenon of immune-metabolism was introduced alongside some of the 
hallmarks of inflammatory macrophage metabolism. While it can be argued that 
using a single inflammatory stimulus reduces biological noise, several studies 
have used the single stimulus (LPS) (Tannahill et al. 2013) or a combination of 
stimuli (IFNγ and LPS) (Jha et al. 2015; Lampropoulou et al. 2016) to obtain a 
Chapter 6  205 
 
phenotype to profile. These studies have not examined what each stimulus does 
nor how they interact.  
This is, to our knowledge, the first study to examine the contribution of each 
factor and how each stimulus can enhance or inhibit the other. The linear model 
used here will also be applicable to other systems of where combinations of 
inputs used. An example of this is combinatorial medical treatments or models 
of infection of host with multiple species. 
In the context of the inflammatory macrophage, well-established metabolic 
features include the presence of the Warburg shift in conjunction with rapidly 
upregulated glucose uptake and flux through glycolysis. Increased flux through 
the pentose phosphate pathway for the purpose of generating NADPH and 
ribonucleotide precursors is another key feature (Haschemi et al. 2012). Finally, 
perturbations of the TCA cycle such as increases in both itaconate production 
and succinate have been shown to be essential for M1 macrophage functions 
(Lampropoulou et al. 2016).  
The protocol used in this project consistently showed perturbations in these key 
pathways showing that our methodology can and does detect biologically 
relevant processes. At this point the author would like to stress that while 
confidence in metabolite identifications can be strengthened by use of authentic 
standard and fragmentation, many metabolites are solely identified by accurate 
mass and predicted retention time and thus are only putatively identified. This 
is clearly denoted throughout this thesis. 
No previous study has investigated if immune stimuli act synergistically, 
additively or antagonistically. An immediate and obvious test of this would be 
iNOS activity. The action of this enzyme requires synergistic activity from IFNγ 
and LPS. Additionally, the incidental product of this enzyme, L-citrulline, is a 
key part of the arginino-succinate shunt that replenishes the fragmented 
(anapleurotic) TCA cycle. Our LM correctly calls L-citrulline as being exclusively 
dependent on the interaction of IFNγ and LPS. Next, pathways that have not 
been examined in detail in the context of immune-metabolism were 
interrogated. 
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Two metabolites/pathways that were strongly modulated by IFNγ were taurine 
and β-alanine. Interestingly both of these have previously been shown to prevent 
apoptosis and modulate lipid metabolism and in some instances this involves 
signalling pathways modulated by IFNγ (Prabha et al. 1988; Harris et al. 2008; 
Kim et al. 2009d). Lipid metabolism has previously been identified as important 
for M2 macrophages (Huang et al. 2014). However a recent study using 
macrophages deficient in a key enzyme in this pathway, carnitine 
palmitoyltransferase 2 (Cpt2), found that while the cells could not undergo fatty 
acid oxidation (FAO), this was not required for M2 polarisation (Nomura et al. 
2016).  LPS driven perturbation of carnitine related metabolites were detected, 
some of which were repressed by IFNγ. Given the uncertainty about the role of 
FAO in macrophage polarisation, further work will be needed to elucidate the 
biological relevance of this. 
The engagement of a transcriptional profile is expected to require increased 
nucleotide synthesis and consumption. Changes in the pathways of purine and 
pyrimidine metabolism were also detected. Interestingly these changes are not 
consistent within pathways and stimulus-specific increases are not uniform. 
Guanine and inosine have been shown to modulate cell function so it will be 
interesting to determine if they have a similar role in inflammation (Verghese & 
Snyderman 1983; Jonsson & Carlsten 2002). Finally, there were two modified 
nucleotide analogues that had altered levels; 5’-methyl-2’deoxycytidine (marker 
of de-novo DNA methylation:  decreased by all stimuli) and 3-methyguanine 
(altered in leukaemia, tumours and immunodeficiency: increased by all stimuli). 
Whether these changes potentially are new examples of metabolites having roles 
outwith their biosynthetic pathway remains to be determined. 
6.1.3 The Leishmania infected macrophage 
Once a robust protocol was established, the next stem was to move from simple 
models of inflammation to a model of Leishmania infection of host cells. It is 
reasonable to expect this to be more representative of disease as pathogens 
engage multiple receptors on the host cell (Mosser et al. 1986). Furthermore, 
different host responses are engaged depending on the dose of stimulus used or 
the cell type. For instance in the case of LPS stimulation, primary human 
immune cells are more sensitive than primary murine immune cells which in turn 
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are more sensitive than cultured cell lines (Copeland et al. 2005; Schroder et al. 
2012). Furthermore, use of LPS at high concentrations (≥1µg/mL) can result in 
apoptosis (Haase et al. 2003).  
This is to our knowledge, the first application of integrative omics approaches to 
a pathogenic disease, which in this study is Leishmania infection. Here the high 
coverage of transcriptomics, our robust metabolomics protocol and a heat-killed 
antigen control are combined to gain a detailed insight into host-pathogen 
interactions. At a metabolite level, potential parasite specific metabolites stood 
out while glycerolipid and glycerophospholipid metabolism displayed a highly 
reproducible profile. These perturbations, in combination with transcriptome 
alterations in the same pathways as well as PPAR signalling can be used to 
inform further experiments of the key targets and processes to target. 
Among the most significantly altered metabolites were, unsurprisingly, parasite 
specific metabolites. However, this is the first instance of Leishmania-
macrophage samples being subjected to untargeted metabolic profiling using 
LC-MS. L-argininic acid, L-pipecolic acid, ovothiol A, 4-imidazolone-5-propanoate 
(Imidazole lactic acid: see text (4.3.2.1)) and trypanothione disulphide have 
previously been reported to be produced by multiple parasite species (Westrop 
et al. 2015). In the current study the author has shown that the parasite 
synthesis these metabolites within the macrophage and that neither naive 
macrophages nor polarised (M1 or M2) macrophages make them. Further in vivo 
studies will be required to investigate if these metabolites might serve as 
biomarkers indicative of the presence of Leishmania. If so, a simple and cheap 
assay can be developed to aid quick, easy and large-scale diagnostic screening. 
On its own, the list of DE genes obtained from analysis of our transcriptomics 
data matches well with a recent transcription profiling of Leishmania infected 
human macrophages (Fernandes et al. 2016). As this study subtracted the effect 
of phagocytosis, the combination of these two data sets can help distinguish 
between antigenic, phagocytic and live parasite induced host perturbations.  
While in the first result chapter there is list of marked perturbed metabolites, 
many of which are key to macrophage function. By including these controls it is 
obvious that Leishmania infection causes much less drastic alterations. 
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Interestingly, some previously reported changes (Jha et al. 2015) at a metabolite 
and transcript level are present in our data. Based on the results of our pathway 
analysis, it seems that the live parasite activates the TCA cycle, which is more in 
line with M2 macrophages while the heat-killed parasite up-regulates glucose 
metabolism, which is more in line with M1 macrophages. While significant, many 
of the increases and decreases were not very large (<1.5 fold) so their biological 
significance is not immediately obvious and further work will be required. It is 
important to note that the magnitude of some of these changes are not much 
less that those reported to be important for M1 macrophage function (i.e. 
succinate, Tannahill et a, 2012). 
On both a metabolite and transcript level, perturbations in lipid metabolism 
were observed. This is particularly interesting seeing that L. mexicana parasites 
have been reported to enter into a stringent metabolic state, up-regulating the 
uptake of fatty acids (Saunders et al. 2014) While lipid metabolism in the 
context of fatty acid oxidation has been associated with M2 macrophages, the 
role of this process may be more complex than previously thought, as mentioned 
above (Nomura et al. 2016). In our metabolomics data, the heat-killed parasites 
cause increases also caused by M1 stimuli. At a transcript level, the live and 
heat-killed parasites causes distinct changes, with some of the most marked 
differences being in PPAR pathway, a key network in regulating lipid 
metabolism. More work is needed to dissect the role of this pathway the context 
of L. mexicana. 
6.1.4 L-arginine: at the interface of host-parasite interactions 
At the crux of host-parasite interactions, L-arginine has essential roles in 
determining whether disease progresses or is resolved. The reporting of 
L-argininic acid synthesis by multiple Leishmania species by Westrop et al 
showed that there is much to learn about L-arginine metabolism in the parasite. 
While previous studies have reported NOS activity in Leishmania (Basu et al. 
1997; Genestra et al. 2006), the use of stable isotope labelling here strongly 
indicate that detected L-citrulline is an incidental artefact of bovine NOS 
present in serum. 
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A previous study reported that L. mexicana promastigotes and amastigotes have 
unique amino acid transporters that preferentially import L-proline to use as an 
intracellular energy reservoir (Mazareb et al. 1999). In the current study the 
author has shown that L-arginine is preferentially taken up by L. mexicana 
promastigotes and that it is the main source of intercellular L-proline in our 
culture conditions. Whether the reported L-proline abundance in the tsetse fly 
(Bursell 1966) applies to the sandfly remains should be tested, but it seems that 
profound physiological differences exist between these dipteran insects. 
Finally, the use of stable isotope labelling presented here gives strong 
confirmation of the synthesis of L-argininic acid by Leishmania parasites. While 
its presence has been reported in the context of human disease where there are 
defects in known arginine-metabolism related enzymes (C. G. da Silva et al. 
1999; Livesay et al. 2008). These studies proposed that 2 keto-arginine was 
formed from the transamination of L-arginine and that the 2 keto-arginine is 
subsequently hydrogenated to L-argininic acid. However, the enzymes that are 
responsible for these reactions are unknown. Furthermore, there is no evidence 
to preclude the possibility of a direct conversion of L-arginine to L-argininic 
acid, and our data is consistent with both routes. 
One previous study reported that L-argininic acid can inhibit iNOS activity (IC50 
388.0 ± 46.5 µM) (Grant et al. 1998). While the concentrations of L-argininic acid 
within the macrophage have not quantified in the current study, further work 
should be done to determine if it reaches these levels within the host cell and if 
its synthesis, in combination with host and parasite arginase activity, lowers 
L-arginine levels enough to effects iNOS activity. 
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Appendices 
Supplementary File 2-1: MS2 settings used in current study. 
Supplementary File 2-2: Contains r code, Deseq2 session info (versions) used in 
this study as well as the final (including SPIA pathway analysis) and intermediate 
files. 
Supplementary File 3-1: Kegg IDs and their equivalent metabolite name. Note 
that for metabolites without existing Kegg IDs, an arbitrary name was chosen 
(i.e., Nokegg1). 
Supplementary File 3-2: Input file as used for analysis of MetaboAnalyst (ANOVA 
and PCA). 
Supplementary File 3-3: Input file used for GLM analysis. 
Supplementary File 3-4: Results of GLM, ANOVA and there overlap is shown. 
Metabolites where significance was reported for only one method are coloured in 
red. For significantly altered metabolites in the GLM results (second tab), 
maximum fold change, and Venn class information is shown. In the Zero column, 
metabolites that were absent from one condition are indicated as a NA. 
Supplementary File 3-5: Script used to implement GLM. A text file with the 
samples in rows is required. The first column can have the header sample, the 
second row is IFN, third is LPS, and after this are the metabolites and their 
intensities. 0 and one denote presence or absence of these stimuli (Ex: M0 is 0, 
0; IFN is 1, 0; LPS is 0, 1; and IFN_LPS is 1, 1). 
Supplementary Figure 4-1: Results of FACS enrichment on Aria-I. 
Supplementary File 4-1: Kegg IDs and their equivalent metabolite name. Note 
that for metabolites without existing Kegg IDs, an arbitrary name was chosen 
(i.e., Nokegg1). This is for non-FACS-sorted samples. 
Supplementary File 4-2: Input file as used for analysis of MetaboAnalyst (ANOVA 
and PCA). This is for non-FACS-sorted samples. 
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Supplementary File 4-3: Results of ANOVA and multiple comparisons are shown. 
This is for non-FACS-sorted samples. 
Supplementary File 4-4: Kegg IDs and their equivalent metabolite name. Note 
that for metabolites without existing Kegg IDs, an arbitrary name was chosen 
(i.e., Nokegg1). This is for FACS-sorted samples. 
Supplementary File 4-5: Input file as used for analysis of MetaboAnalyst (ANOVA 
and PCA). This is for FACS-sorted samples. 
Supplementary File 4-6: Results of ANOVA and multiple comparisons are shown. 
This is for FACS-sorted samples. 
Supplementary Table 4-1: 26 genes unique to the LRT, DE (p adjusted (LRT) 
<0.5) genes, the Venn subset information, Log2 fold change, normalised counts 
and gene description are available. 
Supplementary Table 4-2: Same information as Supplementary Table 4-1 but 
the Log2 fold change revers to HV vs M0. 
Supplementary Table 4-3: Overlap between current study and Fernandes et al 
2016 (Figure 4-9), Rabhi et al 2012. 
Supplementary Table 4-4: Detailed results of SPIA analysis as conducted on 
Graphite. 
Supplementary File 5-1: Full results of Phyre2 analysis are presented in this file. 
Supplementary File 5-2: Kegg IDs and their equivalent metabolite name. Note 
that for metabolites without existing Kegg IDs, an arbitrary name was chosen 
(i.e., Nokegg1).  
Supplementary File 5-3: Input file as used for analysis of MetaboAnalyst (ANOVA 
and PCA).  
Supplementary File 5-4: Results of ANOVA and multiple comparisons are shown.  
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Supplementary Figure 5-1: Alignment of ADI from Mycoplasma arginini, 
Mycoplasma hominis, Clostridium perfringens, Pseudomonas aeruginosa and 
Pseudomonas putida with Lmxm.08.1225.  Purple represent key conserved 
sequence motifs among ADIs. Green are residues involved in binding of the 
substrate and/or catalysis. 
Supplementary Figure 5-2: Phylogenetic analysis of all Lmxm.08.1225 
alongside ADI genes, all DDAH genes with human NOS2 set as an out-group. 
Supplementary Figure 5-3: A and B are results of 2’5’ ADP agarose) 
chromatography purification. A: Elutions are as described in methods. B: Results 
of subsequent anion exchange chromatography. Elutions are as described in 
methods. Most abundant proteins are highlighted. 
Supplementary Figure 5-4: Comparison of the authentic standards for both L 
argininic acid and L-citrulline (100µM each). 
Supplementary Figure 5-5: Comparison of the L-citrulline and L-argininic acid 
levels in fresh and spent medium samples. 
Supplementary Figure 5-6: Results of MTT assay was first used to ensure that 
compounds (L-pipecolic acid and L-argininic acid) were not toxic at levels tested 
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